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Abstract 
 
Treatments with natural products rich in anti-oxidants have attracted remarkable 
interest in the cosmetic and pharmaceutical industry to combat oxidative stress and 
reverse the effects of ageing.  Rooibos (Aspalathus linearis) is a South African 
fynbos plant, well-known for its strong anti-oxidant capacity and use in many 
cosmetic products.  However, little published research exists on its potential as an 
anti-ageing treatment. The anti-ageing properties of fermented and green rooibos 
were investigated using an in vitro cell culture model designed to evaluate the 
involvement of mitochondrial dysfunction in the age related decline in preadipocyte 
function.  Mitochondrial DNA (mtDNA) deficient preadipocytes, ρ0 3T3-
L1preadipocytes, were generated following continuous long-term exposure to sub 
lethal concentrations of ethidium bromide (EtBr). Depletion of the mtDNA resulted in 
a significantly reduced mitochondrial membrane potential, rate of proliferation in 
culture, as well as an increased glucose utilization and lactate production. Treatment 
with the green rooibos (100 µg/mL) stimulated cell growth rates for both the wildtype 
and mutant cell lines.  MtDNA depleted cells showed arrest in the G1 phase (48.8 ± 
3.34%) compared to wildtype cells (44.6 ± 1.38%), which was significantly attenuated 
after treatment with green rooibos for mutant (42.0 ± 0.83%) and wildtype  (36.5 ± 
5.80%) treated cells.  The results obtained for glucose utilization and lactate 
production, indicated a significant increase in glucose utilization along with a 
concomitant increase in lactate production after treatment with both green and 
fermented rooibos for wildtype and mutant cell lines.  A significant improvement in 
mitochondrial membrane potential was also later observed after treatment with green 
and fermented rooibos on both the wildtype and mutant cell lines.  The results 
obtained indicate that rooibos extracts, particularly the green rooibos, exhibit effects 
which preserve the functional capacity of preadipocytes exposed to ageing related 
insults, and indicate that rooibos could cause a metabolic shift in cells redirecting 
carbon flow away from mitochondrial metabolism, and towards lactate production and 
consequently, cells become resistant to mitochondrial dysfunction.   
Keywords: ageing, preadipocytes, rooibos, mitochondrial dysfunction. 
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CHAPTER 1: Research rationale, aims and objectives 
 
The natural process of ageing in multicellular organisms is associated with the 
progressive accumulation of deleterious changes in the functional capacity of 
biological systems, which subsequently leads to an exponential decrease in the 
ability of cells to maintain homeostasis and ultimately increases the probability of 
death (Lui et al., 2010; Ashok & Ali, 1999; Sohal et al., 2002).  Numerous molecular 
pathways have been identified in the ageing process however, apart from 
improvements in the longevity of model organisms such as mice and worms, and the 
fact that these pathways seem to be conserved in humans, no real advancements 
have been made in the field of anti-ageing.  Nonetheless humans are living longer 
than ever, and it is predicted that by 2050 the number of people aged 65 years and 
older, will far exceed the number of younger people, which has numerous social, 
political and economic implications (Fontana et al., 2014).   
 
Although population statistics reveal that South Africa has a relatively young 
population, with 48.5% of the population under 24 years of age and 38.2% between 
the ages of 25 – 54, and that the average life expectancy has increased from 52.7 
years in 2002 to 59.6 in 2013, the occurrence of age related diseases such as heart 
disease, diabetes, and neurodegenerative diseases has shown an even greater 
increase (Stats SA, 2014; The World Factbook, 2013).  Ultimately, research into the 
ageing process is not aimed at increasing the lifespan of our species, but to rather 
increase the quality of life in ageing populations.          
 
The free-radical hypothesis first proposed by Denham Harman in 1956 (Harman, 
1956) is currently considered as the most accepted, and most widely tested theory of 
ageing.  Since then, it has evolved and been modified to include the concept of 
oxidative stress, and therefore it is now believed that the process of ageing is 
induced at least in part, by an imbalance between endogenous reactive oxygen 
species (ROS) and anti-oxidant defences (Calabrese et al., 2011).  Treatment with 
anti-oxidants such as vitamin C, -E and polyphenols have been shown to be effective 
in improving resistance to oxidative stress, and subsequently prevent or improve 
cellular ageing (Masaki, 2010; Queen & Tollefsbol, 2010; Baret et al., 2013).   
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Therefore it is not surprising that natural products rich in anti-oxidants have attracted 
remarkable interest in the cosmetic and pharmaceutical industry for its potential to 
restore and reverse the effects of ageing.   
 
Rooibos (Aspalathus linearis) is a South African fynbos plant, well-known for its 
strong anti-oxidant capacity, yet little published research exists on its precise 
molecular and cellular involvement against ageing.  Recent studies have 
demonstrated that preadipocytes lose their ability to replicate and differentiate during 
ageing (Zamboni et al., 2014).  Therefore it is possible that preventing preadipocyte 
dysfunction may slow down or even reverse age related adipose dysfunction and its 
associated risks.   
 
The aim of this study was to investigate the potential anti-ageing properties of 
rooibos using an in vitro cell culture model and molecular mechanisms involved in the 
ageing process.   
 
To meet the aims of this study, the objectives were:  
 
 To establish an in vitro cell culture model representative of the age related 
decline in preadipocyte function.   
 To characterise the biochemical indicators of the ageing cell culture model 
relative to normal cells. 
 To determine the effects of rooibos on the biochemical indicators defined 
in the ageing and normal cell models. 
 To provide evidence to substantiate the anti-ageing properties or Rooibos 
beyond that of its already known anti-oxidant capacity. 
 
Overview of chapters 
 
Key concepts, such as characteristics of ageing, adipose tissue and its involvement 
in ageing, as well as an overview of plant phenolic compounds, their associated 
health benefits and involvement in the ageing processes are reviewed in Chapter 2.   
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Chapter 3 provides a comprehensive description of all the principles and other 
background information relating to the methods used in this study, including: cell 
culture conditions, experimental principles, as well as a brief overview of flow 
cytometry which was primarily used throughout this study.  Chapter 4 describes the 
development and characterisation of the mtDNA depleted ρ0 3T3-L1 preadipocyte 
cell line as an in vitro cell culture model representative of mitochondrial dysfunction 
observed in preadipocytes during the ageing process.  The ρ0 and wildtype 3T3-L1 
preadipocytes were then used, as described in Chapter 5, to determine the in vitro 
effects of green and fermented rooibos extracts on mitochondrial dysfunction through 
parameters such as: cell growth, mitochondrial membrane potential and metabolic 
parameters.  Chapter 6 summarizes the findings of this study and describes 
considerations for its improvement.  Prospective for future studies are also 
presented.   
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CHAPTER 2: Introduction to this study 
 
2.1 Ageing process 
 
2.1.1 Introduction 
 
The natural process of ageing in multicellular organisms is associated with the 
progressive accumulation of deleterious changes in the functional capacity of 
numerous biological systems, including cellular function (Lui et al., 2010).  This 
subsequently leads to an exponential decrease in the ability of cells to maintain 
homeostasis, increasing the probability of disease and ultimately death (Lui et al., 
2010; Ashok & Ali, 1999; Sohal et al., 2002).  Even though humans have arguably 
been around for thousands of years, no real advancements have been made to 
improve the maximal lifespan of our species, or at least slow down the detrimental 
effects of ageing, whether it is related to our physical appearance (sagging skin, 
wrinkles, hair loss etc.) or age related diseases such as osteoporosis, diabetes, 
cancer, cardiovascular diseases, and neurodegenerative diseases such as 
Alzheimer’s and Parkinson’s (Lui et al., 2010; Calabrese et al., 2011).  
 
The fundamental reason for this lies in the fact that the ageing process is extremely 
complex, and even though hundreds of theories have been proposed to explain the 
phenomenon of ageing, it is clear that not one specific theory or concept adequately 
describes the complete physiology and mechanisms of ageing in humans (Ashok & 
Ali, 1999).  Currently the most accepted and widely tested theory of ageing is based 
on the free-radical hypothesis first proposed by Denham Harman in 1956 (Harman, 
1956).  Gradually, the free radical hypothesis has evolved and been modified to 
include the concept of oxidative stress, and therefore it is now believed that the 
process of ageing is induced by an imbalance between endogenous reactive oxygen 
species (ROS) and anti-oxidant defences, consequently allowing the accumulation of 
structural damage from free-radical reactions (Calabrese et al., 2011; Ashok & Ali, 
1999; Sohal et al., 2002).   
 
5 
 
2.1.2 Reactive oxygen species (ROS) 
 
ROS such as superoxide (O2¯
˚), hydrogen peroxide (H2O2) and peroxynitrite 
(ONOO¯), can be defined as ubiquitous, highly reactive molecules that are 
continuously derived both exogenously through environmental factors (environmental 
pollutants, solar radiation, physical stress etc.) and endogenously as by-products of 
normal cellular pathways through:     
 
 Mitochondria: by product of aerobic respiration through oxidative 
phosphorylation (Chapter 4), 
 Endoplasmic reticulum (ER): cytochrome P450 catalytic cycle in which 
enzymes generate ROS in order to metabolize and degrade hydrophobic toxic 
substances, steroids, drugs etc., 
 Phagocytes: produce ROS as a defensive response to infectious 
microorganisms, bacteria- and virus-infected cells, cancer cells etc.,   
 Peroxisomes: by product of oxidative metabolic processes such as fatty acid 
β-oxidation, 
 Enzymatic reactions: by-products of oxygenases such as lipo-oxygenase and 
COX, as well as oxidases such as NADPH- and xanthine oxidase (Barbieri et 
al., 2003; Le Bras et al., 2005; Núñez-Sellés, 2005; Alfadda & Sallam, 2012).    
 
At low concentrations, these small, rapidly diffusing molecules play a vital role as 
second messengers in numerous intracellular signalling pathways including: 
regulation of cell growth, differentiation, proliferation, cell death through apoptosis or 
necrosis, induction or suppression of gene expression (AP-1, NF-κB transcription 
factors), activation of cell signalling pathways (MAPK, Erk and guanylyl cyclase), 
energy production, as well as phagocytosis and defence against invading pathogens 
(Page et al., 2010; Le Bras et al., 2005).  At slightly more elevated levels however, 
ROS initiates pathways for the adaptation to stress,  and at even higher levels ROS 
can result in cell death or senescence (Chandel, 2014).   
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The activity of ROS is tightly regulated by intracellular anti-oxidants through 
preventive, repairing and scavenger mechanisms using enzymatic (superoxide 
dismutase, catalase and glutathione peroxidase) and non-enzymatic (methionine, 
glutathione, melatonin, albumin, myoglobin etc.) anti-oxidant molecules (Núñez-
Sellés, 2005; Le Bras et al., 2005).    
 
An imbalance between ROS and anti-oxidant defences, associated with excessively 
high levels of ROS, leads to a state of oxidative stress, promoting damage to DNA, 
proteins and lipids. 
 
2.1.3 The role of mitochondria in ageing  
 
Given the damaging effects of ROS, together with the fact that mitochondria are the 
primary source of endogenous ROS, the free radical theory was extended to include 
the role of mitochondria in the ageing process, as described by D. Harman in “The 
biologic clock: the mitochondria?” (1972).  Decades of research into the involvement 
of mitochondria in the ageing process ensued, and the mitochondrial free radical 
ageing theory is supported by several lines of evidence including:   
 
 Mitochondrial ROS production increases with age, and is associated with a 
decline in mitochondrial function,  
 The activity of several ROS-scavenging enzymes declines with age 
 Mutations of mitochondrial DNA (mtDNA) accumulate during ageing, 
 Injection of chemically uncoupled or aged mitochondria reduces cellular 
function in young cells, 
 Reduced mtDNA damage and extended lifespans have been observed in 
knock-in mice with catalase overexpression localized to the mitochondria,  
 Caloric restriction reduces mitochondrial ROS production, mtDNA damage 
and extends lifespan (Seo et al., 2010; Benz & Yau, 2008; Lauri et al., 2014; 
Bratic & Larsson, 2013) 
 
Considerable evidence challenging this theory has also been presented, and is 
discussed in Chapter 4.    
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Numerous studies have shown that treatment with anti-oxidants such as vitamins A, C 
and E, and various polyphenols, are effective in improving resistance to oxidative 
stress and subsequently prevent or improve cellular ageing and age related diseases 
(Masaki, 2010; Queen & Tollefsbol, 2010; Baret et al., 2013).  It is therefore not 
surprising that anti-oxidant properties of natural products rich in anti-oxidants have 
attracted tremendous interest in the cosmetic and pharmaceutical industry for its 
potential to restore and reverse the effects of ageing.   
 
 
2.2 Adipose tissue and ageing 
 
2.2.1 Introduction 
 
Adipose tissue is one of the largest organs in the human body, and apart from its 
primary energy storing function, it is also involved in immune and endocrine functions, 
thermoregulation, mechanical protection, and tissue regeneration (Tchkonia et al., 
2010).  A correlation between adipose tissue and mechanisms involved in longevity, 
age-related diseases, inflammation, and metabolic dysfunction has been established 
(Tchkonia et al., 2010; Sepe et al., 2011). Adipose mass and tissue distribution 
change dramatically throughout life. In old age, adipose tissue becomes dysfunctional 
and is redistributed from subcutaneous to intra-abdominal visceral depots as well as 
other ectopic sites, including bone marrow, skeletal muscle, heart, pancreatic β cells 
and the liver (Sepe et al., 2011; Heilbronn et al., 2004).   
 
The loss of subcutaneous adipose tissue predisposes to the development of altered 
cosmetic appearance (wrinkles, sunken eyes, skin folds), whereas the accumulation of 
visceral adipose tissue is associated with increased risk of age related diseases, 
including those encompassed by the metabolic syndrome such as: diabetes, 
hypertension, cancer, cognitive dysfunction, and atherosclerosis leading to heart 
attacks and strokes (Tchkonia et al., 2010)  Since adipose cell size and number are 
related to insulin sensitivity, glucose and fatty acid uptake, and cytokine release, 
changes in function and cellular composition of fat tissue might lead to changes in 
metabolic state and subsequent clinical complications (Cartwright et al., 2007).  
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The age-related decline in adipose tissue depot size is a result of decreased 
adipocyte size and not a decrease in cell number, since new cells appear to be 
formed throughout the lifespan and fat cell number remains constant or increases in 
old age (Cartwright et al., 2007; Kirkland et al., 2002).   
 
2.2.2 Regulation of adipogenesis 
 
The formation of new adipocytes in adult tissues is a complex process, starting with 
the adipogenic commitment of mesenchymal precursor cells and ending in their 
terminal differentiation into metabolically active lipid laden adipocytes (Figure 2.1) 
(Cartwright et al., 2007). 
 
 
Figure 2.1: Diagram illustrating the process of adipocyte formation (Cartwright et al., 
2007).  Preadipocyte differentiation is initiated through exposure to nutrients, hormonal 
effectors such as insulin, glucocorticoids and IGF-1, as well as paracrine and autocrine 
effectors, including free fatty acids and cyclic AMP, which activate pathways that modulate 
the expression and activity of a set of adipogenic transcription factors, which subsequently 
impacts the expression of numerous downstream differentiation dependent genes 
(Cartwright et al., 2007) 
 
Preadipocytes (adipocyte progenitor cells) account for 15 – 50% of all adipose tissue 
cells, and are capable of strongly influencing adipose tissue function (Cartwright et 
al., 2007).  The process of preadipocyte differentiation is commenced after exposure 
to nutrients, hormonal effectors such as insulin, glucocorticoids, paracrine and 
autocrine effectors, including free fatty acids and cyclic AMP (Cartwright et al., 2007; 
Unger, 2005).  
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These signals subsequently activate pathways that modulate the expression and 
activity of adipogenic transcription factors, which ultimately affect the expression of 
thousands of downstream differentiation-dependent genes.  It has been shown that 
extensive changes in preadipocyte function occur with ageing, including a decreased 
capacity to replicate and differentiate (Tchkonia et al., 2010; Cartwright et al., 2007) 
and that these age-dependent cell dynamic features are specific and inherent to the 
ageing preadipocyte.  Reduced adipogenesis contributes to fat cell dysfunction, 
reduced fat depot size, and redistribution of fat to non-adipose tissues (Cartwright et 
al., 2007). 
 
Although the precise mechanism responsible for this age associated decline in 
preadipocyte function remains to be established, it has been suggested that factors 
which are likely to contribute include oxidative stress, hypoxia and mitochondrial 
dysfunction, and inflammation (Tchkonia et al., 2010; Sepe et al., 2011).   
 
Therefore, considering the central role of mitochondria in the ageing process, as well 
as its involvement in preadipocyte dysfunction, the primary aim of this study was to 
develop an in vitro cell culture model, representative of mitochondrial dysfunction 
associated with the age related decline in preadipocyte function.    
 
 
2.3  Plant phenolic compounds 
 
Plant metabolism is divided into primary and secondary metabolism.  Primary 
metabolism produces essential lipids, proteins, carbohydrates, and nucleic acids 
required for growth and development, whereas secondary metabolic pathways 
(shikimate, phenylpropanoid, and flavonoid pathways) produce metabolites such as 
alkaloids, terpenoids, and phenolic compounds, which provide unique survival or 
adaptive strategies according to the particular requirements of the plant (Giada, 
2013; Jaganath & Crozier, 2010).  An overview of the association between the 
primary and secondary metabolism in plants can be seen in Figure 2.2.      
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Figure 2.2: Overview of the association between primary and secondary metabolism in 
plants (Giada, 2013). 
 
In plants, secondary metabolites have numerous functions including: sensorial 
properties including colour, aroma, taste, astringency, as well as providing structural 
support, stress protection, natural defence against predation, assisting the 
germinative processes of seeds and subsequent development and reproduction, not 
to mention their role as signalling molecules between plants and their environment 
(Han et al., 2007; Jaganath & Crozier, 2010).    
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Apart from their functional roles in plants, secondary metabolites have gained 
increased commercial significance for their use as dyes, fibres, glues, oils, waxes, 
perfumes, flavouring agents, as well as being regarded as potential sources of new 
natural drugs, antibiotics, insecticides, and herbicides (Jaganath & Crozier, 2010).  
The important role of phytochemicals as protective dietary components has become 
a significant area of research, and numerous studies have shown that modest long-
term intake may be beneficial in the prevention or treatment of degenerative diseases 
such as cardiovascular diseases, diabetes, obesity, cancer, osteoporosis, 
neurodegenerative diseases and ageing (Scalbert et al., 2005; Jaganath & Crozier, 
2010; Kim et al., 2014).  While extensive literature is available on the proposed 
health benefits of phytochemicals, evidence-based information regarding the exact 
molecular, cellular and physiological mechanisms, as well as possible adverse or 
toxic reactions are however quite limited.   
 
Phenolic compounds constitute one of the largest and most widely distributed groups 
of phytochemicals, comprising more than 8000 isolated compounds, all of which are 
identified by a shared common structural feature, namely one or more aromatic rings 
bearing at least one hydroxyl group (Giada, 2013; Jaganath & Crozier, 2010).  
Although phenolic compounds exhibit remarkable structural diversity, they can be 
broadly categorized into flavonoids and non-flavonoid phenolic compounds.   
 
2.3.1 Flavonoids  
 
Flavonoids are widely distributed throughout nature, and are commonly located in the 
nucleus of mesophyll cells and within ROS generating centres of plants (Kumar & 
Pandey, 2013).  Unsurprisingly they have been identified as some of the most potent 
anti-oxidants in plants, and have thus been widely studied for their associated 
diversity of health benefits.  Flavonoids occur as aglycones, glycosides, and 
methylated derivatives.  Esterification with glucose or other carbohydrates 
(glycosides) increases their solubility in water, whereas methyl and isopentyl group 
substitutions result in lipophilic configurations (Han et al., 2007; Jaganath & Crozier, 
2010).  Flavonoids are structurally defined as polyphenolic compounds consisting of 
15 carbons, with 2 aromatic rings connected by a 3-carbon bridge.   
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Based on modifications of the central C-ring, further structural classifications can be 
identified including: flavonols, flavones, flavan-3-ols, flavanones, isoflavones, and 
anthocyanidins and coumarins (Table 2.1).  In an alternative arrangement, the 6-
membered heterocyclic ring C is replaced by a 5-membered ring, as is observed in 
chalcones. 
 
Table 2.1: Overview of flavonoid subclasses and commonly associated dietary sources.  
(Adapted from Han et al., 2007; Jaganath & Crozier, 2010) 
Class Compounds Dietary sources 
Flavanols 
Kaempferol 
Apples, berries, broccoli, onions, tea, 
black grapes 
Myricetin Apple, berries, tea, beans 
Quercetin 
Apples, berries, grapes, olives, raisins, 
chilli pepper, lettuce, onions, tomatoes, 
coriander, tea, oregano, sage, thyme 
Flavones 
Apigenin 
Olives, celery, parsley, marjoram, sage, 
berries 
Luteolin 
Olives, lemon, chilli pepper, oregano, 
sage, thyme, celery, red pepper, apples, 
parsley, cereals 
Flavanones 
Hesperetin Lemon, lime, orange, cumin, peppermint 
Naringenin Grapefruit, oranges, berries 
Flavan-3-ols 
 
Monomers Apples, apricots, berries, grapes, beans, 
chocolate, tea,  red wine (+)-Catechins, (+)-Epicatechin 
Polymers and oligomers 
Sour cherry, greengage plums, cherry, 
apricots  
Proanthocyanidins / 
Condensed tannins 
Anthocyanins 
Cyanidin 
Apples, berries, cocoa, asparagus, black 
grapes, red wine 
Delphinidin Pomegranate, berries, aubergine skin 
Malvidin Grape, blueberry 
Isoflavones / 
flavans 
Genistein Soybeans, black beans, peas, sprouts 
Daidzein Soybeans, black beans, peas, sprouts 
 
Dietary sources of polyphenols have received decidedly more attention over the last 
few years, which is expected considering the vast amount of epidemiological studies 
supporting the notion that a high dietary intake of fruits, vegetables and other plant 
products rich in polyphenols, is conducive towards a decreased risk of diseases such 
as cancer, neurodegenerative and cardiovascular diseases (Crozier et al., 2009; Hu, 
2011).   
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Additionally, natural compounds are often regarded as a safer alternative to 
conventional pharmaceutical drugs, and is generally also more accepted by the 
public, and more easily integrated into lifestyle changes (Kim et al., 2014).   
 
2.3.2 Non-flavonoid phenolic compounds 
 
Of most significant dietary importance are phenolic acids and the polyphenolic 
stilbenes.  Phenolic acids can be classified into two main groups namely 
hydroxybenzoic acids, containing seven carbon atoms, or hydroxycinnamic acids, 
containing nine carbon atoms.  Phenolic acids are rarely found as free acids, possibly 
due to their toxic nature, and generally form part of complex structures such as 
lignins and hydrolyzable tannins, but can also be found linked to cellulose, proteins, 
flavonoids, glucose, terpenes etc. (Jaganath & Crozier, 2010; Giada, 2013).  
Phenolic acids are abundant in nature, and known to have high anti-oxidant activities, 
especially hydroxycinnamic acid, caffeic acid and chlorogenic acid (Giada, 2013).   
 
Resveratrol is one of the most well characterised polyhydroxylated stilbenes, and is 
known to affect numerous biological processes.  Interestingly, studies have shown 
that resveratrol promotes mitochondrial biogenesis during ageing (Ungvari et al., 
2011).  Furthermore, another study combined resveratrol and the isoflavone equol, in 
a novel treatment strategy to investigate the combined effect of these polyphenols in 
the enhancement of mitochondrial biogenesis (Davinelli et al., 2013).  Their results 
indicated that co-administration of these natural products increased mitochondrial 
mass and mtDNA content through the upregulatation of mitochondrial biogenesis 
enzymes in human endothelial cells (Davinelli et al., 2013).  Therefore supporting the 
role of polyphenols in the treatment of ageing and age related diseases.     
 
2.3.3 Health benefits and mode of action 
 
The biological activity of phenolic compounds is dependent on their chemical 
structure, relating to the structural class, degree of hydroxylation, substitutions and 
conjugations, as well as the degree of polymerization (Scalbert et al., 2005).  
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These structural characteristics determine the redox potential of phenolic compounds, 
which allows them to act as reducing agents, hydrogen donors, and singlet oxygen 
quenchers, as well as influencing their ability to subsequently stabilize the scavenged 
radicals.  Phenolic compounds are able to act as anti-oxidants through several ways:    
 
 Radical scavenging through hydrogen or electron donating reactions to 
hydroxyl, peroxyl, and peroxynitrite radicals, thereby stabilizing them and 
producing a relatively stable phenolic radical,  
 Chelating metal ions such as copper (Cu) and iron (Fe) involved in the 
generation of free radicals through the Fenton reaction or related enzymatic 
reactions,  
 Direct interaction with proteins / enzymes through the hydrophobic benzenoid 
rings and hydrogen-bonding potential of the phenolic hydroxyl groups, 
subsequently inhibiting enzymes involved in free radical generation, or 
interacting with receptors and enzymes involved in signal transduction 
ultimately modulating vital intracellular signalling cascades (Scalbert et al., 
2005; Pereira et al., 2009; Jaganath & Crozier, 2010; Kumar & Pandey, 2013). 
 
The biphasic effects of polyphenols have also been identified, with many polyphenols 
exhibiting both anti- and pro-oxidant activities in vitro and in vivo (Hu, 2011, Kim et al., 
2014).  Small phenolic compounds such as quercetin and gallic acid are easily 
oxidized and exhibit significant pro-oxidant activities, whereas phenolics with higher 
molecular weights, such as condensed and hydrolysable tannins, have little or no pro-
oxidant activity (Hu, 2011).  Pro-oxidant activities are associated with increased ROS 
levels and/or modulation of endogenous anti-oxidant defences such as depletion of 
cellular GSH, resulting in enhanced oxidative damage to cellular components, and 
ROS-induced apoptosis (Hu, 2011).  The balance between anti-oxidant/pro-oxidant 
activities are said to be determined, at least in part, by oxidative status within the 
cellular environment (Joubert et al., 2005; Magcwebeba, 2013).  Considering that 
normal cells generally have a lower basal intracellular ROS level, together with 
functional anti-oxidant defence mechanisms, pro-oxidant activities would have a 
significantly reduced impact, relative to that of stressed or diseased cells with high 
intracellular ROS and ineffective anti-oxidant defences (Gibellini et al., 2010).  
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Consequently, pro-oxidant activities of phenolic compounds have attracted 
tremendous interest in chemoprevention, due to their ability to induce selective 
toxicity towards tumour cells (Scalbert et al., 2005; Jaganath & Crozier, 2010; 
Magcwebeba, 2013).   
 
Phenolic compounds are capable of exhibiting pleiotropic effects, which in 
combination provide better protection against chronic disease (Jaganath & Crozier, 
2010).  Synergistic effects of phenolics with other phenolics, and anti-oxidants such 
as vitamin C, -E, and -A have been reported, especially when anti-oxidative agents 
with different modes of action are combined in an effort to increase efficacy whilst 
minimizing toxicity (Jaganath & Crozier, 2010; Giada, 2013).  
 
Apart from the well characterized anti-oxidant and pro-oxidant activities of phenolic 
compounds, numerous other biological effects and mechanisms of action have been 
reported in association with the extensive health benefits of phenolic compounds 
including, but not limited to: anti-allergic, anti-atherosclerotic, antibacterial, 
antidiabetic, anti-inflammatory, antimutagenic/anticarcinogenic and antiviral activity 
(Jaganath & Crozier, 2010; Kumar & Pandey, 2013).  Additionally, effects such as 
cardioprotection, endothelial protection, hepatoprotection, hormone modulation, 
immune protection and neuroprotection have also been observed (Jaganath & 
Crozier, 2010; Kumar & Pandey, 2013; Giada, 2013).   
 
In most cases, conclusive and direct experimental support is however still lacking.  
Nonetheless, although progress has been hindered by the complex mechanisms of 
action and non-specific effects due to polyphenols with pleiotropic activities, 
interactions with polyphenols and several biochemical pathways have been well 
characterised and include: modulation of the NF-κB signalling pathway, upregulation 
of nuclear transcription factor erythroid 2p45 (NF-E2) related factor 2 (Nrf2), 
suppression of Activator protein-1 (AP-1), induction of MAPK signalling, etc. (Scalbert 
et al., 2005; Hu, 2011; Kim et al., 2014).  Therefore this provides countless new 
opportunities to further investigate the potential of polyphenols in the treatment of 
disease.       
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CHAPTER 3: Methodology 
 
This chapter provides a description of all the principles and other background 
information relating to the methods used in this study.  Detailed methods and 
materials information are described in the relevant chapters.  A comprehensive 
materials list can be found in Appendix I.   
 
 
3.1 Culture conditions 
 
In this study 3T3-L1 preadipocyte cells, kindly donated by the South African Medical 
Research Council (MRC, Cape Town, South Africa), were used.  The 3T3-L1 
preadipocyte cell line is a continuous substrain of Swiss albino (3T3) mouse 
embryonic tissue fibroblasts, originally isolated by Dr. Howard Green of Harvard 
Medical School (Green & Kehinde, 1975).  Under appropriate conditions, 3T3-L1 
preadipocytes can be differentiated into adipocytes and have therefore been 
fundamental in mammalian adipogenesis and metabolic disease research specifically 
relating to diabetes and obesity (Zen-Bio, 2010).   
 
Adherent 3T3-L1 preadipocytes were routinely maintained in 10 cm culture dishes with 
Dulbecco’s modified Eagle’s medium (DMEM) containing 4 mM L-glutamine, 4.5 g/L 
glucose and sodium pyruvate, supplemented with 10% foetal bovine serum (FBS) (GE 
Healthcare Life Sciences, Logan, Utah, USA).  Constant environmental conditions 
were maintained by keeping cells in a humidified 37°C incubator continuously supplied 
with 5% CO2, which assists in maintaining the pH at physiological levels (pH 7.2 – 
7.4).  No antibiotics were added during routine maintenance, however, 1% (v/v) 
penicillin / streptomycin (P/S) (Sigma-Aldrich, St. Louis, MO, USA) was added to long 
term experiments exceeding 5 days.  Throughout experimental procedures cells were 
seeded during log phase, at a density of 20 000 cells/mL, unless otherwise stated, in 
appropriate culture vessels – as indicated by the requirements for each experiment.  
Cells were left overnight to attach and recover before exposure to treatments.  
Cultures were routinely observed using an Axiovert 40C inverted microscope (Carl 
Zeiss, Göttingen, Germany) with phase contrast.  Whenever necessary, photographs 
were taken using a PowerShot A640 digital camera (Canon, China).  
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3.2 Endotoxin analysis 
 
Endotoxin is a lipopolysaccharide (LPS) component of the outer cell membrane of 
gram-negative bacteria.  LPS consists of a hydrophilic polysaccharide tail, comprising 
a core polysaccharide and a repeating O-specific polysaccharide region (O-antigen), 
covalently bound to a highly conserved hydrophobic lipid group (lipid A) (Figure 3.1) 
(Ryan, 2008; Zu et al., 2009).   
 
 
Figure 3.1: Basic structure of LPS produced by gram negative bacteria (Ryan, 2008).  
The molecular weight ranges from 3000 – 40 000 Daltons according to the size of the highly 
variable O-specific polysaccharide side chains.  Lipid A is the active moiety responsible for 
most of its biological effects (Dawson, 1998; Ryan, 2008).        
 
Lipid A anchors LPS to the bacterial membrane, and is the active moiety responsible 
for most of its biological effects through the interactions of its fatty acid chains with 
lipid membranes and hydrophobic regions of proteins, as well as its phosphate 
groups that react with cationic proteins (Dawson, 1998; Ryan, 2008). The O-antigen 
elicits specific antigenic responses in humans due to its high variability between and 
within bacterial species, ultimately providing immunity against gram negative 
infections (Ryan, 2008; Zu et al., 2009).  These amphipathic molecules are classed 
as pyrogens due to their ability to induce an intense immune response, most 
commonly a fever, upon injection or infection of a mammalian body (Dawson, 1998; 
Sandle, 2012).     
 
The effects of endotoxins on in vitro cell functions and growth vary greatly depending 
on the culture conditions, as well as the cell type and specific cell line (Ryan, 2008).  
Adipocytes are particularly sensitive to LPS and other factors such as tumour 
necrosis factor-α (TNF-α), interleukin-6 (IL-6), and interferon-γ (IFN-γ) (Chirumbolo et 
al., 2014). 
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This is due to the fact that apart from its primary energy storing function, adipose 
tissue also forms an integral component of the innate immune response, mediated 
primarily through highly conserved pattern recognition receptors such as toll-like 
receptors (TLRs) (Schäffler & Schölmerich, 2010; Tchkonia et al., 2010).  Adipocytes 
constitutively express toll-like receptor 4 (TLR4), which can be activated by the lipid A 
moiety of LPS, resulting in: 
 
 Lipolysis through the stimulation of MEK1/2-ERK1/2 signalling pathways, 
resulting in the up-regulation of hormone sensitive lipase and adipose 
triglyceride lipase expression, as well as down-regulating and phosphorylating 
perilipins, which coat lipid droplets in adipocytes (Zu et al., 2009; Cullberg et 
al., 2014).     
 Insulin resistance and inflammation.  Activation of TLR4 not only stimulates 
the secretion of proinflammatory adipocytokines such as monocyte 
chemoattractant protein-1 (MCP-1), a key regulator of macrophage 
recruitment, but also up-regulates toll-like receptor 2 (TLR2) expression (Lin et 
al., 2000; Ajuwon et al., 2009; Quintero-Fabián et al., 2013; Cullberg et al., 
2014).  TLR2 recognizes multiple ligands and induces a chronic inflammatory 
state through the expression of IL-6 and down-regulation of adiponectin 
receptors 1 and 2 in adipocytes (Lin et al., 2000; Ajuwon et al., 2009).  
Perhaps most importantly is the increased nuclear factor-kappa B (NF-κB) 
signalling and expression of inflammatory cytokines such as TNF-α and IL-6 
(Berg et al., 2004; Song et al., 2006; Quintero-Fabián et al., 2013; Chirumbolo 
et al., 2014).  TNF-α directly impairs insulin sensitivity and stimulates lipolysis, 
whereas IL-6 inhibits insulin action through the inhibition of insulin receptor, 
insulin receptor substrate-1, and glucose transporter type 4 expression 
(Harkins et al., 2004; Song et al., 2006).  Furthermore, LPS can induce 
increased IL-6 production through several other signalling pathways including: 
JNK, ERK, inhibitory G protein and PKC mediated processes (Ajuwon et al., 
2009; Quintero-Fabián et al., 2013). 
 
Small amounts of LPS are constantly released into the environment during bacterial 
cell division, and upon cell death and lysis, all of the associated LPS is liberated into 
the environment (Ryan, 2008; Sandle, 2012).   
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Additionally, when considering that endotoxins are heat stable, and unaffected by 
standard steam sterilization and submicron filtration (0.20 µm) techniques, the 
importance of endotoxin testing in the medical and pharmaceutical industry, as well 
as cell culture experiments, becomes clear (Ryan, 2008; Sandle, 2012).   
 
Endotoxin concentrations were measured using the Pierce® Limulus Amebocyte 
Lysate (LAL) Chromogenic Endotoxin Quantitation Kit (Thermo Scientific, Logan, 
Utah, USA) capable of detecting endotoxin levels as low as 0.1 endotoxin unit 
(EU)/mL or ± 0.01 ng endotoxin/mL.  The principle of this assay (Figure 3.2) is based 
on the activation of the proenzyme Factor C, found in circulating amebocytes of the 
horseshoe crab Limulus Polyphemus (Thermo Scientific, 2013).  Upon interaction 
with endotoxins, the proteolytic activity of factor C is activated, allowing the 
subsequent proteolysis of a synthetic peptide substrate to release p-nitroaniline 
(pNA) (Thermo Scientific, 2013).  The amount of endotoxin is then quantified as a 
function of the amount of yellow coloured pNA produced.  A standard curve is 
constructed using an endotoxin standard of known concentration derived from E. coli 
strain O111:B4 in order to determine the exact concentration of endotoxin present in 
the sample.           
 
 
Figure 3.2: Diagrammatic illustration of the principle of the Pierce
®
 LAL Chromogenic 
Endotoxin Quantitation Kit (Thermo Scientific, 2015).  Activation of the proenzyme factor 
C through the interaction with endotoxins is followed by the cleavage of a synthetic peptide 
linked to p-nitroaniline (pNA).  The coloured pNA product is quantified as a function of the 
concentration of endotoxin.   
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3.3 Cell counts and viability 
 
Cell numbers and viability were routinely monitored using an automated cell counter, 
Luna™ (Logos Biosystems, Inc., Korea).  Luna™ utilizes trypan blue exclusion to 
distinguish between viable and non-viable cells, as well as numerous mathematical 
algorithms to identify debris and cell clusters.  Parameters such as cell number (total, 
live and dead), % viability and average cell size can therefore be determined 
simultaneously for each sample.   
 
 
Figure 3.3: Chemical structure of trypan blue (Sigma-Aldrich, 2015c).  Trypan blue is a 
cell membrane impermeable dye that is excluded from healthy, viable cells but can enter 
cells with compromised cell membranes (non-viable cells).   
 
The trypan blue exclusion assay is a common cell culture technique used to estimate 
the number of viable and non-viable cells.   Living cells have an intact cell membrane 
and can exclude the dye from the cytoplasm, whereas dead cells have a damaged 
cell membrane thereby allowing trypan blue (Figure 3.3) to enter the cytoplasm 
where it will bind to intracellular proteins and stain the cell blue (Strober, 1997).  Blue 
stained and unstained cells are clearly discernible under a light microscope and can 
be used in conjunction with a haemocytometer to estimate viable and non-viable cell 
numbers.   
 
 
3.4 Cell viability, cytotoxicity and IC50 determination 
 
The CellTiter-Blue™ cell viability assay (Promega, Madison, WI, USA) provides a 
sensitive fluorometric method to evaluate changes in cell viability and / or 
proliferation.  This assay measures the metabolic activity of cells through the 
reduction of the blue redox indicator dye resazurin, to a highly fluorescent pink dye 
resorufin (Figure 3.4) (Promega, 2013).   
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Nonviable or growth arrested cells will rapidly lose their metabolic activity and will be 
unable to reduce resazurin, whereas healthy, viable cells will easily metabolize the 
dye.  The concentration of the fluorescent resorufin end product released into the 
culture medium can be quantified at 540 nm (Ex) / 590 nm (Em) and is directly 
proportional to amount of viable cells. 
 
 
Figure 3.4: Illustration of the principle reaction in the CellTiter-Blue
™
 cell viability 
assay (Promega, 2013).  In metabolically active cells, resazurin is reduced to highly 
fluorescent resorufin.   
 
Cytotoxicity describes the ability of a compound to produce a change in cell viability 
or proliferation, in which case an IC50 value, which represents the compound or 
extract concentration required to inhibit cell viability by 50%, would be determined.   
 
 
3.5  Flow cytometry 
 
3.5.1 Introduction 
 
Flow cytometry can be described as the process of measuring characteristics such 
as the relative size, internal complexity and fluorescence intensity of cells or particles 
in a fluid suspension, based on the way in which the cell or particle scatters incident 
light and emits fluorescence (BD Biosciences, 2000; Ormerod, 2000).   
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What sets flow cytometry apart from other traditional quantitative / semi-quantitative 
methods such as radioisotope assays, ELISAs, and Western Blots is the fact that 
instead of providing an average measurement for the entire sample population, it 
provides a fast and sensitive method to perform a wide variety of analyses on 
heterogeneous, whole cell suspensions and delivers detailed quantitative and 
qualitative information on each individual cell / particle in the sample (Leslie, 2006; 
Ormerod, 2000).  
 
 
Figure 3.5: Diagram illustrating the light-scattering characteristics of a cell (BD 
Biosciences, 2000).  Forward-scattered light is proportional to the surface area or cell size, 
whereas side-scattered light is proportional to granularity or internal complexity.     
 
As illustrated in Figure 3.5, light scatter measurements are made with regards to 
forward-scattered (FS) light, which is proportional to the cell / particle surface area or 
size, as well as side-scattered (SS) light – indicating changes in refractive index 
along any interface within the cell / particle, which is proportional to granularity or 
internal complexity (BD Biosciences, 2000; Ormerod, 2000).  The overall shape and 
surface topography also contributes to the total light scatter (BD Biosciences, 2000).   
 
Correlated FS and SS measurements can identify different cell types within a 
heterogeneous cell population, such as allowing individual populations of 
lymphocytes, monocytes and neutrophils to be identified within a lysed whole blood 
sample (Leslie, 2006).  Variations in FS and SS can also indicate changes in cell 
viability due to cell shrinkage and fragmentation, as well as cell activation and 
proliferation, accompanied by an increase in both FS and SS (Leslie, 2006).  
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In addition to FS and SS data, a wide range of fluorophores are also available and 
can be used to either directly estimate cellular parameters such as: nucleic acid 
content, enzyme activity, calcium flux, membrane potential, and pH, or it can be 
conjugated to ligands, polyclonal, and monoclonal antibodies to measure the density 
and distribution of cell-surface markers, cytoplasmic components, receptors etc. 
(Ormerod, 2000; Leslie, 2006).  Furthermore fluorescent probes with similar 
excitation wavelengths but different emission wavelengths can be used 
simultaneously to allow concurrent detection of numerous factors (Ormerod, 2000; 
Brown & Wittwer, 2000). 
 
3.5.2 Flow cytometer 
 
Generally, a flow cytometer design involves fluidic, optic, and electronic systems.  
Within the fluidics system the sample is injected into a pressurised stream of liquid, 
known as sheath fluid, which accelerates the particles and restricts them to the 
centre of the stream.  This keeps the sample core separate but parallel to the sheath 
fluid stream through a process known as hydrodynamic focussing.  One by one the 
particles will pass though the flow cell where any particle within 0.2 – 150 μm will be 
detected by the optics system, which consists of lasers to illuminate and excite the 
particles, as well as optical filters to direct the resulting light signals to the appropriate 
detectors (BD Biosciences, 2000).  The scattered light is collected, and through a 
combination of beam splitters and filters, the fluorescent light is collected at 
appropriate detectors.  The electronics system converts the detected light signals into 
electronic signals which will be processed by the computer, to ultimately provide list 
mode (event by event) data that occurred within the sample.    
 
In this study a Beckman Coulter Cytomics FC500 Flow Cytometer (CA, USA) was 
used.  The FC500 is a bench top instrument equipped with a quartz-cuvette flow cell 
employing a vertical (upwards) flow path for better hydrodynamic focusing.  An air-
cooled argon-ion laser (488 nm), as well as a solid state red diode laser (635 nm) is 
available, together with 5 high sensitivity photomultiplier tube (PMT) detectors 
ranging in sensitivity from 185 – 900 nm (Beckman Coulter, 2010).   
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Using interchangeable optical filters, 5 different colours within specific fluorescent 
light (FL) channels can be detected:  
 
 FL1: Green (525 nm) 
 FL2: Yellow (572 nm) 
 FL3: Orange (620 nm) 
 FL4: Red (675 nm) 
 FL5: Long wavelength red (755 nm)    
 
3.5.3 Data collection and analysis 
 
The light scatter and fluorescence parameter values measured for each event, is 
recorded in the exact order in which the cell / particle passed thought the 
interrogation point (laser beam), and collected into a list mode file (BD Biosciences, 
2000).  This data can then be represented as single and dual parameter plots 
although, if required, 3 parameter plots can be developed using specialized software 
applications.   
 
A single parameter plot, also known as a histogram, displays the number of events 
detected as a function of its intensity, and is generally used to obtain quantitative 
data about a particular marker (Figure 3.6, left) (Leslie, 2006).  Dual parameter or dot 
plots on the other hand coordinate two parameters such as FS and SS, with each cell 
represented as a single dot, thereby allowing the identification and quantification of 
individual sub-populations within a heterogeneous sample (Figure 3.6, right) (Leslie, 
2006).   
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Figure 3.6: Examples of single and dual parameter plots obtained from flow cytometric 
analysis of blood leukocytes.  A histogram illustrating the fluorescence intensity 
distribution of blood leukocytes stained with a B cell marker (left), accompanied by the dual 
parameter plot correlating the FS and SS characteristics of the leukocytes (right) (Adapted 
from Leslie, 2006). 
 
Further analysis can be performed by defining and isolating specific sub populations 
within a sample through the application of a gate or graphical boundary, thereby 
excluding all other data outside the region of interest (Figure 3.7).   
 
 
Figure 3.7: Examples of the gating selection process utilized in all flow cytometry 
analysis experiments in this study.  FS vs SS plots (left) display populations in the sample 
according to their respective size and optical homogeneity, and is used to identify the actual 
cell population.  FL3 Lin vs AUX (right) display the fluorescent signal detected in FL3 (signal 
area) as a function of the signal height, and used to exclude cell debris and doublets for cell 
cycle analysis where DNA was stained using propidium iodide.  Doublet distributions are 
shown in accordance with their respective cell cycle phase. 
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The cell population is first isolated using the FS vs SS plot according to the 
respective size and optical homogeneity of the cells (Figure 3.7, left).  Even with 
careful sample preparation cell doublets and debris can still be present, which is of 
particular importance when analysing cellular DNA content and distribution (3.6), due 
to the fact that two (or more) cells stuck together may register as a single event 
(Brotherick, 2006; Leslie, 2006; Ormerod, 2000).  For example, if both cells in the 
doublet are diploid (2N), the resultant signal will record it as a single tetraploid (4N) 
cell, which can obviously be highly misleading.   
 
The elimination of cell doublets and debris necessitates the use of a signal area vs 
signal height plot (FL3 Lin vs AUX) (Figure 3.7, right).  When the cell passes through 
the laser beam, a signal is generated based on the maximum fluorescence given out 
by the cell (signal height), the total amount of fluorescence emitted (signal area), and 
the time it takes the cell to pass though the laser beam (signal width) (Brotherick, 
2006).  These characteristics are easily discernible for a cell that is about to divide 
compared to two cells stuck together, in that a doublet will produce a signal of the 
same total fluorescence emitted (signal area), but at a lower intensity (signal height) 
over a longer period (signal width) (Brotherick, 2006).  This becomes even more 
discernible when doublets consist of cells with varying DNA content, as is illustrated 
in Figure 3.5, where G1 + G1 (2N + 2N), G1 + S (2N + >2N), G2 + G1 (4N + 2N), as 
well as larger clump distributions are shown.   
     
3.5.4 Applications of flow cytometry   
 
Besides the numerous research applications, flow cytometry also has clinical and 
diagnostic applications including, haematology (leukaemia and lymphoma 
phenotyping), immunology (transplantation rejection, immunodeficiency studies) and 
oncology (measurement of proliferation markers and DNA content distribution) 
(Brown & Wittwer, 2000).  In this study, flow cytometry was utilized in DNA cell cycle 
analysis (3.6) and mitochondrial membrane potential determination (3.7).   
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3.6 Cell cycle analysis 
 
Proliferating eukaryotic cells undergo a tightly regulated, precisely ordered sequence 
of biochemical events to grow and divide (Nelson & Cox, 2008).  This cycle of 
division (the cell cycle), consists of four active phases: gap 1 (G1), synthesis (S), 
gap2 (G2) and mitosis (M) (Figure 3.8).  Fully differentiated or quiescent cells 
essentially leave the cell cycle and may remain in the G0 phase permanently, where 
no cell division occurs.  Some G0 cells can however return to the G1 phase through 
the correct mitogenic signals (growth factors, cytokines etc.) (Koolman & Roehm, 
2005).  Diploid cells (2N) present in the G1/G0 phase will start to synthesise the 
required RNAs and proteins to pass the G1-S restriction point, after which cells are 
committed to transfer into the S phase.  During the S phase, DNA is replicated, and 
by the beginning of the G2 phase tetraploid cells (4N) are present, and will 
synthesise the remaining RNAs and proteins in preparation for M phase.  Therefore 
the amount of DNA present in each phase varies according to its function, and 
quantification thereof provides important information regarding cell cycle distribution 
and cellular activity.    
 
 
Figure 3.8: Illustration of a typical eukaryotic cell cycle (Koolman & Roehm, 2005).  
DNA is replicated during the S (synthesis) phase, and segregate to produce two daughter 
cells during the M (mitosis) phase.  Separating these two phases are the G1 and G2 (gap) 
phases, during which required cellular components are synthesised.   
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Cell cycle analysis aims to measure the DNA content distribution for a population of 
cells through the utilization of propidium iodide (PI) (Figure 3.9).  PI is a positively 
charged ionic dye and similar to trypan blue, PI is excluded from healthy, intact cells 
and can therefore also be used as an indicator of cell viability (Sigma-Aldrich, 
2015b).  For the purpose of cell cycle analysis however, cell are fixed and 
permeabilized to allow entry of PI into the cell.  PI binds to double stranded DNA in a 
specific stoichiometric ratio through intercalation with the nucleic acid bases, upon 
which a yellow fluorescence is emitted that can be quantified using flow cytometry 
(Life Technologies™, 2015). 
 
 
Figure 3.9: Chemical structure of propidium iodide (Sigma-Aldrich, 2015b).  PI is a 
positively charged ionic dye that intercalates with DNA in a stoichiometric ratio of 1 PI:  4 / 5 
base pairs, upon which PI emits a quantifiable yellow fluorescence.   
 
 
3.7 Mitochondrial membrane potential 
 
Metabolically active cells generate a mitochondrial membrane potential (ΔΨm) of ± 
150 − 180 mV through the activity of the electron transport chain during oxidative 
phosphorylation.  Fluctuations in ΔΨm impact the functioning of the mitochondria with 
respect to energy metabolism, intracellular ion homeostasis, and perhaps most 
importantly is the role of ΔΨm in the cell life – death transition (Perry et al., 2011).  
During the process of apoptosis ΔΨm collapses as a result of the formation of 
mitochondrial permeability transition pores through the activation and assembly of 
pro-apoptotic Bcl-2 family proteins in the mitochondria (Zamzami, 2000).  Changes in 
ΔΨm is therefore often used as an indicator for the energetic state of the 
mitochondria and the cell (Rottenberg & Wu, 1998; Perry et al., 2011).   
 
 29 
 
The lipophilic, cationic dye JC-1 (5,5’,6,6’-tetrachloro-1,1’,3,3’-tetraethyl-
benzimidazolylcarbocyanine iodide) (Figure 3.10) is a ΔΨm sensitive polychromatic 
probe used to detect changes in ΔΨm through fluorescence detection techniques 
such as flow cytometry, and fluorescence microscopy (Sigma-Aldrich, 2015a; Perry 
et al., 2011).   
 
 
Figure 3.10: Chemical structure of JC-1 (Sigma-Aldrich, 2015a).  The cell membrane 
permeable dye JC-1, exhibits a potential-dependent accumulation within the mitochondria.  
The more polarized (more negatively charged) the mitochondria, the more dye will 
accumulate within the mitochondria, subsequently forming red fluorescing aggregates.     
 
JC-1 molecules generally exist in a monomeric configuration and have excitation and 
emission wavelengths of 485 and 535 nm, respectively (Würthner et al., 2011).  
However, if present at a sufficiently high concentration, JC-1 monomers will undergo 
self-association in a process governed by strong intermolecular van der Waals‐like 
attractive forces, resulting in the end – to – end, stacked and parallel arrangement of 
molecules (Würthner et al., 2011).  The resulting aggregate complexes are called J-
aggregates after E. Jelley (1936) who first studied this phenomenon.  Aggregate 
formation causes a bathrochromic shift or change in the spectral band position, 
thereby shifting the absorption and emission spectrum to a longer wavelength of 520 
– 570 nm and 570 – 610 nm, respectively (Würthner et al., 2011).  J-aggregates are 
also characterized by a very small stroke’s shift, and therefore the resulting 
fluorescence exhibits a high quantum yield, ideal for analysis with fluorescence 
microscopy, etc. (Würthner et al., 2011).  The lipophilic and cationic nature of JC-1 
molecules facilitates its preferential accumulation within the mitochondria, due to the 
negative charge established by the intact mitochondrial membrane potential.   
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The accumulation of JC-1 within the mitochondria is inversely proportional to the 
ΔΨm therefore in healthy, non-apoptotic cells JC-1 will accumulate within the 
polarized (more negative) mitochondria and form J-aggregates which emit a red 
fluorescence.  Depolarized mitochondria will accumulate less JC-1 and consequently 
more dye will diffuse into the cytoplasm, where the monomeric form will emit a green 
fluorescence (Würthner et al., 2011; Perry et al., 2011).   
 
 
3.8  Mitochondrial mass determination 
 
Mitochondrial mass can fluctuate according to changes in mitochondrial functions 
during metabolism, differentiation, and cell cycle progression.  Mitochondrial mass is 
measured using ΔΨm insensitive dyes such as MitoTracker
® Green FM (Molecular 
Probes®, Life technologies, USA) (Figure 3.11).  
  
 
Figure 3.11: Chemical structure MitoTracker® Green FM (Molecular Probes®, 2008).  
MitoTracker® Green FM is a ΔΨm insensitive fluorescent probe used to determine changes in 
mitochondrial mass and morphology.       
 
MitoTracker® Green FM is a cell permeable, mitochondrion-selective carbocyanine 
dye containing a mildly thiol-reactive chloromethyl moiety (Cottet-Rousselle et al., 
2011; Pendergrass et al., 2004; Molecular Probes®, 2008).  It is essentially non-
fluorescent in aqueous solution, becoming fluorescent once accumulated within the 
lipid rich environment of mitochondria (Cottet-Rousselle et al., 2011).   
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The pH of the inner mitochondrial membrane contributes to the preferential 
accumulation of the dye within the mitochondrial membrane, where it reacts with free 
thiol groups of cysteine residues of mitochondrial proteins (Cottet-Rousselle et al., 
2011; Molecular Probes®, 2008).  Careful consideration has to be given to the fact 
that the amount of fluorescence observed correlates more with the inner 
mitochondrial membrane quantity, and may differ slightly from the full mitochondrial 
mass (Cottet-Rousselle et al., 2011).  Additionally, inner mitochondrial membrane 
topology may vary amongst different species and cell types, as well as different 
metabolic states within the same cells (Cottet-Rousselle et al., 2011).         
 
 
3.9  Metabolic assays 
 
3.9.1 Glucose utilization assay 
 
An enzymatic assay based on the method described by Trinder (1969) was used to 
estimate changes in cellular glucose utilization.  The glucose oxidase assay is a 
quantitative colourimetric assay that involves a 2 step reaction process (Figure 3.12).   
 
 
Figure 3.12: Principle of the glucose oxidase assay (Adapted from Phuoc et al., 2010).  
This two-step reaction process allows the quantification of glucose as a function of the 
concentration of N-antipyridine-p-benzoquinoneimine, which can be measured at 520 nm.  
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Firstly, glucose is oxidized by glucose oxidase to produce gluconic acid and hydrogen 
peroxide (H2O2), which subsequently reacts with phenol and 4-aminoantipyrine in the 
presence of peroxidase, to form a red-coloured quinoamine dye complex.  The 
intensity of the coloured product is directly proportional to the concentration of 
glucose, and can be measured at 520 nm.  The assay reagent was prepared as 
described in appendix II.     
 
3.9.2 Lactate production assay 
 
The lactate oxidase assay is a quantitative colourimetric assay based on the exact 
same principle as described for the glucose oxidase assay, the only difference being 
the first reaction step in which lactate is oxidized by lactate oxidase to produce 
pyruvate and hydrogen peroxide (H2O2) (Figure 3.13).  The H2O2 subsequently reacts 
with phenol and 4-aminoantipyrine in the presence of peroxidase, to form a red-
coloured quinoamine dye complex, which can be measured at 520 nm.  The intensity 
of the coloured product is therefore directly proportional to the concentration of lactate.   
 
 
Figure 3.13: Principle of the lactate oxidase assay (Adapted from Phuoc et al., 2010; 
Nelson & Cox, 2008).  This two-step reaction process allows the quantification of lactate as a 
function of the concentration of N-antipyridine-p-benzoquinoneimine, which can be measured 
at 520 nm. 
 
The assay reagent was prepared as described for the glucose oxidase reagent 
(appendix II) with the exception of glucose oxidase, which was substituted for lactate 
oxidase.   
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3.10 Data analysis and statistics   
 
Unless otherwise stated, each experiment was performed in triplicate and repeated 3 
independent times (n=3).  Standard deviation (SD) of the mean of three independent 
experiments was calculated and expressed using error bars where appropriate.  
Statistical significance was determined using the two-tailed student’s t-test where p < 
0.05 (*) and p < 0.005 (**) were considered significant.  For all flow cytometry assays, 
a minimum of 10 000 events were recorded for each sample, and data was analysed 
using FlowJo v10 software (Tree Star Inc., USA).  Cell cycle histograms and 
histogram overlays are one representative of each experiment.  Confocal microscopy 
images represent one of at least 15 images, taken during a single experiment.  Post-
acquisition processing of confocal microscopy images was performed using ZEN 
2012 software (Carl Zeiss Microscopy GmbH, 2011).  
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CHAPTER 4: Mitochondrial dysfunction 
 
4.1 Introduction  
 
4.1.1 The mitochondria 
 
Mitochondria, from the Greek mitos (thread-like) and khondros (grain or granule), are 
cellular organelles of endosymbiotic origin present in all nucleated cells (Schon et al., 
2012; Sagan, 1967; Wallace, 2005).  The number of mitochondria present in each 
cell varies according to the metabolic activity of the cell, and collectively mitochondria 
can occupy up to 25% of the cytoplasmic volume (Khan et al., 2007; Pieczenik & 
Neustadt, 2007).  Commonly described as the cell’s biochemical powerhouse, 
mitochondria produce about 90% of the required cellular ATP through oxidative 
phosphorylation.  However, its cellular involvement far exceeds ATP production 
alone.  These dynamic organelles play an essential role in the maintenance of 
cellular homeostasis through the regulation of numerous metabolic and signalling 
pathways (Alexeyev et al., 2013; Bratic & Larsson, 2013; Chandel, 2014; Nunnari & 
Suomalainen, 2012).   
 
Structurally mitochondria consist of two functionally distinct membranes.  The smooth 
outer membrane is essential in the scaffolding of signalling complexes, initiation of 
apoptosis as well as the regulated import and export of molecules (Nunnari & 
Suomalainen, 2012).  The folded inner membrane on the other hand, encapsulates 
the intermembrane space and mitochondrial matrix, respectively.  Numerous energy-
yielding metabolic pathways, including the tricarboxylic acid cycle, fatty acid β-
oxidation, glutaminolysis, branched-chain amino acid catabolism, ketogenesis, and 
pyruvate oxidation occur within the mitochondrial matrix and culminate at the inner 
mitochondrial membrane (Nunnari & Suomalainen, 2012).   
 
Residing within the inner mitochondrial membrane is the five respiratory chain 
complexes required for oxidative phosphorylation, namely complexes I – IV and ATP 
synthase (Complex V) (Figure 4.1).   
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Although frequently depicted as individual components, recent studies have shown 
that respiratory chain complexes I – IV form part of a larger supercomplex thought to 
permit easier channelling of electrons through the different complexes during 
oxidative phosphorylation (Nelson & Cox, 2008; Demine et al., 2014; Dudkina et al., 
2010).  The correct and stable assembly of such supercomplexes are essential to the 
function of the mitochondria, especially since dysfunction or absence of any one of 
the subunits can disturb the stability of the supercomplex (Demine et al., 2014; 
Dudkina et al., 2010).  
 
 
Figure 4.1:  ATP production through oxidative phosphorylation.  Electron carriers are 
oxidized by respiratory chain complexes within the inner mitochondrial membrane, prompting 
a series of sequential reactions to ultimately ensure the phosphorylation of ADP to ATP 
(Trifunovic & Larsson, 2008). 
 
 
During oxidative phosphorylation, electron carriers produced during metabolic 
reactions in the matrix, such as NADH and FADH2 donate electrons to complex I and 
II, respectively, after which electrons are sequentially transferred to complex III and 
IV, and finally donated to O2 which is subsequently reduced to H2O (Figure 4.1).  
Energy released during electron transfer is used to pump protons (H+) through 
complexes I, III, and IV, from the matrix into the intermembrane space, creating an 
electrochemical gradient across the inner mitochondrial membrane.  The electrical 
potential of -150 to -180 mV established across the inner mitochondrial membrane is 
crucial for other mitochondrial functions such as protein import and responses to 
mitochondrial dysfunction (Nunnari & Suomalainen, 2012; Trifunovic & Larsson, 
2008).   
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The proton gradient is released through the passive flow of H+ back into the 
mitochondrial matrix, through the ATP synthase complex which drives the 
phosphorylation of ADP to ATP.  Alternatively protons can enter the mitochondrial 
matrix through uncoupling proteins (UCPs), which leads to the uncoupling of 
oxidative phosphorylation and ATP synthesis (Bratic & Larsson, 2013). 
 
Mitochondria also produce the majority of endogenous reactive oxygen species 
(ROS) as a by-product of oxidative phosphorylation.  Electrons can escape the 
respiratory chain at several sites and react with O2 or other electron acceptors to 
produce free radicals.  As illustrated in Figure 4.1, complex I and III are predicted to 
be the key sites of superoxide production (Lagouge & Larsson, 2013).   
 
Superoxide (O2
¯ ˚) is the most abundant ROS in the cell, and can react with nitric 
oxide (NO) to produce a peroxynitrite (ONOO¯) anion, or be converted to hydrogen 
peroxide (H2O2) by the mitochondrial and cytosolic enzymes Mn superoxide 
dismutase (SOD) and Cu/ZnSOD, respectively  (Wallace, 2005; Lagouge & Larsson, 
2013).  H2O2 is much more stable than O2
¯ ˚ and diffuse freely throughout the cell 
(Wallace, 2005).  H2O2 can be detoxified by peroxisomal catalase and glutathione 
peroxidase (GPx) to produce water and oxygen.  Alternatively, H2O2 is converted to 
the highly reactive hydroxyl radical (OH˚) in the presence of transition metals via the 
Fenton reaction.  These ROS are highly reactive, especially hydroxyl radicals – which 
are considered to be the most damaging form of ROS.   
 
As mentioned in Chapter 2, several enzymatic and non-enzymatic defence 
mechanisms exist to scavenge ROS and thereby protect the cell from oxidative 
damage.  Consequently, an imbalance between antioxidant defences and ROS 
production leads to a state of oxidative stress, through which ROS damage can 
accumulate within cellular components including DNA with a concomitant increase in 
the rate of DNA mutations, commonly associated with ageing (Wallace, 2005).   
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Mitochondria are unique in that they contain their own genetic material, mitochondrial 
DNA (mtDNA), of which the inheritance is almost exclusively maternal (Nunnari & 
Suomalainen, 2012; Alexeyev et al., 2013).  MtDNA, originally referred to as ρ-
nucleic acid, is highly redundant with thousands of copies present in each cell (Khan 
et al., 2007; Alexeyev et al., 2013; Schon et al., 2012).  Within each mitochondrion, 
several copies of mtDNA are packaged with key mitochondrial maintenance proteins 
to form protein-DNA complexes known as nucleoids that are closely associated with 
the inner mitochondrial membrane (Taylor & Turnbull, 2005; Spelbrink, 2010; Park & 
Larsson, 2011; Chen, 2013).     
 
 
Figure 4.2:  Organization of human mitochondrial DNA.  The two strands represent the 
heavy (H) and light (L) strands.  Single letters indicate the positions of the corresponding 
tRNA genes. ND: NADH dehydrogenase genes, cyt b: cytochrome b gene, COX: cytochrome 
c oxidase genes, ATPase 6/8: ATP synthase genes 6 and 8, 12S/16S: ribosomal RNA genes 
(Spelbrink, 2010). 
 
Human mtDNA is a double-stranded, circular molecule of ± 16.6 kb that encodes 2 
ribosomal RNAs and 22 transfer RNAs, required for mitochondrial protein synthesis, 
as well as 13 polypeptides.  These polypeptides are subunits to 4 out of the 5 
mitochondrial respiratory complexes, namely: complex I (NADH dehydrogenase), 
complex IV (cytochrome c oxidase), complex V (ATP synthase), as well as 
cytochrome b which is a subunit of complex III (Alexeyev et al., 2013).   
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Interestingly, studies have indicated that mammalian mitochondria can contain over 
1500 proteins, all of which are encoded by nuclear DNA, translated in the cytoplasm 
and actively imported into the mitochondria (Nunnari & Suomalainen, 2012).  
Therefore mitochondrial activity, including mtDNA organization, replication, repair 
and transmission, is completely dependent on nuclear DNA (Chen, 2013).  The 
reasoning behind this seemingly impractical genetic distribution is unclear, but 
supposedly involves the hydrophobic nature of the mtDNA gene products, which 
would otherwise be prevented from import into the mitochondria (Park & Larsson, 
2011).  In an alternate hypothesis, it was suggested that mtDNA endured for a 
regulatory purpose and that perhaps the biogenesis of the oxidative phosphorylation 
system necessitates direct interactions between the mtDNA and respiratory chain 
subunits (Park & Larsson, 2011; Allen, 2003).   
 
The extensive amount of resources a cell must provide in order to maintain 
mitochondrial function, highlights the significance and diversity of its overall cellular 
involvement, especially when considering the increasing number of diseases 
associated with mitochondrial dysfunction (Nunnari & Suomalainen, 2012). 
 
4.1.2 Mitochondrial dysfunction 
 
Mitochondrial dysfunction relates to the impairment and / or alteration of the 
mitochondria and any of its associated functions, including inhibition of oxidative 
phosphorylation and respiration, mitochondrial network fragmentation, membrane 
depolarization, mitochondrial uncoupling or proton leak, ROS production, as well as 
the build-up of mitochondrial protein aggregates (Demine et al., 2014; Brand, & 
Nicholls, 2011; Pellegrino et al., 2012).  The consequences of mitochondrial 
dysfunction is as diverse as its cellular involvement, and it has not only been 
implicated in numerous mitochondrial diseases, but also in age-related metabolic and 
neurodegenerative diseases, as well as the process of ageing (Yakes & van Houten, 
1997; Trifunovic & Larsson, 2008; Page et al., 2010; Wallace, 2005; Park & Larsson, 
2011; Bratic & Larsson, 2013; Lagouge & Larsson, 2013).  The primary cause of 
mitochondrial dysfunction is attributed to any number of mutations in mitochondrial 
and / or nuclear DNA implicated in mitochondrial function (Park & Larsson, 2011; 
Nunnari & Suomalainen, 2012).   
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Apart from the substantial amount of somatic mutations such as point mutations, 
large-scale deletions and insertions accumulated in both the coding and control 
regions of mtDNA, quantitative changes in mtDNA are commonly identified in various 
types of solid tumours, hematologic malignancies, and age related diseases (Yu, 
2011).     
 
The mitochondrial genome is known to be more susceptible to DNA damage, with a 
reported 10 times greater frequency of mutagenesis compared to nDNA (Yakes & 
van Houten, 1997; Alexeyev et al., 2013; McInnes, 2013; Kolesar et al., 2014).  This 
is primarily attributed to the close proximity of mtDNA to the large amounts of ROS 
produced through oxidative phosphorylation (Yakes & van Houten, 1997; Wallace, 
2005).  The lack of mutation-suppressing elements such as intron sequences, 
absence of complex chromatin organization and altered DNA repair activity has also 
been proposed to contribute to the greater accumulation of mutations (Yakes & van 
Houten, 1997; Alexeyev et al., 2013; McInnes, 2013).  Conversely, studies have 
indicated that mtDNA associated proteins and associated nucleoid organization may 
offer at least the same protective effect as histones in some cases (Alexeyev et al., 
2013).  Faulty mtDNA repair mechanisms also play an important role in the 
accumulation of mtDNA mutations (Schapira, 2012).  Despite the fact that 
mitochondria possess most of the DNA repair pathways available in the nucleus, 
damage to mtDNA is more slowly repaired compared to nDNA (Yakes & van Houten, 
1997; Kolesar et al., 2014). 
 
Contrasting to the nuclear genome, the mitochondrial genome is highly redundant, 
with thousands of copies present in each cell.  Therefore, a “repair or die” restraint is 
not imposed on mtDNA, and a heteroplasmic intracellular population of mutant and 
normal mtDNA can be present within the same cell and will be randomly distributed 
into daughter cells (Wallace, 2005; Alexeyev et al., 2013).  Conceivably, a significant 
amount of damaged mtDNA can persist without detrimental effects, provided that the 
residual mtDNA can compensate for the loss of function.  As the degree of mtDNA 
mutations increase in association with mitochondrial dysfunction, so does the 
susceptibility to apoptosis, which subsequently results in the progressive loss of cells 
over time.   
40 
 
Ultimately, this contributes to a decline in tissue function, and clinical symptoms will 
appear when the number of functional cells declines below the threshold required to 
maintain normal tissue function, as is seen during the process of ageing (Taylor & 
Turnbull, 2005; Wallace, 2005).   
 
4.1.3 Role of mitochondrial dysfunction in disease and ageing 
 
As described in Chapter 2, the involvement of mitochondria in the ageing process 
was first proposed by Denham Harman (1972).  Ever since, a wealth of correlative 
data has supported the role of increased ROS production and oxidative damage 
within the mitochondria in age related diseases (Benz & Yau, 2008; Seo et al., 2010; 
Bratic & Larsson, 2013).  However, evidence that challenge this theory in mammals 
has also been presented, and includes:  
 
 Transgenic mice expressing an error-prone mtDNA polymerase show 
accelerated signs of ageing, and a concurrent decrease in lifespan, but are 
not subject to ROS overproduction or oxidative stress,  
 Knockout mice heterozygous for the superoxidase dismutase 2 gene, exhibit 
increased oxidative damage in their nuclear DNA and mtDNA, however no 
signs of accelerated ageing, or a reduced lifespan is observed (Benz & Yau, 
2008; Raffaello & Rizzuto, 2010; Bratic & Larsson, 2013). 
 
The role of oxidative stress in association with mitochondrial dysfunction has 
therefore been subjected to considerable debate, however the fact that a functional 
decline in mitochondria occurs with age, together with the fact that properly 
functioning mitochondria are crucial for longevity and minimizing age related 
diseases, cannot be refuted (Seo et al., 2010; Raffaello & Rizzuto, 2010; Lauri et al., 
2014).  Changes in mitochondrial function associated with the ageing process have 
been well documented, and are centred around the decrease in mitochondrial quality 
control, as well as deteriorating respiratory chain function, increased ROS and ROS 
mediated damage, decreased protein disposal activity by the ubiquitin proteasomal 
and autophagy systems, as well as decreased mitochondrial dynamics (Khan et al., 
2007; Seo et al., 2010).   
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Mitochondrial dynamics refer to the continuous cycles of fission and fusion events that 
occur throughout the life span of a cell.  Fusion allows the exchange of solutes, 
metabolites, proteins and mtDNA over the entire mitochondrial network, and is 
therefore critical in reducing content heterogeneity, rescuing damaged units and 
providing resistance against mitochondrial dysfunction (Ferree & Shirihai, 2012; 
Lopez-Mejia & Fajas, 2015).  Fission, on the other hand, is involved in numerous cell 
signalling pathways including mitochondrial inheritance during cellular division, 
mitophagy, and apoptosis (Ferree & Shirihai, 2012; Lopez-Mejia & Fajas, 2015).  
Apart from the role of mitochondrial dynamics in its own life cycle and within the 
broader concept of the cell cycle, mitochondria also modify their overall mass, sub-
cellular localization, morphology and network configurations in response to cellular 
stress (Twig et al., 2008; Margineantu et al., 2002). Responsive mitochondrial 
dynamics and continuous network remodelling is therefore vital to maintaining 
mitochondrial fitness, ensuring optimal mitochondrial activity, and maintaining the 
integrity of the mtDNA (Ferree & Shirihai, 2012; Lopez-Mejia & Fajas, 2015).  
Consequently, mitochondrial dysfunction is characterised by an imbalance in the 
fission and fusion events, associated with a decrease in mitochondrial dynamics. 
 
4.1.4 Cell culture models of mitochondrial dysfunction through mtDNA 
depletion 
 
The most common method used to study the effects of mtDNA mutations and 
mitochondrial dysfunction in ageing and age related diseases, was developed as early 
as 1970, and is based on the intentional depletion of mtDNA from cultured cells.  Such 
intentionally depleted cells, referred to as “ρ-nucleic acid depleted” or “ρ0” cells, were 
developed using mutagens such as rhodamine 6-G, dideoxynucleoside analogues, 
methotrexate and, most commonly, ethidium bromide (Khan et al., 2007). Ethidium 
bromide (3,8-diamino-5-ethyl-6-phenylphenanthridinium bromide) is a cationic 
phenanthridine dye that binds to, and intercalates with double stranded DNA through 
electrostatic interactions (Khan et al., 2007; Das et al., 2014).  Its positive charge 
allows it to preferentially accumulate within the negatively charged mitochondria, 
where it inhibits replication and transcription of mtDNA, subsequently leading to the 
gradual depletion of mtDNA without significantly affecting nuclear DNA (King & Attardi, 
1989; Khan et al., 2007).   
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Accordingly, the aim of this chapter was to establish an in vitro cell culture model 
representative of mitochondrial dysfunction using 3T3-L1 preadipocytes, in order to 
mimic the age related decline in preadipocyte function.     
 
Several mtDNA depleted cell lines have since been established, and are commonly 
used to study the process of ageing and age related diseases such as diabetes, 
cancer, photo-aged skin and neurodegenerative diseases such as Parkinson’s 
(Amuthan et al., 2002; Arnould et al., 2002; Lim et al., 2006; Park & Lee, 2007; 
Schroeder et al., 2008).   
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4.2. Methods and materials  
 
4.2.1 Establishment of an mtDNA depleted 3T3-L1 preadipocyte cell line 
 
Cells were routinely maintained as described in section 3.1.  Briefly, 3T3-L1 
preadipocytes (wildtype) were routinely maintained in 10 cm culture dishes with 
DMEM medium containing 4 mM L-glutamine, 4.5 g/L glucose and sodium pyruvate, 
supplemented with 10% FBS (GE Healthcare Life Sciences, Logan, Utah, USA).  It is 
generally recommended that newborn calf serum (NCS) be used in the complete 
growth medium for 3T3-L1 cells, however due to changes in legislation and import 
criteria at the time, NCS could not be obtained initially and FBS was used instead.  
To minimise additional variables, FBS was subsequently used throughout this study.  
The use of FBS is deemed acceptable if the intent is to maintain cells as 
preadipocytes.   
 
In order to generate a mtDNA depleted 3T3-L1 preadipocyte cell line (ρ0 mutants) 
wildtype preadipocytes were exposed to 50 ng/mL EtBr (Sigma-Aldrich, St. Louis, 
MO, USA) every day for a minimum of 30 days, in complete medium (DMEM: 10% 
FBS) supplemented with 50 μg/mL uridine (Sigma-Aldrich, St. Louis, MO, USA).  Due 
to the short half-life of EtBr in culture medium, the culture medium was replaced 
daily.  During routine maintenance, a small sample of the ρ0 mutant cell population 
was frequently sub-cultured in pyruvate free DMEM culture medium, without uridine 
and EtBr in order to evaluate the mtDNA status of the ρ0 mutants.  Ρ0 cells are 
characteristically auxotrophic for pyruvate and pyrimidines (uridine) and were 
therefore unable to survive in their absence.  Both cell lines were used from passage 
number 8 to 24, and confluency never exceeded 80%.  No antibiotics were added 
during routine maintenance, however, 1% (v/v) penicillin / streptomycin (P/S) (Sigma-
Aldrich, St. Louis, MO, USA) was added to long term experiments exceeding 5 days. 
 
Throughout this study, ρ0 mutants were used in experimental procedures after 
exactly 30 days of exposure to EtBr, and never more than 40 days.  This not only 
limited the depletion of specific cell phenotypes that occur as a result of excessive 
passaging, but also reduced the possibility of unintended nDNA depletion due to 
continuous EtBr exposure.   
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4.2.2 Characterization of ρ0 3T3-L1 preadipocytes 
 
Throughout experimental procedures wildtype and ρ0 mutant cells were seeded during 
log phase, at a density of 20 000 cells/mL, unless otherwise stated, in appropriate 
culture vessels – as indicated by the requirements for each experiment.  Cells were 
left overnight to attach and recover.  Negative controls (untreated cells) and 
appropriate positive controls were used wherever possible.  Unless otherwise stated, 
each treatment was performed in triplicate and the experiment was repeated 3 times 
(n=3).     
 
4.2.2.1 Cell growth characteristics 
 
Cell growth characteristics relating to viability and proliferation were continuously 
evaluated using an automated cell counter, Luna™ (Logos Biosystems, Korea) (3.3).  
Wildtype and ρ0 mutant cells were seeded at a density of 10 000 cells/mL in 10 mL 
aliquots in 10 cm culture dishes.  After 24 hours of incubation, cells were collected 
from culture plates by first washing with 500 μL of Dulbecco’s phosphate buffered 
saline  (DPBS, without Ca2+ and Mg2+) (Lonza, Walkersville, MD, USA), followed by 
trypsinization (trypsin: EDTA) for 10 minutes at 37°C, and resuspension in 1 mL of 
complete medium.  A 10 μL aliquot of the cell suspension was removed and added to 
10 μL of 0.4% trypan blue, followed by analysis using the automated cell counter.  The 
remaining cells were seeded back into the original culture dish, and the process 
repeated every 24 hours for a total of 6 consecutive days as described by Yu et al. 
(2007).    
 
4.2.2.2 Cell cycle analysis 
 
Cell cycle analysis was performed on synchronized wildtype and ρ0 mutant cells using 
the Coulter® DNA Prep™ kit (Beckman Coulter, CA, USA) which utilizes propidium 
iodide (PI) to stain DNA and determine cell cycle distribution (3.6).  Wildtype and ρ0 
mutant cells were seeded in 1.5 mL aliquots at 20 000 cells/mL in 6 well culture dishes 
and left overnight to attach and recover.  Cells were synchronised through serum 
deprivation overnight, after which the serum free medium was replaced with complete 
culture medium containing 10% FBS, to permit re-entry into the cell cycle.   
45 
 
DNA cell cycle analysis was performed using the Coulter® DNA Prep™ kit, as per 
manufacturer’s instructions.  Cells were collected 24, 48, and 72 hours after adding 
the 10% FBS (in the absence of EtBr) by washing with 500 μL of DPBS (without Ca2+ 
and Mg2+) (Lonza, Walkersville, MD, USA), followed by trypsinization for 10 minutes 
at 37°C, and resuspension in 500 μL of DPBS (with Ca2+ and Mg2+) (Lonza, 
Walkersville, MD, USA).  Cell suspensions were transferred into suitable 
polypropylene tubes, and the cells collected by centrifugation at 500 x g for 5 minutes 
at room temperature.  A 100 μL aliquot of lysis reagent (< 0.1% sodium azide, non-
ionic detergents, saline, and stabilizers) was added to each sample, vortexed and 
incubated for 5 minutes at room temperature.  A 500 μL aliquot of PI (50 μg/mL) was 
then added to the samples and incubated in the dark for 15 minutes at 37°C, after 
which samples were analysed using a Beckman Coulter Cytomics FC500 Flow 
Cytometer (CA, USA) (3.5) and data was recorded in FL3.  Results were analysed on 
FlowJo v10 software (Tree Star Inc., USA).       
 
4.2.2.3 Mitochondrial membrane potential 
 
The effect of EtBr treatment and mtDNA depletion on the mitochondrial membrane 
was evaluated using the cytofluorimetric, lipophilic cationic dye JC-1 (Sigma-Aldrich, 
St. Louis, MO, USA) (3.7).  Wildtype and ρ0 mutant cells were seeded in 1.5 mL 
aliquots at 20 000 cells/mL in 6 well culture dishes and left overnight to attach and 
recover.  Cells were collected after 24, 48, and 72 hours (in the absence of EtBr) into 
polypropylene tubes, and JC-1 (1 mg/mL) was added to a final concentration of 2 
µg/mL in pre-warmed, complete medium.  Samples were allowed to incubate for 10 
minutes in the dark at room temperature, after which three wash steps were 
performed using 500 µL of DPBS (Lonza, Walkersville, MD, USA) and centrifugation 
at 500 x g for 5 minutes.  Red (FL3) and green (FL1) fluorescence was recorded 
using a Beckman Coulter Cytomics FC500 Flow Cytometer (CA, USA) (3.5).  Results 
were analysed on FlowJo v10 software (Tree Star Inc., USA).  Valinomycin (Sigma-
Aldrich, St. Louis, MO, USA), a K+ ionophore, was used as a positive control due to 
its ability to dissipate the mitochondrial membrane potential (Felber & Brand, 1982).  
Positive control wildtype and ρ0 mutant cells were incubated with 400 nM 
Valinomycin for 30 minutes prior to JC-1 staining and flow cytometric analysis.    
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4.2.2.4 Metabolic parameters: glucose utilization and lactate production 
 
Depletion of mtDNA results in defective mitochondrial respiration and oxidative 
phosphorylation, therefore alternative energy yielding pathways are used in order to 
produce cellular ATP.  Changes in glucose utilization and lactate production were 
considered markers for mitochondrial dysfunction and analysed using the glucose 
oxidase (3.9.1) and lactate oxidase (3.9.2) assay, respectively.    
 
4.2.2.4.1  Glucose utilization assay  
 
Wildtype and ρ0 mutant cells were seeded at a density of 20 000 cells/mL in 200 μL 
aliquots in a 96 well plate, and allowed to attach and recover overnight.  After 24, 48 
and 72 hours of incubation, 5 μL of the culture medium was removed and added to 
200 μL of the glucose oxidase assay reagent (prepared as described in Appendix II), 
incubated for 10 minutes at 37°C and the absorbance was read at 520 nm using a 
BioTek® PowerWave XS spectrophotometer (Winooski, VT, USA).  The resultant 
absorbance values indicated the amount of glucose remaining in the culture medium, 
and glucose utilization was subsequently calculated as a percentage of the control 
(wildtype cells).    
 
4.2.2.4.2  Lactate production assay  
 
Similar to the glucose oxidase assay, wildtype and ρ0 mutant cells were seeded at a 
density of 20 000 cells/mL in 200 μL aliquots in a 96 well plate, and allowed to attach 
and recover overnight.  After 24, 48 and 72 hours of incubation, 5 μL of the culture 
medium was removed and added to 200 μL of the lactate oxidase assay reagent 
(prepared as described in Appendix II), incubated for 10 minutes at 37°C and the 
absorbance was read at 520 nm using a BioTek® PowerWave XS spectrophotometer 
(Winooski, VT, USA).  The resultant absorbance values indicated the amount of 
lactate remaining in the culture medium, and lactate production was subsequently 
calculated as a percentage of the control (wildtype cells).  
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4.2.2.5 Confocal microscopy 
 
To characterise mitochondrial function in wildtype and ρ0 mutants, cells were stained 
with JC-1 (3.7) and MitoTracker® Green FM (3.8).  Confocal microscopy was 
subsequently used to observe the mitochondrial membrane potential, as well as the 
mitochondrial mass and distribution, respectively.   
 
Confocal microscopy imaging was performed at the Confocal and Light Microscope 
Imaging Facility at the University of Cape Town, under the supervision of Professor 
Dirk Lang and Mrs. Susan Cooper.  A Zeiss Axiovert LSM 510 META confocal 
microscope, equipped with a Zeiss AxioCam camera for fluorescent imaging, was 
used.  The confocal microscope stage was also equipped with a specialized pre-
heated (37°C) humidified chamber supplied with 5% CO2, thus enabling live cell 
imaging.  This was required due to the fact that MitoTracker® Green FM and JC-1 
dyes are not well retained after fixation, and enabled real time observation of 
mitochondrial movement and cellular activities.   
 
Cells were maintained as described in section 3.1 and 4.2.1.  Wildtype and ρ0 mutant 
cells were seeded in 500 μL aliquots at a density of 2 000 cells/mL in specialized 35 
mm glass bottom culture dishes to enable the use of higher objective imaging, and 
left overnight to attach and recover.  JC-1 (Sigma-Aldrich, St. Louis, MO, USA) and 
MitoTracker® Green FM (Molecular Probes®, Life technologies, USA) staining was 
performed according to manufacturer’s instructions.  Briefly, cells were incubated 
with pre-warmed complete culture medium containing either JC-1 (2 µg/mL) or 
MitoTracker® Green FM (20 nM) for 20 minutes, in the dark at 37°C.  The staining 
solutions were removed and cells were carefully washed using DPBS (Lonza, 
Walkersville, MD, USA).  Fresh complete culture medium was added to the culture 
dishes, which were then allowed to equilibrate in the chamber for ± 10 minutes.   
 
A 488 nm laser line was used for excitation, along with appropriate band pass filters 
(CH2: BP 500-550 IR; CH3: BP 575-630 IR) to enable detection of green (CH2) and 
red (CH3) fluorescence emissions.  High resolution static images, time lapse images, 
as well as optical slice (Z-stack) images taken at 1 μm intervals along the z axis, 
were acquired using a Plan-Apochromat 63x oil immersion objective (NA=1.4).   
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The laser light intensity and detector gains were set such that fluorescence 
intensities of both dyes were below saturation levels.  Similarly, the pinhole size was 
kept constant throughout acquisition at 192 μm (CH2) and 220 μm (CH3) to avoid 
oversampling.  Post-acquisition processing was performed using ZEN 2012 software 
(Carl Zeiss Microscopy GmbH, 2011).   
 
  
49 
 
4.3 Results and discussion 
 
The aim of this chapter was to establish and characterize an in vitro cell culture 
model mimicking mitochondrial dysfunction observed during the ageing process.  
This was achieved by continuous, long term exposure of 3T3-L1 preadipocytes to low 
levels of EtBr, which has been shown to specifically deplete mtDNA without affecting 
the nuclear DNA of cultured cells, due to its preferential accumulation within the 
mitochondria (Armand et al., 2004; King & Attardi, 1989; Leibowitz, 1971).  No 
literature pertaining to mtDNA depletion using EtBr with 3T3-L1 preadipocytes could 
be found, but studies on other cell lines reported using EtBr concentrations of 50 – 
500 ng/mL, and exposure times varying between 20 to 40 days (Biswas et al., 1999; 
Arnould et al., 2002; Armand et al., 2004; Lim et al., 2006; Park & Lee, 2007; Yu et 
al., 2007; Magda et al., 2008; Schroeder et al., 2008).  After numerous attempts 
conducted on a trial-and-error basis, using cell growth parameters and mitochondrial 
membrane potential to monitor the effects of EtBr treatment, it was determined that a 
50 ng/mL treatment every day over a period of 30 days was sufficient to decrease 
mitochondrial function corresponding to expectations for mtDNA depleted cells 
(Results not shown).   
 
The resultant ρ0 mutant cells were then further characterised by examining 
biochemical indicators of mitochondrial dysfunction including changes in: cell 
proliferation, population doubling time, cell cycle distribution, mitochondrial 
membrane potential, lactate production and glucose utilization.  Together these 
characteristics confirmed that 3T3-L1 preadipocytes treated with EtBr produced a 
model representative of mitochondrial dysfunction.  
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4.3.1 Characterization of ρ0 3T3-L1 preadipocytes 
 
4.3.1.1 Cell growth characteristics 
 
Compared to wildtype cells, ρ0 mutants displayed noticeable morphological and 
biochemical differences in culture.  During routine observation of cultures with phase 
contrast microscopy, the most apparent difference was the clearly reduced rate of 
proliferation exhibited by ρ0 mutants (Figure 4.3).  Phase contrast photographs were 
taken of untreated wildtype and ρ0 mutants after 6 days in culture, providing a 
representation of the significantly altered growth kinetics as a result of EtBr 
treatment.   
 
      
Figure 4.3:   Phase contrast images illustrating the contrasting growth kinetics 
between untreated wildtype (left) and EtBr treated (ρ0) 3T3-L1 preadipocytes (right).  
Both cell lines were seeded at 100 000 cells/10mL in 10 cm culture dishes, photographs 
were taken after about 8 days in culture.  Scale bar: 50 μm.   
 
Figure 4.3 simply provides an illustration of the contrasting growth kinetics between 
wildtype and EtBr treated 3T3-L1 preadipocytes.  It is important that 3T3-L1 
preadipocytes never reach confluency during routine cell maintenance, due to the 
fact that contact-inhibited preadipocytes enter a unique temporary quiescent state, 
arresting at the G0/G1 cell cycle boundary, in preparation for mitotic clonal expansion 
and subsequent differentiation into adipocytes (Patel & Lane, 2000).   
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Using an automated cell counter, wildtype and ρ0 mutant cell numbers (total, live and 
dead) and % viability were evaluated every day for 6 consecutive days in order to 
establish growth curves (Figure 4.4) from which population doubling times could be 
calculated.  
 
 
Figure 4.4: Comparison of the growth rate of wildtype and EtBr treated (ρ0) 3T3-L1 
preadipocytes.  Total cell number indicates the viable cell density determined using trypan 
blue staining.  Error bars represent SD of nine replicate values (n=3).  Statistical significance 
was determined using the two-tailed Student t-test and is indicated for p < 0.05 (*) and p < 
0.005 (**) relative to ρ0 mutant cells.   
 
A statistically significant difference between the total number of viable wildtype and 
EtBr treated ρ0 cells is already evident after just 2 days in culture (Figure 4.4).  Using 
these results population doubling times were calculated during the most linear growth 
phases (48 – 120 hours) using the formula:  
 
 
Wildtype cells had a mean population doubling time of 18.8 ± 2.1 hours, compared to 
30.2 ± 4.2 hours for ρ0 mutants, which is in accordance with findings by other studies 
(Yu et al., 2007; Magda et al., 2008).         
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In addition to the analysis of total cell numbers displayed in Figure 4.4, total live and 
dead cell numbers were recorded by the automatic cell counter, and subsequently 
used to display the % cell viability for each analysed sample during the experiment 
(Figure 4.5).  These results were confirmed using standard cell counting techniques 
involving a haemocytometer and trypan blue exclusion.      
 
 
Figure 4.5: Percentage (%) cell viability of ρ0 mutant and wildtype cells observed over 
5 days in the presence of EtBr.  Data represents total % viable cells determined using 
trypan blue staining.  Error bars represent SD of nine replicate values (n=3).  No statistically 
significant difference between wildtype and ρ0 mutant cells could be determined using the 
two-tailed Student t-test.    
 
Continuous treatment with EtBr had no detectable effect on cell viability relative to 
wildtype cells (Figure 4.5).  However, ρ0 mutants are characteristically auxotrophic for 
pyruvate and pyrimidines (uridine) and were therefore unable to grow in media 
devoid of pyruvate and uridine.  Culture medium was routinely replaced with a 
pyruvate free substitute without additional uridine supplementation in order to 
evaluate the mtDNA status of ρ0 mutants.  After ± 3 days cell viability progressively 
decreased until ± day 7 (Results not shown).  The reliance on external 
supplementation of pyruvate and uridine can be attributed to dysfunctional 
mitochondrial respiration and oxidative phosphorylation (Armand et al., 2004; Yu et 
al., 2007; Magda et al., 2008).   
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Uridine dependence is attributed to inactive dihydroorotate dehydrogenase, an 
enzyme that relies on the activity of the electron transport chain to catalyse the 
conversion of dihydroorotic acid to orotic acid and following downstream processes 
to produce uridine (Khan et al., 2007).  Similarly, pyruvate auxotrophy is a result of a 
compensatory overreliance on glycolysis to produce cellular energy, thereby leading 
to increased accumulation of cytosolic NADH (Armand et al., 2004; Khan et al., 2007; 
Yu et al., 2007).  Excess pyruvate can therefore assist in the regeneration of NAD+ 
through the conversion of pyruvate to lactate via lactate dehydrogenase (Armand et 
al., 2004; Khan et al., 2007; Yu et al., 2007). 
 
Collectively all of the above results, defining the growth characteristics of ρ0 mutants, 
illustrate that mitochondrial dysfunction induced through mtDNA depletion using EtBr 
treatment severely decreased the proliferation rate and population doubling time of 
treated cells without affecting cell viability.  This is in accordance with findings by Lim 
et al. (2006) using C2C12 myotubes, and Yu et al. (2007) using T47D human breast 
cancer cells.  However, whilst decreased proliferation is observed in some ρ0 cell 
lines, others have illustrated normal and even two times faster proliferation rates 
compared to wildtype cells (Armand et al., 2004; Haque et al., 2006; Magda et al., 
2008, Yu et al., 2007). Therefore, various cell types respond differently to intracellular 
changes induced by mtDNA depletion, and the isolation and characterisation of a ρ0 
3T3-L1 preadipocyte cell line presents a novel finding in mitochondrial research 
relating to preadipocyte dysfunction and ageing.       
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4.3.1.2  Cell cycle analysis 
 
The profoundly delayed growth rate observed for ρ0 cells prompted the investigation 
of cell cycle distribution.  Cell cycle analysis was performed on synchronised wildtype 
and ρ0 mutant cells after 24, 48 and 72 hours.  A summary of the percentage cells 
present in each cell cycle phase is presented in Table 4.1, and representative 
histograms in Figure 4.6.     
 
 
Figure 4.6: Representative cell cycle histograms illustrating DNA distribution for 
wildtype and ρ0 mutants.  Cells were synchronised through serum deprivation overnight, 
after which re-entry into the cell cycle was initiated by the addition of 10% FBS to the culture 
medium.  Cell cycle analysis was performed after 24 hours using PI staining.  Ten thousand 
events were recorded for each sample on a Beckman Coulter Cytomics FC500 flow 
cytometer, and results were analysed using FlowJo v10 software.  Percentage (%) values 
indicate the amount of cells present in each phase.  Note difference in y axis for wildtype 
(left) and ρ0 mutant (right) histograms.  One representative of 3 experiments performed in 
triplicate.       
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Table 4.1: Summary of cell cycle analysis results obtained for wildtype and ρ0 mutants.  
Cell cycle analysis was performed using PI staining 24, 48, and 72 hours after re-entry into the 
cell cycle following synchronization through serum deprivation. 
 
wildtype ρ0 mutants 
24 hours 
Sub-G1 3.13 ± 0.38 2.43 ± 1.53 
G1/G0 44.6 ± 1.38 48.8 ± 3.34 * 
S 20.2 ± 1.26 18.8 ± 3.02 
G2/M 26.5 ± 1.04 23.2 ± 2.68 * 
48 hours 
Sub-G1 2.93 ± 0.55 2.02 ± 0.46 * 
G1/G0 42.2 ± 2.78 49.0 ± 2.70 ** 
S 18.5 ± 4.66 13.3 ± 3.47 * 
G2/M 30.0 ± 3.17 31.7 ± 2.15 
72 hours 
Sub-G1 3.70 ± 0.54 2.99 ± 0.95 
G1/G0 43.0 ± 1.51 47.7 ± 2.22 ** 
S 15.2 ± 2.65 11.6 ± 1.68 * 
G2/M 31.7 ±1.76 32.2 ± 1.05 
Experiments were conducted in triplicate and performed 3 independent times.  
Values indicate mean % ± SD of all experimental data.  Statistical significance 
was determined using the two-tailed Student t-test and is indicated for p < 
0.05 (*) and p < 0.005 (**) relative to untreated control.   
 
Ρ0 mutants progressed through the cell cycle much slower than wildtype cells, as 
indicated by the significantly increased number of cells remaining in the G1/G0 phase, 
as well as the reciprocal reduction in the number of cells present in the S phase after 
24, 48, and 72 hours.  It has been hypothesised that the persistent delay or arrest in 
G1/G0 phase could be a result of the activation of the mitochondrial damage check 
point or mitocheckpoint, which is activated by mitochondrial damage and mtDNA 
depletion (Singh, 2004; Yu et al., 2007).  This will permit cells to arrest in the cell 
cycle, and repair some mitochondrial function in order to avoid apoptosis, but if the 
damage is too severe, cells will become senescent and ultimately undergo 
programmed cell death (Singh, 2004; Yu et al., 2007).  The lack of a significant sub-
G1 cell population (Table 4.1) supports this theory, especially when considering that 
no change in cell viability was evident for ρ0 mutants relative to wildtype cells as 
discussed previously (Figure 4.5).   
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The presence of cell populations in the sub-G1 region generally indicates the 
presence of apoptotic cells, this is however not a conclusive test for apoptosis and 
other assays are generally used to confirm apoptosis.   
 
It has also been shown that cell cycle progression is influenced by mitochondrial 
dynamics and bioenergetics (Mitra et al., 2009; Lopez-Mejia & Fajas, 2015).  In 
conjunction with an increased mitochondrial membrane potential, mitochondria 
coalesce into a large hyperfused tubular network prior to the transition from G1 to S 
phase (Mitra et al., 2009; Boland et al., 2013; Lopez-Mejia & Fajas, 2015).  This 
allows the expression and accumulation of cyclin E, a cell cycle regulator protein 
required to form the active cyclin-CDK2 (cyclin dependent kinase) complex that 
regulates numerous cellular processes and perhaps most importantly G1 to S phase 
progression (Siu et al., 2012).  Consequently, mitochondrial dysfunction has been 
linked to a delay in S phase entry (Boland et al., 2013; Mitra et al., 2009).  The 
effects of EtBr treatment on mitochondrial function and membrane polarization is 
discussed further throughout this study.     
           
4.3.1.3  Mitochondrial membrane potential 
 
The mitochondrial membrane potential (ΔΨm), established through the activity of 
oxidative phosphorylation (4.1), is an important indicator of mitochondrial function 
and the overall health-status of a cell.  Complex I, III, and IV pump H+ from the 
mitochondrial matrix into the intermembrane space, thereby creating an 
electrochemical gradient across the inner mitochondrial membrane with an 
associated electrical potential of about ± 150 – 180 mV.  Complex I, III, and IV 
subunits are encoded by the mitochondrial genome, therefore depletion of 
mitochondrial DNA will result in dysfunctional oxidative phosphorylation and possible 
depolarization of the mitochondrial membrane, resulting in the attenuation of 
mitochondrial functions. 
 
Changes in ΔΨm can be detected through the use of the lipophilic cationic dye JC-1, 
which exhibits a potential-dependent accumulation in the mitochondria (3.7).   
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JC-1 will either be retained in the mitochondria due to the negative charge established 
by the intact ΔΨm and form J-aggregate complexes emitting a red fluorescence 
(polarised mitochondria) or, will diffuse into the cytoplasm due to a collapse in ΔΨm, 
where the monomeric form will exhibit a green fluorescence (depolarised 
mitochondria).  The results shown in Figure 4.6 illustrate the changes in the mean 
green fluorescence intensity (FL1) of cells stained with JC-1 observed after 24 hours, 
and results shown in Table 4.2 illustrate the ratio of red (FL3) to green (FL1) 
fluorescence observed after 24 hours.   
      
 
Figure 4.7: Histogram overlay representing the decreased mitochondrial membrane 
potential in ρ0 mutants compared to wildtype cells as well as valinomycin treated 
wildtype and ρ0 mutant cells.  Cells were stained with the polychromatic, ΔΨm sensitive 
probe JC-1.  An increase in the mean fluorescence intensity of FL1 (green) is indicative of a 
decrease in mitochondrial membrane potential.  Ten thousand events were recorded for each 
sample on a Beckman Coulter Cytomics FC500 flow cytometer, and results were analysed 
using FlowJo v10 software.  One representative of 3 experiments performed in triplicate. 
 
A significant increase in green fluorescence intensity was evident for ρ0 mutant cells 
(Figure 4.7), and indicates that EtBr treatment causes depolarization of the 
mitochondrial membrane, resulting in a decreased ΔΨm.  Valinomycin (400 nM) was 
used as a positive control due to its ability to completely dissipate the ΔΨm.  Treatment 
of wildtype cells with valinomycin induced an intense depolarization of the 
mitochondrial membrane as illustrated by the rightward shift in the green fluorescence 
intensity peak relative to untreated wildtype cells.  Similarly, treatment of ρ0 mutant 
cells with valinomycin produced an even more intense depolarization of the 
mitochondrial membrane. 
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Interpretation of JC-1 fluorescence intensity results requires special consideration 
when looking at single-component fluorescent signals compared to a ratio of red 
(FL3) to green (FL1) fluorescence intensities.  Single-component fluorescent signals 
merely indicate changes in either the relative amount of JC-1 monomers (green 
fluorescence) or aggregate complexes (red fluorescence), and can be influenced by 
factors such as mitochondrial size, shape and density.  Considering the impact of 
valinomycin treatment on the green fluorescence intensities observed for wildtype 
and ρ0 mutant cells (Figure 4.7), along with the fact that the valinomycin treatment 
time of 30 minutes is too short to induce changes in the mitochondrial content, it 
would suggest that changes in single-component fluorescent signals can still provide 
an additional view point when analysing changes in ΔΨm. 
 
Table 4.2:  Summary of results obtained for analysis of mitochondrial membrane 
potential for wildtype and ρ0 mutants.  Representing the mitochondrial membrane 
potential is the ratio of the mean fluorescence intensity of FL3 (red) to FL1 (green).    
    Ratio (FL3/FL1) 
wildtype 1.503 ± 0.69 
wildtype + Valinomycin 0.564 ± 0.08 * 
ρ0 mutant 1.020 ± 0.50 * 
ρ0 mutant + Valinomycin 0.316 ± 0.05 ** 
Experiments were conducted in triplicate and performed 3 
independent times.  Values indicate the mean fluorescence 
intensity ratio ± SD of all experimental data.  Statistical 
significance was determined using the two-tailed Student t-test 
and is indicated for p < 0.05 (*) and p < 0.005 (**) relative to 
wildtype cells, and relevant untreated control cell populations.   
 
Mitochondrial depolarization is indicated by a decrease in the red / green 
fluorescence intensity ratio (Table 4.2) independent of changes in mitochondrial size, 
shape or density.  An approximately 2.5 fold decrease in ΔΨm is observed for ρ
0 
mutants relative to wildtype cells.  Valinomycin treatment resulted in a respective ± 
3.2 and 2.7 fold decrease in ΔΨm for wildtype and ρ
0 mutants, relative to the 
untreated controls.  Therefore, the results obtained clearly indicate that EtBr 
treatment results in a significantly decreased mitochondrial membrane potential. 
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4.3.1.4 Metabolic parameters: glucose utilization and lactate production  
 
Mitochondria play a fundamental role in several metabolic pathways and produce 
about 90% of the required cellular ATP through oxidative phosphorylation conducted 
by respiratory chain on complexes located within the inner mitochondrial membrane.  
Out of the 5 respiratory chain complexes, 4 are encoded by the mitochondrial 
genome.  Therefore, depletion of mtDNA results in defective mitochondrial respiration 
and oxidative phosphorylation, and subsequently alternative energy yielding 
pathways have to be used.  Changes in glucose utilization and lactate production into 
the culture medium were examined in untreated wildtype and ρ0 mutant cells using 
glucose oxidase and lactate oxidase assays, respectively.  Considering the variation 
in cell growth characteristics (4.3.1.1), results were normalised to the respective cell 
densities.     
 
  
Figure 4.8: Glucose utilization by ρ0 mutants after 24, 48 and 72 hours, represented as 
a percentage of the wildtype control (100%).  Error bars represent SD of nine replicate 
values (n=3).  Statistical significance was determined using the two-tailed Student t-test and 
is indicated for p < 0.005 (**) relative to untreated control. 
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Figure 4.9: Lactate production by ρ0 mutants after 24, 48 and 72 hours, represented as 
a percentage of the wildtype control (100%).  Error bars represent SD of nine replicate 
values (n=3).  Statistical significance was determined using the two-tailed Student t-test and 
is indicated for p < 0.005 (**) relative to untreated control. 
 
From the above results it is evident that, compared to untreated wildtype cells, ρ0 
mutants had utilized 2.83 ± 1.86 %, 18.0 ± 2.32 %, and 39.0 ± 2.74 % more glucose 
after 24, 48 and 72 hours respectively (Indicated as % increase in glucose utilization 
relative to wildtype cells ± SD).  Correspondingly, an increase in lactate production of 
16.2 ± 2.98 %, 57.8 ± 3.93 %, and 150 ± 12.7 % is seen after 24, 48, and 72 hours 
respectively (Indicated as % increase in lactate production relative to wildtype cells ± 
SD).   
 
Glucose is a primary source of energy in mammalian cells, and is catabolized 
through glycolysis to form NADH and pyruvate.  Generally, pyruvate is converted to 
acetyl-Co-A by pyruvate dehydrogenase and enters the TCA cycle to produce 
electron carrying intermediates for oxidative phosphorylation.  Mitochondrial 
respiration and oxidative phosphorylation is however impaired in ρ0 mutants, 
therefore a big compensatory increase in glycolysis is necessary in order to produce 
the required cellular ATP (Qian & van Houten, 2010).  Only 2 ATP molecules are 
produced per glucose molecule during glycolysis alone, compared to a total of 36 
produced through the complete mitochondrial respiration process.  Therefore an 
increase in glucose utilization is expected to compensate for this energy deficit.   
0
50
100
150
200
250
300
24 48 72
%
 L
a
c
ta
te
 p
ro
d
u
c
e
d
 c
o
m
p
a
re
d
 t
o
 
w
ild
ty
p
e
 c
o
n
tr
o
l 
Time (hours) 
 ** 
 
          ** 
   ** 
 
 
 
61 
 
The overreliance on glycolysis leads to an accumulation of NADH which has to be 
regenerated to NAD+ through the conversion of pyruvate to lactate via lactate 
dehydrogenase.  This accounts for the fact that ρ0 cells are dependent on externally 
supplied pyruvate discussed previously (4.3.1.1) for survival, as well as the observed 
increase in lactate production.  It is also important to consider that the culture 
medium contains pyruvate and glutamine, which are also involved in bioenergetic 
processes associated with the mitochondria and could therefore underestimate the 
effects observed.      
 
4.3.1.5 Confocal microscopy  
 
JC-1 staining was used to confirm and visualise the mitochondrial membrane 
potential (ΔΨm) changes observed using flow cytometry (4.3.1.3), whereas 
mitochondrial mass was measured through accumulation of the ΔΨm insensitive 
fluorescent probe, MitoTracker® Green FM. 
 
Using the confocal microscopy images obtained for JC-1 stained mitochondria, 
individual wildtype and ρ0 mutant cells were isolated and analysed using Zen 
software post-acquisition processing.  A ratio of red / green fluorescence intensity, 
indicating mitochondrial membrane potential, was determined for 10 randomly 
selected cells from both the wildtype and ρ0 mutant cell populations.  A ratio of 1.550 
± 0.39 was determined for wildtype cells, compared to 1.093 ± 0.20 * for ρ0 mutants, 
therefore indicating that EtBr treatment decreased the mitochondrial membrane 
potential.  (Ratio = red / green ± SD, statistical significance determined using the two-
tailed Student t-test and is indicated for p < 0.05 (*)).  This is in agreement with 
results obtained for JC-1 staining and analysis using flow cytometry (4.3.1.3).  
Representative images are presented in Figure 4.10. 
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Figure 4.10: Representative confocal microscopy images of JC-1 stained mitochondria 
in individually characterised wildtype and ρ0 mutant cells.  Live cell imaging was 
performed using confocal microscopy (63x oil immersion magnification).  JC-1 is a 
polychromatic ΔΨm sensitive fluorescent probe, exhibiting membrane potential dependent 
accumulation and aggregate formation within the mitochondria.  Polarized (red) and 
depolarized (green) mitochondria are indicated with yellow colouration representing overlap.  
One representative of 15 images taken for each respective cell population, during a single 
experiment.   
 
MitoTracker® Green FM accumulates in the mitochondria irrespective of ΔΨm and is 
commonly used to determine and observe mitochondrial mass, morphology and 
distribution (Cottet-Rousselle et al., 2011; Pendergrass et al., 2004; Stankov et al., 
2010).  However, some studies have reported varying sensitivities to ΔΨm in some cell 
lines (Cottet-Rousselle et al., 2011; Mitra & Lippincott-Schwartz, 2010; Pendergrass et 
al., 2004).  Although the use of MitoTracker® Green FM as a ΔΨm insensitive probe 
has previously been established in 3T3-L1 preadipocytes (Stankov et al., 2010; 
Wilson-Fritch et al., 2003), the potential sensitivity of MitoTracker® Green FM to 
changes in ΔΨm was evaluated for both the wildtype and ρ
0 mutant cells using 
valinomycin (400nM).  No discrepancies were found, confirming the independence on 
mitochondrial membrane potential (Results not shown).  Using the confocal 
microscopy images obtained for MitoTracker® Green FM stained mitochondria, 
individual wildtype and ρ0 mutant cells were isolated and analysed using Zen software 
post-acquisition processing (Figure 4.11).   
    wildtype            ρ0 mutants 
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Fluorescence intensities, indicating the accumulation of MitoTracker® Green FM 
within the mitochondria, was determined for 10 randomly selected cells from both the 
wildtype and ρ0 mutant cell populations.  The mean green fluorescence intensity ± 
SD obtained for ρ0 mutants 42.19 ± 5.97 was similar to that obtained for the wildtype 
cells 42.72 ± 7.01.  This is in accordance with findings by Armand et al. (2004), 
Holmuhamedov et al. (2003), Gilkerson et al. (2000) and Kukat et al. (2008), 
indicating that mtDNA depletion does not affect the number or biogenesis of 
mitochondria.  These findings are however somewhat subjective, seeing as results in 
this study only represent the mean fluorescence intensity measured for a few 
individual cells within the respective wildtype and ρ0 mutant cell populations.  It 
should also be considered that mitochondrial mass changes during cell cycle 
progression (Figure 4.12),  therefore even though no significant changes in 
mitochondrial mass was observed for ρ0 mutant cells in this study, further analysis 
should be performed to confirm.       
 
        wildtype              ρ0 mutants 
         
Figure 4.11: Confocal microscopy images of MitoTracker® Green FM stained 
mitochondria in wildtype and ρ0 mutant cells.  Live cell imaging was performed using 
confocal microscopy (63x oil immersion magnification). MitoTracker® Green FM accumulates 
in the mitochondria irrespective of the mitochondrial membrane potential (ΔΨm insensitive) 
and is used to determine mitochondrial mass and distribution.  Refer to text for explanations 
of “A” and “B”.  One representative of 10 images taken during a single experiment.  Scale 
bar: 20 μm.   
                                   A 
B 
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Mitochondria are dynamic organelles that exist in networks continually remodelled 
through fusion and fission.  The balance of mitochondrial fission and fusion adapts to 
the metabolic demands of the cell to ensure the bioenergetic efficiency of the 
mitochondrial population within a cell, and is also involved in cellular stress 
responses (Ferree & Shirihai, 2012; Twig et al., 2008).  During the progression of the 
cell cycle, mitochondria undergo changes in morphology, size, distribution and 
abundance (Ferree & Shirihai, 2012; Arakaki et al., 2006).  This morphological 
spectrum has been characterised according to the cell cycle progression into tubular, 
intermediate and fragmented conformations (Mitra et al. 2009; Margineantu et al., 
2002).          
 
   (Mitra et al., 2009) 
 
This provides valuable insight into the mitochondrial networks observed in Figure 
4.11.  As expected, wildtype cells (left) exhibited a more intermediate distribution 
typical of proliferating cells.  The swollen donut shaped mitochondria visible in 
wildtype cell denoted A, is typical of apoptotic cells, whereas the localization of 
condensed filamentous mitochondria around the nuclear region in the cell denoted B 
is indicative of late G2 / early M phase.  A primarily fragmented mitochondrial 
distribution was observed in ρ0 mutant cells (right), indicating G1 arrested or G0 
phase cells, which is consistent with the results obtained for cellular growth 
characteristics (4.3.1.1) and cell cycle analysis (4.3.1.2).  This is in accordance with 
findings by Margineantu et al. (2002), Minamikawa et al. (1999) and Arduíno et al. 
(2012) indicating similar trends in mitochondrial morphology and distribution for 
mtDNA depleted 143B osteosarcoma cells NT2 teratocarcinoma cells.   
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Figure 4.12: Confocal microscopy image of MitoTracker® Green FM stained 
mitochondria in ρ0 mutant cells (left) accompanied by the corresponding bright field 
image (right). Live cell imaging was performed using confocal microscopy (63x oil 
immersion magnification).  One representative of 10 images taken during a single 
experiment.  Scale bar: 20 μm. 
 
Figure 4.12 illustrates the different cellular dynamics within a given ρ0 mutant cell 
population.  Within the same image, one cell can be observed during the final stage 
of mitosis (A), compared to the other cell undergoing apoptosis (B) (indicated by the 
swollen donut shaped mitochondria, as well as the membrane blebbing indicated with 
the red arrow, observed in the bright field image (right)).  The mitotic cell also has 
visibly more green fluorescing mitochondria (Mean fluorescence intensity = 65.526) 
compared to the apoptotic cell (Mean fluorescence intensity = 43.605), supporting the 
argument made with regards to the subjective nature of the mitochondrial mass 
estimation.   
 
It should also be mentioned that ρ0 mutant cells were much more sensitive to the 
process of confocal microscopy image acquisition, and would easily start to exhibit 
membrane blebbing and undergo apoptosis long before the onset of photobleaching 
effects.  Interestingly, this effect was much more prominent for MitoTracker® Green 
FM stained cells compared to those stained with JC-1.   
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This could be attributed to photosensitisation, which occurs when chromophores 
induce chemical damage to cells through the excessive generation of ROS in 
response to photoirradiation during processes such as confocal microscopy, resulting 
in cell death (Minamikawa et al., 1999).  However no literature could be found 
pertaining to photosensitisation effects of MitoTracker® Green FM.     
 
Although the inclusion of a nuclear stain such as DAPI or Hoechst would have 
provided more definitive images and assisted in the interpretation thereof, these dyes 
were unavailable at the time of experiment.   
 
Mitochondrial depolarization as a result of EtBr treatment was therefore confirmed 
using flow cytometry and confocal microscopy.  Additionally, results indicated that 
EtBr treatment did not appear to affect the number or biogenesis of mitochondria.
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4.4  Conclusion  
 
The induction of mitochondrial dysfunction through long term exposure to sub lethal 
concentrations of EtBr have been used to study many age related diseases such as 
diabetes, cancer, photo-aged skin and neurodegenerative diseases such as 
Parkinson’s (Amuthan et al., 2002; Arnould et al., 2002; Lim et al., 2006; Park & Lee, 
2007; Schroeder et al., 2008).  The depletion of mtDNA has previously been studied 
in adipocytes using nucleoside reverse transcriptase inhibitors (NRTI) (Stankov et al., 
2010).  This is due to the fact that NRTI therapy results in mitochondrial dysfunction 
as a consequence of mtDNA depletion, which has been suggested as a possible 
pathogenic mechanism involved in lipoatrophy or the progressive subcutaneous fat 
wasting observed in HIV-infected patients (Stankov et al., 2010).  However, the 
establishment and characterisation of a ρ0 3T3-L1 preadipocyte cell line in this study, 
presents a novel pathway in mitochondrial research relating to preadipocyte 
dysfunction and ageing.        
 
Summarising the results obtained throughout this study, the following observations 
can be made.  In comparison to wildtype cells, ρ0 mutant cells exhibited:  
 
Reduced cell growth kinetics:  
 
Ρ0 mutant cells exhibited a significantly reduced growth rate, as illustrated by the 
substantially increased population doubling time of 30.2 ± 4.2 hours, compared to 
18.8 ± 2.1 hours for wildtype cells, as well as the delayed cell cycle progression 
indicated by an average increase of ± 12% in the number of cells remaining in the 
G1/G0 phase, with a reciprocal reduction of ± 19% in the number of cells in the S 
phase.  These results may be attributed to the activation of mitocheckpoint, which will 
permit cells to arrest in the cell cycle and repair some mitochondrial function in order 
to avoid apoptosis (Singh, 2004; Yu et al., 2007).  Additionally, reduced mitochondrial 
dynamics and bioenergetics associated with mitochondrial dysfunction could also be 
a contributing factor due to the fact that mitochondria are required to coalesce into a 
large hyperpolarised, hyperfused tubular network prior to the transition from G1 to S 
phase (Finkel & Hwang, 2009; Mitra et al., 2009).   
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This is in turn associated with the mitochondrial membrane potential alterations 
observed in ρ0 cells, discussed below.        
 
Metabolic alterations: 
 
Cell viability remained unaffected throughout EtBr treatment, however metabolic 
alterations became visibly apparent as a progressive increase in acidification (as 
indicated by the colour changes of the pH indicator phenol red) of the cell culture 
medium was observed during routine maintenance of ρ0 mutant cells.  This was 
attributed to an increase in lactate production, which was confirmed by the ± 150% 
increase in lactate production relative to wildtype cells after 72 hours.  An increased 
rate of lactate production can be attributed to a number of factors relating to 
mitochondrial dysfunction.  The decline in ATP production in dysfunctional 
mitochondria, leads to a compensatory increase in the glycolytic flux with a 
concomitant increase in pyruvate, the substrate for lactate dehydrogenase (LDH).  In 
addition, ρ0 mutant cells are dependent on pyruvate and uridine supplementation for 
cell growth and survival, as removal of pyruvate and uridine from the cell culture 
medium resulted in a progressive decline in cell number over a period of ± 7 days. 
 
Auxotrophic reliance of EtBr treated cells on pyruvate and uridine is commonly 
associated with ρ0 cells, and is considered a useful indicator of the cellular respiratory 
status and therefore mtDNA content (King & Attardi, 1996; Yu et al., 2007).  
Depletion of mtDNA, encoding complex I, III, and IV of the respiratory chain, results 
in dysfunctional mitochondrial respiration and oxidative phosphorylation, thereby 
constraining the cell to use alternative energy generation pathways namely 
glycolysis.   The overreliance on this more inefficient ATP generating process results 
in a significantly increased demand for glucose, which was evident in the ± 33% 
increase in glucose utilization after 72 hours relative to wildtype cells.  It should 
however be considered that although these results were normalised to compensate 
for the differences in cell growth kinetics, glucose utilization and lactate production is 
indicated as a percentage of the control (wildtype cells).  This is of importance when 
comparing the ± 33% increase in glucose utilization to the ± 150% increase in lactate 
production by ρ0 mutants relative to wildtype cells.   
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Although during glycolysis the breakdown of 1 glucose molecule ultimately results in 
the production of 2 lactate molecules, the discrepancy is also due to the fact that 
under normal conditions, wildtype cells do not produce significant amounts of lactate.  
Additionally the culture medium also contains other bioenergetic intermediates such 
as glutamine which is mitochodrially metabolised and can ultimately increase the 
production of NADPH or be converted to metabolic intermediates such as pyruvate, 
and may therefore underestimate the results obtained.   
 
It is also important to consider that glucose is not exclusively used as an energy 
source, and that it is also the main carbon source in many other biochemical 
pathways and cellular components required for cell growth.  Therefore, the different 
growth characteristics would also impact the ratio of glucose utilization to lactate 
production.  Considering the reduced growth rate of ρ0 mutants relative to wildtype 
cells, it would indicate that more glucose carbon would end up as lactate compared 
to wildtype cells.         
 
Decreased mitochondrial membrane potential (ΔΨm): 
 
Relative to wildtype cells, a small but significant decrease in ΔΨm was observed.  
Considering that no changes in cell viability or sub-G1 phase cell populations were 
observed for ρ0 mutants relative to wildtype cells, it shows that the decrease in ΔΨm 
was insufficient to induce cell death.  This can be related to the results obtained 
during cell cycle analysis and confocal microscopy, seeing as in order to progress 
from the G1 to S phase, mitochondria need to coalesce into a continuous, 
hyperpolarised network, to ensure the expression and accumulation of cyclin E.  This 
is required to form the active cyclin-CDK2 complex that regulates numerous cellular 
processes and ensures the progression from G1 to S phase.  Thus it can be said that 
the reduced ΔΨm, associated with mitochondrial dysfunction, impedes the formation 
of the hyperpolarised, hyperfused mitochondrial network required for progression 
from the G1 to S phase, as illustrated by the reduced cell growth characteristics, 
increase in G1/G0 cell populations and reduced S phase population.  This is 
supported by the fragmented mitochondrial distribution, indicative of G1/G0 arrested 
cells, observed in ρ0 mutant cells.     
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Bearing in mind that the ΔΨm is established by the activity of oxidative 
phosphorylation, it begs the question of how these ρ0 cells are able to maintain this 
moderately low ΔΨm, considering that ATP production primarily proceeds via 
glycolysis.  The observation that nuclear DNA encoded mitochondrial proteins were 
still imported into the mitochondria of ρ0 cells despite the reduction in ΔΨm, prompted 
Buchet & Godinot (1998) to investigate the F1/F0-ATPase assembly in mtDNA 
depleted HeLa S3 and 143B cells.  Surprisingly, their results indicated that despite 
the absence of the mtDNA encoded F0 subunits, the F1-ATPase α and β subunits 
were present, and involved in the maintenance of the ΔΨm and ρ0 cell growth.  The 
identification of a functional adenine nucleotide translocater of mitochondria in ρ0 
T47D and other ρ0 cells could also be of significance, however in both cases, the 
precise mechanisms involved still need to be elucidated (Buchet & Godinot, 1998; Yu 
et al., 2007). 
 
 
Together these characteristics confirmed that 3T3-L1 preadipocytes treated with EtBr 
produced an in vitro cell culture model representative of mitochondrial dysfunction as 
a consequence of the proposed effect of EtBr treatment on mtDNA.  Furthermore, the 
growth characteristics of these mitochondrial dysfunctional cells reflect that of ageing 
adipose tissue preadipocytes and therefore provide a suitable model to investigate 
potential anti-ageing therapeutics.    
71 
 
CHAPTER 5: Anti-ageing properties of Rooibos: Effects on 
mitochondrial dysfunction    
 
Preadipocytes lose their ability to replicate and differentiate during ageing, and 
although the precise mechanisms involved remains to be established, it has been 
suggested that factors which are likely to contribute include mitochondrial dysfunction 
(Cartwright et al., 2007; Tchkonia et al., 2010; Sepe et al., 2011).  Treatment with 
natural products rich in antioxidants has attracted remarkable interest in the cosmetic 
and pharmaceutical industry to combat oxidative stress and reverse the effects of 
ageing.  Rooibos (Aspalathus linearis) is a South African fynbos plant, well-known for 
its strong antioxidant capacity and use in many cosmetic products, however little 
published research exists on its potential as an anti-ageing treatment.  The anti-
ageing properties of fermented and unfermented rooibos extracts were investigated 
using an in vitro cell culture model designed to evaluate the involvement of 
mitochondrial dysfunction.   
 
 
5.1 Introduction 
 
5.1.1 Rooibos (Aspalathus linearis) 
   
The leaves and stems of the Aspalathus linearis plant, commonly referred to as 
rooibos or red bush, have been used for hundreds of years to make a uniquely 
aromatic and soothing herbal tea that is well known for its health-promoting 
properties (Joubert & de Beer, 2011).  It is caffeine free, rich in minerals and 
polyphenols, and lower in tannins compared to traditional Camellia sinensis tea, 
thereby minimising the risk of reduced iron absorption observed in tea drinkers, due 
to iron-tannin complexation (Erickson, 2003; Joubert & de Beer, 2011).  Apart from its 
reputation as an enjoyable, healthy herbal tea, countless anecdotal reports 
supporting its therapeutic value has encouraged the use of rooibos in numerous 
other products, however it is clear that its phytopharmaceutical potential is only just 
being realised.    
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5.1.1.1  Geographical distribution, classification and identification 
 
Rooibos (Aspalathus linearis (Burm.f.), R. Dahlgren) is a robust fynbos plant endemic 
to the Cederberg Mountain region in the Western Cape of South Africa (Figure 5.1) 
(Morton, 1983; Joubert & de Beer, 2011).  It is the only commercially important 
species within the genus Aspalathus (Family Fabaceae; Tribe Crotalarieae) which 
contains a total of ± 278 species native to South Africa, most of which are endemic to 
the Cape Floristic Region with a few others spreading to southern KwaZulu-Natal 
(van Heerden et al., 2003; Joubert & de Beer, 2011)   
 
 
Figure 5.1: Geographical distribution of Rooibos in South Africa (Adapted from 
Rooibos Ltd, 2015). Rooibos is naturally distributed around the Cederberg Mountain region, 
encompassing the western and south-east areas of the Western Cape Province, as well as 
limited areas within the south-west of the Northern Cape Province (Joubert & de Beer, 2011).    
 
Rooibos is highly polymorphic and numerous wild types varying in geographical 
distribution patterns, morphology, ecology, and chemical composition have been 
described (Morton, 1983; van Heerden et al., 2003).  Out of all the naturally occurring 
Aspalathus species and ecotypes originally used to produce rooibos tea, only the red 
type or Rocklands type is cultivated for commercial use today (Morton, 1983; Joubert 
& de Beer, 2011).   
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The Rocklands type is categorised into the wild-growing Cederberg type, and the 
improved, cultivated Nortier type named after Dr. P. le Fras Nortier who initiated the 
selection and cultivation of rooibos in plantations (Morton, 1983; Joubert & de Beer, 
2011).  In recent years the growing demand for rooibos has also reignited support for 
the development of small scale organisations that harvest and export several wild 
types of rooibos to niche markets under organic and fair-trade certification (Joubert & 
de Beer, 2011; van Heerden et al., 2003).     
 
Even though morphological characteristics such as size, density of branching, leaf 
size and colour, etc. vary considerably within the species, this shrub-like bush can 
typically grow up to 2 m high in its natural state, compared to 0.5 – 1.5 m for 
cultivated plants, depending on its age, environmental conditions, and geographical 
distribution (Rooibos Ltd., 2015; Joubert & de Beer, 2011).  As shown in Figure 5.2, 
the needle-like leaves are bright green, long (15 – 60 mm) and thin (± 1 mm), 
however coarser and broader leaves are generally observed in wild type plants 
(Morton, 1983; Joubert & de Beer, 2011).  During spring or early summer, small 
yellow sweet pea-like flowers appear at the tips of the straight, slender branches 
which are often red-brown in colour, and the fruit is a small lance-shaped legume 
usually containing one or two hard yellow seeds (Morton, 1983; South African 
National Biodiversity Institute, 2007).   
 
 
Figure 5.2: The rooibos (Aspalathus linearis) plant (Beltrán-Debón et al., 2011).  This 
highly polymorphic plant species is generally identifiable by its thin needle-like green leaves 
and woody red stem.  
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5.1.1.2  History and commercial importance 
 
Rooibos was first discovered hundreds of years ago by the indigenous Khoi tribe of 
the Cederberg and Elephants river valley region of the Western Cape (Joubert et al., 
2008; Morton, 1983).  They used the leaves and stems to make an herbal tea 
infusion traditionally used for its calming effects on the nervous and digestive system, 
as well as alleviating insomnia (van Niekerk & Viljoen, 2008).  This practice was 
documented in 1772 by European botanist Carl Humberg, during his travels through 
Africa (Morton, 1983).  Commercialization and marketing was initiated in 1904 by 
Russian immigrant Benjamin Ginsberg, a merchant of Clanwilliam, and by 1930 
commercial crops were being grown with the assistance of Dr. le Fras Nortier 
(Joubert et al., 2008; Morton, 1983).  Rooibos was listed as a South African 
medicinal plant in 1932 by Watt and Breyer-Brandwijk, although exploitation of its 
extensive therapeutic value (5.1.1.4) only started in 1968 when Annetjie Theron 
discovered that rooibos tea alleviated colic in her baby – ultimately establishing an 
extensive brand of skin-care and wellness products containing rooibos extracts 
(Joubert et al., 2008).  Rooibos extracts are now used as value-added products in 
anything from bread to yoghurt, jams, sauces, hot and cold beverages, liqueur, craft 
beer, skin, hair and pet care products.  In accordance with its increased popularity, 
production of rooibos in South Arica has grown to an average of about 12 000 tons 
per annum, most of which is exported to countries such as Germany, Netherlands, 
United Kingdom, Japan and The United States of America (SARC, 2013; Joubert & 
de Beer, 2011).   
 
5.1.1.3 Processing of plant material 
 
Rooibos is traditionally consumed as a “fermented” product of the plant leaves and 
stems.  The production process begins when plants are harvested during summer 
and early autumn (December to April) (Joubert & Schulz, 2006; Joubert et al., 2008).  
The leaves and stems are shredded, bruised and placed in a fermentation heap.  The 
subsequent addition of water and additional bruising of the plant material accelerates 
the fermentation process initiated during shredding by encouraging the release and 
subsequent enzymatic oxidation of polyphenols, leading to rapid browning and 
producing the characteristic red-brown coloured product (Joubert et al., 2008).  
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Throughout the fermentation process, the heap is turned over several times to aerate 
the plant material, thereby ensuring sufficient oxidation to produce a high quality end 
product (Joubert, 1994; Joubert, 1998).  Depending on the age of the plant material, 
climatic conditions etc., the fermentation process is generally complete within 12 – 14 
hours, or when the sweet, honey-like aroma and red-brown colour have fully 
developed (Joubert, 1994; Joubert & Schulz, 2006).  The heap is then spread out into 
a thin 15 – 20 mm layer, and allowed to dry in the sun before sieving, steam 
pasteurisation and packaging (Joubert & Schulz, 2006). 
 
Numerous studies have shown that the fermentation process significantly reduces 
the polyphenolic content of rooibos products (Bramati et al., 2003; Joubert et al., 
2008; Marnewick et al., 2000; Standley et al., 2001).  As the antioxidant properties of 
polyphenols, and the perceived health benefits thereof became more apparent, 
demand for natural products rich in antioxidants, such as an unfermented or “green” 
rooibos product, increased exponentially. 
 
The production of green rooibos requires minimal oxidative changes, and generally 
involves simply spreading the shredded plant material in a thin layer, and leaving it to 
dry naturally in the sun (Joubert & Schulz, 2006).  This can however be challenging 
due to some loss in aspalathin content, especially if the plant material was not 
properly dried, resulting in uncontrolled fermentation processes.  Alternative methods 
are however available (Joubert & de Beer, 2011).    
 
5.1.1.4  Anecdotal and biological properties 
 
Rooibos is not only enjoyed as a soothing herbal tea with a pleasing and unique 
aroma.  Anecdotal reports have included its use in the alleviation of numerous 
ailments, including:  
 
 Stomach and digestive problems: colic, indigestion, heartburn, nausea, 
vomiting, diarrhoea, stomach cramps, constipation; 
 Allergies: asthma and hay fever; 
 Dermatological problems: eczema, psoriasis, dermatitis, acne and nappy rash; 
 Improve hair growth, reduce hair loss; 
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 Improve appetite and hydration;  
 Reduce nervous tension, depression, insomnia, tension and headaches, and 
promote sound sleep (Morton, 1983; Joubert et al., 2008; Petrova, 2009; 
South African National Biodiversity Institute, 2007).  
 
Even though in some cases there is still limited scientific proof to support these 
anecdotal reports, extensive in vitro, ex vivo and in vivo studies have been conducted 
to evaluate the potential health-promoting effects of rooibos, and have been 
comprehensively reviewed by Joubert et al. (2008) and Joubert & de Beer (2011).   
 
Despite the increasing popularity and the well-known antioxidant capacity of Rooibos 
(see above mentioned reviews), there exists little published research on its precise 
molecular and cellular involvement against ageing.  It is currently believed that 
ageing is caused, at least in part, by an imbalance between antioxidant defences and 
oxidative stress, further associated with mitochondrial dysfunction.  Even though 
numerous in vitro studies have investigated the antioxidant capacity of rooibos, 
subsequent investigations into the ageing process have been limited, and only a few 
in vivo studies have investigated the link between oxidative stress and ageing.  In 
one of the earliest studies Inanami et al. (1995) investigated the effects of rooibos 
treatment on the accumulation of age related lipid peroxidation in 5 week and 24 
month old rats.  The high degree of lipid peroxidation observed in aged rat brain 
tissue is reportedly the result of increased spontaneous free radical generation 
accompanied by an age-related reduction in antioxidant defence mechanisms.  
Rooibos extracts, fed after weaning throughout a 24 month period, was shown to 
significantly decrease the accumulation of lipid peroxides in several regions of the 
brain, presumably due to the superoxide and hydroxyl radical scavenging properties 
of flavonoids (Joubert et al., 2008).   
 
Juráni et al. (2008) investigated the effects of rooibos on the postnatal development 
and egg production in aged Japanese quail (Coturnix coturnix japonica) hens.  Birds 
can be used as a model for ageing in biomedical research due to the fact that most 
species have a relatively slow ageing rate in relation to their high metabolic rates, 
lifetime energy expenditure, body temperature and high blood glucose levels (Juráni 
et al., 2008).   
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Substitution of drinking water with rooibos tea, or supplementation of food with 
rooibos tea extract positively affected body weight and egg production in hens, and 
prolonged the productive period of aged hens.  The effects observed were attributed 
to either the antioxidant activity or the phyto-oestrogenic activity of rooibos (Juráni et 
al., 2008; Joubert et al., 2008).  Using Caenorhabditis elegans, Chen et al. (2013) 
investigated the protective effect of rooibos extracts against oxidative stress induced 
by the pro-oxidant juglone or a high glucose environment.  Their results indicated that 
treatments with aspalathin (one of the main polyphenols in rooibos) can extend the 
life span of C. elegans during stressed conditions via the insulin/IGF signalling 
pathway, in addition to enhancing resistance to oxidative stress through the up-
regulation and expression of stress-response related genes (Chen et al., 2013).     
 
5.1.1.5 Chemical composition 
 
Rooibos has an interesting and unique chemical profile.  An extensive range of 
compounds have been identified in the volatile fraction of fermented rooibos, 
including: ketones, aldehydes, alcohols, esters, ethers, phenols and acids, and are 
reported to contribute to the unique aroma of rooibos (Habu et al., 1985; Kawakami 
et al., 1993).  Several non-phenolic metabolites, and minerals such as sodium, 
calcium, copper, iron, potassium, magnesium, manganese, nickel, phosphorous and 
zinc, have also been identified to a limited extent in rooibos plant material (Joubert et 
al., 2008; Malik et al., 2008).  Most importantly however is the phenolic composition 
of rooibos.  Extensive characterisation of rooibos plant material has revealed a 
diverse mixture of secondary phenolic metabolites including single ring phenolic 
acids, and monomeric flavonoids from the subclasses: dihydrochalcones, flavanones, 
flavones and flavonols (Beelders et al., 2012). 
 
Dihydrochalcones are biogenetic precursors of flavonoids in higher plants and have 
demonstrated an extensive variety of pharmacological effects (Forejtníková et al., 
2005).  Of particular interest are the two rare dihydrochalcone C-glycosides, 
aspalathin and nothofagin, which have been identified in rooibos.  Rooibos is 
currently the only known natural source of aspalathin (2’,3,4,4’,6’-pentahydroxy-3’-C-
β-D-glucopyranosyldihydrochalcone), as well as its cyclised form aspalinin (Snijman 
et al., 2009; Joubert & de Beer, 2011).   
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Nothofagin, the 3-deoxy analogue of aspalathin, has previously only been identified in 
the heartwood of Nothofagus fusca and the bark of a Chinese medicinal plant 
Schoepfia chinensis, and is present in much lower quantities (Snijman et al., 2009; 
Joubert & de Beer, 2011).  Other phenolic compounds of interest that have been 
identified include: 
 
 Flavanones: Dihydro-orientin, dihydro-isoorientin, hemiphlorin,   
 Flavones:   Orientin, iso-orientin, vitexin and iso-vitexin, luteolin, 
luteolin-7-O-glucoside, chrysoeriol, 
 Flavonols:   Quercetin, isoquercitrin, hyperoside, rutin, quercetin-3-O 
-robinobioside,  
 Phenolic acids:  Caffeic acid, ferulic acid, p-coumaric acid, vanillic acid, 
protocatechuic acid, chlorogenic acid, salicylic acid, gallic 
acid, syringic acid,  
 Flavan-3-ols:  (+)-catechin, procyanidin B3 
 Lignans, a phenylpyruvic acid glycoside (PPAG), as well as coumarins 
esculetin and esculin (von Gadow et al.,  1997; Mckay & Blumberg, 2007; 
Joubert et al., 2008; Beelders et al., 2012) 
 
In addition to the compounds listed above, many others can be identified due to the 
fact that they can be present as free aglycones, or undergo extensive hydroxylation, 
methylation and glycosylation with carbohydrates and glycosides (Jaganath & Crozier, 
2010).  This not only contributes to their structural complexity, but also the vast 
number of individual compounds which have been isolated and identified.   
 
5.1.1.5.1 Factors affecting the phenolic composition of rooibos 
 
The phenolic composition of plant material is remarkably variable.  Apart from the 
expected variation in phenolic composition between different populations and 
ecotypes of wild rooibos plants, unpublished data reported by Joubert & de Beer 
(2011) demonstrated large variations in aspalathin and its flavone analogue orientin 
within individual plants from the same plantation.  Numerous factors including: the 
genetic variation of the seedling, geographical location, seasonal variation, cultivation 
methods, and harvest date have been reported to affect polyphenol compositions (van 
Heerden et al., 2003; Joubert & Schulz, 2006; Joubert & de Beer, 2011).   
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Most importantly however, are the effects of plant processing and manufacturing 
processes (5.1.1.3).  Numerous studies have shown that the fermentation process 
significantly reduces the total polyphenolic content of rooibos products (Bramati et 
al., 2003; Joubert et al., 2008; Marnewick et al., 2000; Standley et al., 2001).   
 
Dihydrochalcones are particularly susceptible to oxidative changes.  This is illustrated 
by the extensive degradation of aspalathin and, to a lesser extent, nothofagin during 
fermentation (Bramati et al., 2003; Schulz et al., 2003).  According to the reaction 
mechanism described by Krafczyk & Glomb (2008), aspalathin is photochemically 
and enzymatically converted to its flavone analogues orientin and iso-orientin through 
the flavanone intermediate dihydro-iso-orientin.  A similar reaction mechanism was 
suggested for the oxidation of nothofagin to iso-vitexin and vitexin, but lacks 
experimental support (Hillis & Inoue, 1967; Joubert & de Beer, 2011).  Additionally, 
Krafczyk et al. (2009) demonstrated the formation of high molecular weight 
aspalathin and nothofagin dimers during oxidation.  These high molecular weight 
dimers were subsequently identified as key chromophores contributing to the 
characteristic red-brown colour development during the fermentation of rooibos 
(Joubert & de Beer, 2011; Krafczyk et al., 2009).  These chromophores are ultimately 
degraded into tannin-like structures, which could therefore provide a possible 
explanation for the significant difference in the amount of complex tannin-like 
structures in fermented and green rooibos (Joubert et al., 2008).   
 
Therefore, when considering the numerous factors that influence the already 
complex chemical composition of plants, it becomes clear that quantitative data and 
comprehensive characterisation is required not only for quality control purposes, but 
also to assist in the complete understanding of the potential biological activity.      
 
5.1.1.5.2 Preparation and characterization of rooibos extracts 
 
The fermented and green rooibos extracts used in this study were a kind donation 
from Prof Elizabeth Joubert from the Agricultural Research Council (ARC, Infruitec-
Nietvoorbij, Stellenbosch, South Africa).  Characterisation of the major secondary 
metabolites can be seen in Table 5.1.  Further information regarding the phenolic 
composition of the rooibos extracts will be discussed throughout this chapter.   
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Methods used for the preparation and characterisation of these extracts are 
described in section 5.2.1. 
 
Table 5.1: Characterisation of secondary metabolites in green and fermented rooibos 
extracts used in this study.  Phenolic content (g/100g extract) provided by Prof Elizabeth 
Joubert.  (Muller et al., 2012; Mazibuko et al., 2013).  (General structure and substituents 
adapted from Joubert et al., 2008).   
Structure Compounds Green Fermented 
 
Dihydrochalcones 
Aspalathin 
R1 = OH, R2 = C-β-D-glucosyl 
18.44 0.364 
Nothofagin 
R1 = H, R2 = C-β-D -glucosyl 
1.292 0.070 
 
Flavones 
Orientin 
R1 = C-β-D-glucosyl, R2 = R4 =OH, R3 = H 
1.050 0.721 
Iso-orientin 
R1 = H, R2 = R4 =OH, R3 = C-β-D-glucosyl 
2.054 0.924 
Luteolin-7-O-glucoside 
R1 = R3 = H, R2 = O-β-D-glucosyl, R4 = OH 
ND 0.069 
Vitexin 
R1 = C-β-D-glucosyl, R2 = OH, R3 = R4 = H 
0.270 0.152 
Iso-vitexin 
R1 = R4 = H, R2 = OH, R3 = C-β-D-glucosyl 
0.389 0.140 
 
Flavonols 
Rutin 
R = O-β-D-rutinosyl 
0.536 0.185 
Quercetin-3-O-robinobioside 
R = O-robinosyl 
1.053 0.446 
Hyperoside 
R = O-β-D-galactosyl 
0.266 0.087 
Isoquercitrin 
R = O-β-D-glucosyl 
0.377 0.063 
 
Phenylpyruvic acid derivative 
PPAG 
R = O-glucosyl 
0.491 0.713 
Total 26.22 3.931 
PPAG, 3-phenyl-2-glucopyranosyloxypropenoic acid; ND, not detected.   
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5.2. Methods and materials 
 
5.2.1 Extract preparation and characterisation 
 
 
Please note that the extract preparation and characterisation described below (5.2.1) was not 
done by the author, and that the information supplied is only intended to provide a 
comprehensive overview on the methods that had been used in the preparation of the 
extracts used in this study.  
 
Fermented and green rooibos extracts were prepared and characterised, and then 
received as a kind donation from Prof Elizabeth Joubert from the Agricultural 
Research Council (ARC, Infruitec-Nietvoorbij, Stellenbosch, South Africa).  The 
fermented rooibos extract was prepared on industrial scale (600 kg) as described by 
Mazibuko et al. (2013).  Briefly, a hot water (>90°C) extraction was performed using a 
percolator type extraction vessel on a 1:10 solid: solvent mixture (m/m) for 30 
minutes.  This was followed by centrifugation, concentration, high-temperature short-
time sterilisation and vacuum-drying.  The green rooibos extract was prepared 
according to a patented process involving an organic solvent extraction process 
(80% ethanol–water mixture, at room temperature) to produce an aspalathin-
enriched green rooibos extract (Grüner-Richter et al., 2008).  The extract was filtered, 
vacuum dried and finally the powder was extracted with ethylacetate to reduce the 
chlorophyll content.   
 
Both extracts were characterised in terms of phenolic composition (Table 5.1) using 
high performance liquid chromatography with diode – array detection (HPLC-DAD) 
analysis as described by Beelders et al. (2012) and Muller et al. (2012).  Briefly, the 
water-based fermented extract was dissolved in water and the solvent-based green 
extract was dissolved in 10% DMSO, to a concentration of 2 mg/mL.  Ascorbic acid 
was added to a final concentration of 10 mg/ml, and filtered using a 0.22 μm pore-
size Millex-GV syringe filter devices (Millipore) prior to HPLC analysis.  Finally, 
aspalathin, nothofagin and PPAG were quantified at 288 nm, whereas orientin, iso-
orientin, vitexin, iso-vitexin, hyperoside, isoquercitin, rutin and quercetin-3-O-
robinobioside (as rutin equivalents) were quantified at 350 nm using 5-point 
calibration curves (Muller et al., 2012).   
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Peaks were identified by comparing retention times and UV–Vis spectra with those of 
authentic standards, as well as through comparison to relative retention times 
reported by Beelders et al. (2012) (Muller et al., 2012). 
 
5.2.2 Endotoxin analysis 
 
To detect the presence of bacterial endotoxins in the fermented and green rooibos 
extracts, the Pierce® LAL Chromogenic Endotoxin Quantitation Kit (Thermo Scientific, 
Logan, Utah, USA) was used as per manufacturer’s instructions (3.2).  The 96 well 
microplate was equilibrated at 37ºC for 15 minutes.  A 50 µL aliquot of the rooibos 
extracts (500 μg/mL) dissolved in endotoxin free water was added to the plate, 
covered and allowed to equilibrate at 37ºC.  After 5 minutes, 50 µL LAL was carefully 
added to each well, and the covered plate was placed on a plate shaker and left to 
gently shake for 10 seconds.  After incubating the plate at 37ºC for exactly 10 
minutes, a 100 µL aliquot of the substrate solution was carefully added to each well.  
The plate was again placed on the plate shaker for 10 seconds, followed by 
incubation at 37ºC for 6 minutes.  A 50 µL aliquot of the Stop Reagent (25% acetic 
acid) was added, followed by another 10 seconds on the plate shaker.  Finally the 
absorbance was read at 405 nm using a BioTek® PowerWave XS spectrophotometer 
(Winooski, VT, USA), and the endotoxin concentration of the rooibos extracts was 
then determined from a standard curve prepared as per manufacturer’s instructions.   
 
5.2.3  Cell line maintenance 
 
Cell lines were routinely maintained as described in section 3.1.  Briefly, the 3T3-L1 
preadipocyte cell line (wildtype) was routinely maintained in 10 cm culture dishes with 
DMEM medium containing 4 mM L-glutamine, 4.5 g/L glucose and sodium pyruvate, 
supplemented with 10% FBS (GE Healthcare Life Sciences, Logan, Utah, USA).  The 
mtDNA depleted 3T3-L1 preadipocyte cell line (ρ0 mutants), established and 
characterised in Chapter 4, was routinely maintained in 10 cm culture dishes with 
complete medium (DMEM and 10% FBS) supplemented with 50 μg/mL uridine and 
50 ng/mL EtBr (Sigma-Aldrich, St. Louis, MO, USA).  Due to the short half-life of EtBr 
in culture medium, the culture medium was replaced daily.   
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During routine maintenance, a small sample of the ρ0 mutant cell population was 
frequently sub-cultured in pyruvate free DMEM culture medium, without uridine and 
EtBr in order to evaluate the mtDNA status of the ρ0 mutants.  Ρ0 cells are 
characteristically auxotrophic for pyruvate and pyrimidines (uridine) and were 
therefore unable to survive in their absence.  Both cell lines were used from passage 
number 8 to 24, and confluency never exceeded 80%.  No antibiotics were added 
during routine maintenance, however, 1% (v/v) penicillin / streptomycin (P/S) (Sigma-
Aldrich, St. Louis, MO, USA) was added to long term experiments exceeding 5 days.   
 
5.2.4  Experimental design 
 
Throughout experimental procedures wildtype and ρ0 mutant cells were seeded 
during log phase, at a density of 20 000 cells/mL, unless otherwise stated, in 
appropriate culture vessels – as indicated by the requirements for each experiment.  
Cells were left overnight to attach and recover before exposure to treatments.  Stock 
solutions of fermented and green rooibos extracts were freshly prepared in dimethyl 
sulfoxide (DMSO) and diluted with complete medium (DMEM and 10% FBS) to the 
concentration(s) required for each experiment, and therefore the final concentration 
of DMSO in the cultures never exceeded 0.25% (v/v).  Based on preliminary findings 
in our laboratory a treatment concentration of 100 µg/mL was selected for both 
fermented and green rooibos extracts.  Included in each experiment was an 
untreated control, a vehicle control (0.25% DMSO in complete medium) when 
relevant, as well as appropriate positive controls when available.  Unless otherwise 
stated, each treatment was performed in triplicate and the experiment was repeated 
3 times (n=3).   
   
5.2.5 Cell viability and IC50 determination 
 
In order to determine possible cytotoxic effects of rooibos extracts on wildtype and ρ0 
mutant cells, the CellTiter-Blue™ cell viability assay (Promega, Madison, WI, USA) 
was used (3.4).  Wildtype and ρ0 mutant cells were seeded at a density of 20 000 
cells/mL in 200 μL aliquots in a 96 well plate, and allowed to attach and recover 
overnight.  
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Green and fermented rooibos extract concentration ranges of 5 – 500 μg/mL were 
tested in quadruplicate.  Exposure times of 24, 48 and 72 hours were allowed, after 
which the culture medium was removed and replaced with fresh complete medium 
containing 200 μL/mL CellTiter-Blue™ reagent.  After 3 hours of incubation at 37°C, 
fluorescence was measured at 540 nm (Ex) / 590 nm (Em) using a Fluoroskan Ascent 
FL fluorometer (Thermo Labsystems, Finland).   
   
5.2.6 Cell growth characteristics 
 
Cell growth characteristics relating to viability and proliferation were continuously 
evaluated using an automated cell counter, Luna™ (Logos Biosystems, Korea) (3.3).  
Wildtype and ρ0 mutant cells were seeded at a density of 10 000 cells/mL in 10 mL 
aliquots in 10 cm culture dishes.  After 24 hours of incubation and exposure to 
treatments, cells were collected from culture plates by first washing with 500 μL of 
Dulbecco’s phosphate buffered saline  (DPBS, without Ca2+ and Mg2+) (Lonza, 
Walkersville, MD, USA), followed by trypsinization (trypsin: EDTA) for 10 minutes at 
37°C, and resuspension in 1 mL complete medium.  A 10 μL aliquot of the cell 
suspension was removed and added to 10 μL of 0.4% trypan blue, followed by 
analysis using the automated cell counter.  The remaining cells were seeded back 
into the original culture dish, and the process was repeated on the same plate every 
24 hours for a total of 6 consecutive days as described by Yu et al., 2007.   
 
5.2.7 Cell cycle analysis 
 
Cell cycle analysis was performed on synchronized wildtype and ρ0 mutant cells 
using the Coulter® DNA Prep™ kit (Beckman Coulter, CA, USA) which utilizes 
propidium iodide (PI) to stain DNA and determine cell cycle distribution (3.6).  
Wildtype and ρ0 mutant cells were seeded in 1.5 mL aliquots at 20 000 cells/mL in 6 
well culture dishes and left overnight to attach and recover.  Cells were synchronised 
through serum deprivation overnight, after which the serum free medium was 
replaced with complete culture medium containing 10% FBS, to permit re-entry into 
the cell cycle.  DNA cell cycle analysis was performed using the Coulter® DNA Prep™ 
kit, as per manufacturer’s instructions.   
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Cells were collected 24, 48, and 72 hours after adding the 10% FBS (in the absence 
of EtBr) and exposure to treatments, by washing with 500 μL of DPBS (without Ca2+ 
and Mg2+) (Lonza, Walkersville, MD, USA), followed by trypsinization for 10 minutes 
at 37°C, and resuspension in 500 μL DPBS (with Ca2+ and Mg2+) (Lonza, 
Walkersville, MD, USA).  Cell suspensions were transferred into suitable 
polypropylene tubes, and the cells collected by centrifugation at 500 x g for 5 minutes 
at room temperature.  A 100 μL aliquot of lysis reagent (< 0.1% sodium azide, non-
ionic detergents, saline, and stabilizers) was added to each sample, vortexed and 
incubated for 5 minutes at room temperature.  A 500 μL aliquot of PI (50 μg/mL) was 
then added to the samples and incubated in the dark for 15 minutes at 37°C, after 
which samples were analysed using a Beckman Coulter Cytomics FC500 Flow 
Cytometer (CA, USA) (3.5) and data was recorded in FL3.  Results were analysed on 
FlowJo v10 software (Tree Star Inc., USA).       
 
5.2.8 Mitochondrial membrane potential 
 
The effect of rooibos extracts on the mitochondrial membrane potential of wildtype 
and ρ0 mutant cells was evaluated using the cytofluorimetric, lipophilic cationic dye 
JC-1 (Sigma-Aldrich, St. Louis, MO, USA) (3.7).  Wildtype and ρ0 mutant cells were 
seeded in 1.5 mL aliquots at 20 000 cells/mL in 6 well culture dishes and left 
overnight to attach and recover.  Cells were collected after 24, 48, and 72 hours of 
exposure to treatments (in the absence of EtBr) into polypropylene tubes.  JC-1 (1 
mg/mL) was added to a final concentration of 2 µg/mL in pre-warmed complete 
medium.  Samples were allowed to incubate for 10 minutes in the dark at room 
temperature, after which three wash steps were performed using 500 µL of DPBS 
(Lonza, Walkersville, MD, USA) and centrifugation at 500 x g for 5 minutes.  Red 
(FL3) and green (FL1) fluorescence was recorded using a Beckman Coulter 
Cytomics FC500 Flow Cytometer (CA, USA) (3.5).  Results were analysed on FlowJo 
v10 software (Tree Star Inc., USA).  Valinomycin (Sigma-Aldrich, St. Louis, MO, 
USA), a K+ ionophore, was used as a positive control due to its ability to dissipate the 
mitochondrial membrane potential (Felber & Brand, 1982).  Positive control wildtype 
and ρ0 mutant cells were incubated with 400 nM Valinomycin for 30 minutes prior to 
JC-1 staining and flow cytometric analysis.    
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5.2.9 Metabolic parameters: glucose utilization and lactate production. 
 
To determine the effect of rooibos extracts on glucose utilization and lactate 
production of wildtype and ρ0 mutant cells, the glucose oxidase (3.9.1) and lactate 
oxidase (3.9.2) assays were used.    
 
5.2.9.1 Glucose utilization assay  
 
Wildtype and ρ0 mutant cells were seeded at a density of 20 000 cells/mL in 200 μL 
aliquots in a 96 well plate, and allowed to attach and recover overnight.  After 24, 48 
and 72 hours of exposure to treatments, 5 μL of the culture medium was removed 
and added to 200 μL of the glucose oxidase assay reagent (prepared as described in 
Appendix II) incubated for 10 minutes at 37°C and the absorbance was read at 520 
nm using a BioTek® PowerWave XS spectrophotometer (Winooski, VT, USA).  The 
resultant absorbance values indicated the amount of glucose remaining in the culture 
medium, and glucose utilization was subsequently calculated as a percentage of the 
control (untreated cells).      
 
5.2.9.2 Lactate production assay  
 
Similar to the glucose oxidase assay, wildtype and ρ0 mutant cells were seeded at a 
density of 20 000 cells/mL in 200 μL aliquots in a 96 well plate, and allowed to attach 
and recover overnight.  After 24, 48 and 72 hours of exposure to treatments, 5 μL of 
the culture medium was removed and added to 200 μL of the lactate oxidase assay 
reagent (prepared as described in Appendix II), incubated for 10 minutes at 37°C and 
the absorbance was read at 520 nm using a BioTek® PowerWave XS 
spectrophotometer (Winooski, VT, USA).  The resultant absorbance values indicated 
the amount of lactate present in the culture medium, and lactate production was 
subsequently calculated as a percentage of the control (untreated cells).  
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5.2.10  Confocal microscopy 
 
To characterise mitochondrial function in rooibos treated wildtype and ρ0 mutant 
cells, JC-1 staining (3.7) was used in conjunction with confocal microscopy to 
observe changes in the mitochondrial membrane potential.   
   
Confocal microscopy imaging was performed at the Confocal and Light Microscope 
Imaging Facility at the University of Cape Town, under the supervision of Professor 
Dirk Lang and Mrs. Susan Cooper.  A Zeiss Axiovert LSM 510 META confocal 
microscope, equipped with a Zeiss AxioCam camera for fluorescent imaging, was 
used.  The confocal microscope stage was also equipped with a specialized pre-
heated (37°C) humidified chamber supplied with 5% CO2, thus enabling live cell 
imaging.  This was required due to the fact that JC-1 is not well retained after fixation, 
and enabled real time observation of mitochondrial movement and cellular activities.  
Cells were maintained as described in section 5.2.3.  Wildtype and ρ0 mutant cells 
were seeded in 500 μL aliquots at a density of 2 000 cells/mL in specialized 35 mm 
glass bottom culture dishes to enable the use of higher objective imaging, and left 
overnight to attach and recover.  After 48 hours of exposure to treatments, JC-1 
(Sigma-Aldrich, St. Louis, MO, USA) staining was performed according to 
manufacturer’s instructions.  Briefly, cells were incubated with pre-warmed complete 
culture medium containing JC-1 (2 µg/mL), for 20 minutes in the dark at 37°C.  The 
staining solution was removed and cells were carefully washed using DPBS (Lonza, 
Walkersville, MD, USA).  Fresh complete culture medium was added to the culture 
dishes, which were then allowed to equilibrate in the chamber for ± 10 minutes.  A 
488 nm laser line was used for excitation, along with appropriate band pass filters 
(CH2: BP 500-550 IR; CH3: BP 575-630 IR) to enable detection of green (CH2) and 
red (CH3) fluorescence emissions.  High resolution static images, time lapse images, 
as well as optical slice (Z-stack) images taken at 1 μm intervals along the z axis, 
were acquired using a Plan-Apochromat 63x oil immersion objective (NA=1.4).  The 
laser light intensity and detector gains were set such that fluorescence intensities of 
both dyes were below saturation levels.  Similarly, the pinhole size was kept constant 
throughout acquisition at 192 μm (CH2) and 220 μm (CH3) to avoid oversampling.  
Post-acquisition processing was performed using ZEN 2012 software (Carl Zeiss 
Microscopy GmbH, 2011).  
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5.3 Results and discussion 
 
The aim of this study was to investigate the potential anti-ageing properties of green 
and fermented rooibos extracts using the in vitro cell culture model representative of 
mitochondrial dysfunction associated with the age related decline in preadipocyte 
function, established and characterised in chapter 4.  The effects of rooibos on cell 
growth and proliferation, mitochondrial membrane potential, and metabolic parameters 
such as glucose utilization and lactate production, was therefore evaluated using 3T3-
L1 preadipocytes (wildtype) as well as ρ0 3T3-L1 preadipocytes (ρ0 mutants).    
 
Please note that throughout this chapter, experimental results are presented for wildtype and 
ρ0 mutant cell populations in purple and red, respectively.   
 
Based on previous work done in our laboratory with regards to the positive effect of 
rooibos extracts as well as the lack of cytotoxicity, a treatment concentration of 100 
µg/mL was selected for both fermented and green rooibos extracts, and was used 
throughout this study.  Wisman et al. (2008) showed that polyphenolic compounds 
strongly interfere with the redox chemistry of metabolic assays such as the MTT 
assay.  Therefore, the results obtained from the initial cell viability assays, including 
those described in section 5.2.5 were re-evaluated using the trypan blue exclusion 
assay (as described for cell growth characteristics in section 5.2.6), which revealed 
significantly different results.  It was however confirmed that the concentration of 100 
µg/mL used throughout this study was not cytotoxic, and no IC50 value could be 
established for both the green and fermented rooibos extracts in the wildtype and ρ0 
mutant cell lines in the range tested.   
 
5.3.1 Endotoxin analysis 
 
Adipocytes (including preadipocytes) are particularly sensitive to endotoxins (LPS) 
and other factors such as tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6), and 
interferon-γ (IFN-γ) due to the fact that, apart from its primary energy storing function, 
adipose tissue also forms an integral component of the innate immune response, 
mediated primarily through highly conserved pattern recognition receptors such as toll-
like receptors (TLRs) (Chirumbolo et al., 2013; Schäffler & Schölmerich, 2010; 
Tchkonia et al., 2010).   
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Preadipocytes constitutively express toll-like receptor 4 (TLR4), which can be 
activated by the lipid A moiety of LPS, resulting in lipolysis, insulin resistance and 
inflammation (3.2).  Pharmacopoeias describe acceptance criteria and limits of 
endotoxin levels in in vitro biological test systems, which should be below 1 ng/mL 
(Ryan, 2008).  Using the Pierce LAL Chromogenic Endotoxin Quantitation Kit 
(Thermo Scientific, Logan, Utah, USA), capable of detecting endotoxin levels as low 
as 0.1 endotoxin unit (EU)/mL or ± 0.01 ng endotoxin/mL, it was established that both 
the fermented and green rooibos extracts were free of detectable endotoxins 
(Results not shown).   
 
5.3.2 Cell growth characteristics 
 
Using an automated cell counter, cell numbers (total, live and dead) and % viability 
were evaluated every day for 6 consecutive days in order to establish growth curves 
(Figure 5.3 and 5.5) from which population doubling times could be calculated as 
described in section 4.3.1.1. 
 
 
Figure 5.3: Comparison of the growth rate of untreated and rooibos treated (100 
μg/mL) wildtype cells.  Total cell number indicates the viable cell density determined using 
trypan blue staining.  Error bars represent SD of nine replicate values (n=3).    
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Comparing the growth curve of the untreated cell population with the green and 
fermented rooibos treated cell populations (Figure 5.3) a considerably decreased 
growth rate can be observed.  This was confirmed by the increased population 
doubling times observed for green (19.3 ± 3.8) hours) and fermented (20.6 ± 4.6) 
hours) rooibos treated cell populations, relative to that of untreated cells (18.8 ± 2.1) 
hours).  It should however be considered that the population doubling times were 
calculated during the most linear growth phases (48 – 120 hours), thereby excluding 
and underestimating the positive effects seen within 24 (day 1) and 48 hours (day 2) 
of treatment.  Although the growth curves provide an interesting perspective on the 
effect of extensive rooibos treatment (5 days) on cell proliferation, the observable 
effects within the first two days of treatment are unclear, therefore an alternative 
representation of these results can be seen in Figure 5.4, in which the cell density of 
rooibos treated cells was calculated as a percentage relative to untreated wildtype 
cells.   
 
 
Figure 5.4: Cell density of rooibos treated (100 μg/mL) wildtype cells represented as a 
percentage of the untreated wildtype control (100%).  Total viable cell number determined 
using trypan blue staining, represented as a % value relative to the untreated control.  Error 
bars represent SD of nine replicate values (n=3).  Statistical significance was determined 
using the two-tailed Student t-test and is indicated for p < 0.05 (*) and p < 0.005 (**) relative to 
untreated control. 
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From the results presented in Figure 5.4, it can be seen that although not statistically 
significant, after 48 hours (day 2) of treatment  with green and fermented rooibos, the 
respective cell densities had increased by 11% and 7%, relative to the untreated 
control.  However, after 72 hours (day 3) of treatment with rooibos, the cell densities 
were significantly reduced compared to the untreated control.   
 
As established in section 4.3.1.1, ρ0 mutants have a significantly decreased growth 
rate compared to wildtype cells.  Figure 5.5 and 5.6 illustrate the effect of green and 
fermented rooibos on the growth rate of ρ0 mutants.  
 
 
Figure 5.5: Comparison of the growth rate of untreated and rooibos treated (100 
μg/mL) ρ0 mutant cells.  Total cell number indicates the viable cell density determined using 
trypan blue staining.  Error bars represent SD of nine replicate values (n=3).    
 
Using the above results (Figure 5.5) population doubling times of 29.8 ± 3.8 and 32.4 
± 3.8 hours were determined for green and fermented rooibos treated ρ0 mutant cell 
populations, compared to 30.2 ± 4.2 hours established for untreated ρ0 mutant cells 
(4.3.1.1).  Again it should be considered that population doubling times were 
calculated during the most linear growth phases (48 – 120 hours), thereby excluding 
and underestimating the positive effects seen within the 24 and 48 hours of 
treatment.  Consequently, an alternative representation of these results can be seen 
in Figure 5.6.     
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Figure 5.6: Cell density of rooibos treated (100 μg/mL) ρ0 mutants represented as a 
percentage of the untreated ρ0 mutant control (100%). Total viable cell number 
determined using trypan blue staining, represented as a % value relative to the untreated 
control.  Error bars represent SD of eight replicate values.  Statistical significance was 
determined using the two-tailed Student t-test and is indicated for p < 0.05 (*) and p < 0.005 
(**) relative to untreated ρ0 mutant control. 
 
Relative to untreated ρ0 mutant cells, treatment with green rooibos resulted in a 20% 
increase in the cell density after 24 hours (day 1), an effect which was somewhat 
diminished after 48 hours (day 2) of treatment when only a 10% increase in cell 
density was observed.  Treatment with fermented rooibos on the other hand, only 
resulted in a slight, insignificant 5% increase in cell density after 24 hours (day 1), 
after which a progressive decrease in cell density can be observed.      
 
The results obtained indicate that although an increase in cell density was initially 
observed for wildtype and ρ0 mutant cell populations after 24 and 48 hours of 
treatment with green rooibos, prolonged treatment (day 3 – day 5) resulted in a 
progressive decrease in cell density.  This effect was even more notable for 
fermented rooibos treated wildtype and ρ0 mutant cell populations, thereby 
implicating the different phenolic compositions of the rooibos extracts, as defined in 
Table 5.2, which will be discussed at the end of this results and discussion section.       
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Of particular interest, is the observation that ρ0 mutant cells responded much more 
favourably to the rooibos treatments compared to wildtype cells, as can be seen 
when comparing the cell densities throughout the 5 days of treatment.  Cell viability 
as determined by trypan blue exclusion was unaffected throughout the 5 days of 
treatment with green and fermented rooibos in both the wildtype and ρ0 mutant cell 
populations, thereby indicating that the decrease in cell density is attributed to altered 
cell growth kinetics, possibly involving a delay in the cell cycle progression at certain 
checkpoints.    
 
5.3.3 Cell cycle analysis 
 
The effect of rooibos treatment on the cell growth characteristics prompted the 
investigation of the cell cycle distribution.  Cell cycle analysis was performed on 
synchronised rooibos treated and untreated wildtype and ρ0 mutant cells after 24, 48 
and 72 hours.  A summary of the percentage cells present in each cell cycle phase is 
presented in Table 5.2 and 5.3, and representative histograms in Figure 5.7 and 5.8.     
 
wildtype 
 
 
 
 
 
 
 
Figure 5.7: Representative cell cycle histograms illustrating DNA distribution for 
untreated and rooibos treated (100 μg/mL) wildtype cells.  Cells were synchronised 
through serum deprivation overnight, after which re-entry into the cell cycle was initiated by 
the addition of 10% FBS to the culture medium.  Cell cycle analysis was performed after 48 
hours using PI staining.  Ten thousand events were recorded for each sample on a Beckman 
Coulter Cytomics FC500 flow cytometer, and results were analysed using FlowJo v10 
software.  Percentage (%) values indicate the amount of cells present in each phase.  One 
representative of 3 experiments performed in triplicate. 
94 
 
Table 5.2: Summary of cell cycle analysis results obtained for untreated and rooibos 
treated (100 μg/mL) wildtype cells.  Cell cycle analysis was performed using PI staining 24, 
48, and 72 hours after re-entry into the cell cycle following synchronization through serum 
deprivation. 
 
wildtype green fermented 
24 hours 
Sub-G1 3.13 ± 0.38 4.14 ± 1.48 3.67 ± 0.88 
G1/G0 44.6 ± 1.38 36.5 ± 5.80 * 41.7 ± 7.32 
S 20.2 ± 1.26 29.5 ± 10.9 * 24.1 ± 6.52 
G2/M 26.5 ± 1.04 26.0 ± 6.81 26.9 ± 6.72 
48 hours 
Sub-G1 2.93 ± 0.55 3.59 ± 1.20 3.35 ± 0.38 
G1/G0 42.2 ± 2.78 42.3 ± 3.52 48.0 ± 4.84 * 
S 18.5 ± 4.66 14.6 ± 5.20 15.2 ± 5.68 
G2/M 30.0 ± 3.17 34.2 ± 5.77 * 28.7 ± 4.19 
72 hours 
Sub-G1 3.70 ± 0.54 3.74 ± 1.18 3.09 ± 0.89 
G1/G0 43.0 ± 1.51 45.3 ± 8.75 45.7 ± 9.66 
S 15.2 ± 2.65 19.6 ± 7.80 14.8 ± 4.21 
G2/M 31.7 ±1.76 26.8 ± 2.15 * 31.2 ± 6.53 
Experiments were conducted in triplicate and performed 3 independent times.  
Values indicate mean % ± SD of all experimental data.  Statistical significance was 
determined using the two-tailed Student t-test and is indicated for p < 0.05 (*) and p 
< 0.005 (**) relative to untreated control.   
 
As expected, the most significant changes in the cell cycle distribution of rooibos 
treated wildtype cell populations were observed after 24 and 48 hours of treatment.  
Most notably, after 24 hours of treatment with green rooibos an 8.1% decrease in the 
amount of cells present in the G1/G0 phase is observed, corresponding to a 9.3% 
increase in the amount of cells present in the S phase.  This is followed by a 
concurrent 3.9% increase in the amount of cells present in the G2/M phase after 48 
hours of treatment.  A more moderate response was observed for the fermented 
rooibos treated cells which, after 24 hours of treatment, exhibited a much smaller 
increase in the amount of cells present in the G1/G0 phase (2.9%) corresponding to 
a small increase in the amount of cells present in S phase (4.1%).   
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However, after 48 hours a significant increase (5.8%) in the amount of cells present 
in the G1/G0 phase was observed.  Therefore the cell cycle analysis results were 
consistent with the observed growth rates.  The progression of ρ0 mutants through 
the cell cycle occurred much slower compared to wildtype cells, as indicated by the 
significant increase (5.3%) in the amount of cells remaining in the G1/G0 phase 
associated with the decreased (2.4%) amount of cells present in the S phase.   
 
ρ0 mutants 
 
 
 
 
 
 
 
 
 
 
Figure 5.8: Representative cell cycle histograms illustrating DNA distribution for 
untreated and rooibos treated (100 μg/mL) ρ0 mutants.  Cells were synchronised through 
serum deprivation overnight, after which re-entry into the cell cycle was initiated by the 
addition of 10% FBS to the culture medium.  Cell cycle analysis was performed after 48 
hours using PI staining.  Ten thousand events were recorded for each sample on a Beckman 
Coulter Cytomics FC500 flow cytometer, and results were analysed using FlowJo v10 
software.  Percentage (%) values indicate the amount of cells present in each phase.  One 
representative of 3 experiments performed in triplicate. 
 
Comparing the DNA distribution throughout the cell cycle histogram of the green and 
fermented treated ρ0 mutants, relative to the untreated ρ0 mutant cells, a decrease in 
the size of the G2/M peak area is apparent, together with a small but significant 
increase in the S phase area.  These results are congruent with the growth rates 
observed for ρ0 mutants.   
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Ideally these results would have been confirmed using a proliferation assay to 
determine new DNA synthesis, thereby providing more information on the S phase 
population.  However due to technical difficulties, and subsequent inconsistent results, 
this experiment was excluded from this document and would have to be repeated. 
 
Table 5.3: Summary of cell cycle analysis results obtained for untreated and rooibos 
treated (100 μg/mL) ρ0 mutants.  Cell cycle analysis was performed using PI staining 24, 48, 
and 72 hours after re-entry into the cell cycle following synchronization through serum 
deprivation. 
 
ρ0 mutant green fermented 
24 hours 
Sub-G1 2.43 ± 1.53 1.68 ± 0.35 2.56 ± 0.66 
G1/G0 48.8 ± 3.34 42.0 ± 0.83 ** 47.1 ± 2.17 
S 18.8 ± 3.02 18.3 ± 1.45 17.1 ± 1.87 
G2/M 23.2 ± 2.68 32.0 ± 2.63 ** 28.1 ± 1.77 * 
48 hours 
Sub-G1 2.02 ± 0.46 2.61 ± 0.43 2.68 ± 1.11 
G1/G0 49.0 ± 2.70 52.4 ± 5.60 59.8 ± 4.92 ** 
S 13.3 ± 3.47 16.8 ± 3.91 15.0 ± 4.80 
G2/M 31.7 ± 2.15 24.3 ± 2.95 ** 18.9 ± 3.36 ** 
72 hours 
Sub-G1 3.59 ± 0.95 3.86 ± 1.41 2.96 ± 1.65 
G1/G0 48.7 ± 2.22 55.4 ± 9.21 63.7 ± 8.87 ** 
S 14.6 ± 1.68 18.9 ± 4.76 * 17.8 ± 7.34 
G2/M 33.2 ± 1.05 20.9 ± 5.08 ** 19.94 ± 4.37 ** 
Experiments were conducted in triplicate and performed 3 independent times.  
Values indicate mean % ± SD of all experimental data.  Statistical significance was 
determined using the two-tailed Student t-test and is indicated for p < 0.05 (*) and p < 
0.005 (**) relative to untreated ρ0 mutant control. 
 
Considering that ρ0 mutants generally exhibit a delay in G1-S phase transition, as 
indicated by a significant increase in the amount of cells present in the G1 phase 
relative to wildtype cells, the significant decrease (6.8%) in the amount of cells in the 
G1/G0 phase after 24 hours of treatment with green rooibos, along with a concurrent 
increase (8.8%) in the amount of cells present in the G2/M phase, indicates that the 
rooibos treatment stimulated cell cycle progression.  
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This is in accordance with the increased proliferation and cell density observed after 
24 hours of treatment with green rooibos, as indicated previously (Figure 5.5 and 
5.6).    
 
However, after 48 hours of treatment with green and fermented rooibos, a complete 
change in the cell cycle distribution is seen due to the increase in the amount of cells 
present in the G1/G0 phase, as well as the S phase compared to a significant 
decrease in the amount of cells present in the G2M phase.  Interestingly, after 72 
hours of exposure to rooibos, the most notable change observed is the increased 
number of cells present in the G1/G0 phase for both green and fermented rooibos, 
along with a slight increase in the number of cells present in the S phase, and a large 
decrease in the number of cells present in the G2/M phase.  This is therefore in 
accordance with the decreased proliferation rate, as well as the subsequent 
decrease in cell density, as previously indicated (Figure 5.5 and 5.6).   
 
It is difficult to compare results of other rooibos studies to that of this study, due to 
the fact that different rooibos extracts were used, at different concentrations, for 
different cell lines, at different exposure  times.  Lamosŏvá et al. (1997) showed that 
treatment with 2, 10 and 100% of rooibos tea extract significantly inhibited 
proliferation of chick embryonic skeletal muscle cells.  It was proposed that apart 
from the harmful effect of ROS on cellular constituents, it is also involved in cell 
division and mitosis among other physiological functions.  Therefore, the strong 
antioxidant properties of the rooibos extracts could inhibit mitosis and cell division by 
removing reactive oxygen species needed for mitogenic stimulation of cells 
(Lamosŏvá et al., 1997).  Low physiologic levels of ROS have been shown to 
stimulate cell proliferation in multiple cell types, similarly the reduction of intracellular 
ROS in response to the addition of antioxidants such as vitamins (E, C and A), or N-
acetyl-L-cysteine, has been shown to decrease cellular proliferation (Havens et al., 
2006).  Although this could be relevant to the results obtained in the present study, 
comparing the phenolic composition of the green and fermented rooibos extracts 
(Table 5.1) showed that the green rooibos extract had a total phenolic content of 
26.22 g/100g compared to the fermented extract, 3.931 g/100g.  Bearing in mind that 
antioxidant properties of rooibos are related to its total phenolic content, this does not 
provide an adequate explanation for the results obtained.   
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The synergistic / antagonistic effects between any of these phenolic compounds are 
obviously of critical importance, however very little is known about the exact reaction 
mechanisms involved.  Considering that a positive effect on the cell density, and 
therefore the rate of proliferation was seen within the shorter treatment times of 24 
and 48 hours, and that the inhibitory effects were only seen after 72 hours of 
treatment, it could indicate that oxidative changes in the phenolic compounds could 
have taken place, due to their instability in the culture medium, which could have 
induced a pro-oxidant effect (Joubert et al., 2005; Magcwebeba, 2011).  The pro-
oxidant effects of flavonoids are associated with an increase in ROS and/or variation 
in endogenous antioxidant molecules such as GSH.  Semiquinone or phenoxyl 
radicals and ROS can be generated from flavonoid compounds through processes 
such as auto-oxidation involving redox active polyphenol-metal complexes, radical 
scavenging, as well as the Fenton type reaction (Magcwebeba, 2011; Procházková 
et al., 2011).  
 
The effects of these pro-oxidant properties have been investigated in vitro (Joubert et 
al., 2005; Marnewick et al., 2009).  In this regard, testing lower concentrations of 
rooibos, within a range that does not negatively influence proliferation may provide 
an opportunity to distinguish the apparent biphasic effect of rooibos on preadipocyte 
function.  Nonetheless it is clear that the health benefits of rooibos may be context 
dependent and thus require careful experimental design and data interpretation to 
ensure accurate conclusions. 
 
5.3.4 Mitochondrial membrane potential 
 
The effect of rooibos treatment on the mitochondrial membrane potential (ΔΨm) was 
determined using the lipophilic cationic dye JC-1, which exhibits a potential-
dependent accumulation in the mitochondria (3.7).  JC-1 will either be retained in the 
mitochondria due to the negative charge established by the intact ΔΨm and form J-
aggregate complexes emitting a red fluorescence (polarised mitochondria) or, will 
diffuse into the cytoplasm due to a collapse in ΔΨm, where the monomeric form will 
exhibit a green fluorescence (depolarised mitochondria).   
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The results shown in Figures 5.9 and 5.10 illustrate the effects of rooibos treatment 
on the mitochondrial membrane potential of wildtype and ρ0 mutant cells, 
respectively, observed after 24, 48 and 72 hours.  Representing the ΔΨm is the ratio 
of the mean fluorescence intensity of FL3 (red) to FL1 (green).  
 
 
Figure 5.9: Mitochondrial membrane potential of rooibos treated (100 μg/mL) wildtype 
cells after 24, 48 and 72 hours, represented as a percentage of the untreated wildtype 
control (100%).  Cells were stained with the polychromatic, ΔΨm sensitive probe JC-1.  The 
mitochondrial membrane potential is represented as the ratio of the mean fluorescence 
intensity of FL3 (red) to FL1 (green).  Error bars represent SD of nine replicate values (n=3).  
Statistical significance was determined using the two-tailed Student t-test and is indicated for 
p < 0.05 (*) and p < 0.005 (**) relative to untreated control.  
 
Compared to untreated wildtype cells, the above results show that after 24 hours of 
treatment with green rooibos, a significant reduction (45%) in ΔΨm was observed, 
followed by a significant increase (25%) in ΔΨm after 72 hours.  Treatment with 
fermented rooibos resulted in a significant increase in ΔΨm after 48 (32%) and 72 
(43%) hours. 
 
Ρ0 mutants have a significantly lowered ΔΨm compared to wildtype cells (4.3.1.3).  
The ΔΨm is established through the activity of oxidative phosphorylation, conducted 
by respiratory chain complexes located within the inner mitochondrial membrane.   
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Out of the 5 respiratory chain complexes, 4 are encoded by the mitochondrial 
genome, consequently depletion of mtDNA results in defective mitochondrial 
respiration and oxidative phosphorylation, subsequently dissipating the ΔΨm.    
 
 
Figure 5.10: Mitochondrial membrane potential of rooibos treated (100 μg/mL) ρ0 
mutants after 24, 48 and 72 hours, represented as a percentage of the untreated ρ0 
mutant control (100%).  Cells were stained with the polychromatic, ΔΨm sensitive probe 
JC-1.  The mitochondrial membrane potential is represented as the ratio of the mean 
fluorescence intensity of FL3 (red) to FL1 (green). Error bars represent SD of nine replicate 
values (n=3).  Statistical significance was determined using the two-tailed Student t-test and 
is indicated for p < 0.05 (*) and p < 0.005 (**) relative to untreated ρ0 mutant control.  
 
The results obtained for ρ0 mutants (Figure 5.10) indicate a somewhat similar trend to 
that observed for the wildtype cells (Figure 5.9).  The decrease (30%) in ΔΨm 
observed after 24 hours of treatment with green rooibos could possibly be related to 
the corresponding cell cycle analysis results (5.3.2), due to the observed decrease in 
the amount of cells in the G1/G0 phase relative to untreated ρ0 mutants (explained 
below).  Once again, the observation of hyperpolarization after 48 and 72 hours of 
treatment could be associated with processes such as the activation of 
mitocheckpoint, autophagy, or other metabolic processes.  On the other hand, these 
effects might simply be due to improved mitochondrial health and activity, however 
further investigation into the effects of rooibos on specific mitochondrial bioenergetics 
will have to be done (as discussed in Chapter 6).        
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Fluctuations in ΔΨm impact the functioning of the mitochondria with respect to energy 
metabolism, intracellular ion homeostasis, and perhaps most importantly the cell life 
– death transition (Perry et al., 2011).  A decrease in ΔΨm is often an early indicator 
of apoptosis.  However, considering that no changes in cell viability was observed, it 
indicated that the decreased ΔΨm might be the result of decreased mitochondrial 
respiration which could occur during quiescence or ensuing cellular stress, leading to 
a transient mitochondrial membrane permeabilization.  Although the exact 
mechanisms are still poorly understood, studies have shown that mitochondrial 
dynamics relating to morphology, mitochondrial membrane potential, oxidative 
phosphorylation activity, size, distribution and abundance, are important mediators in 
cell cycle progression (Arakaki et al., 2006; Ferree & Shirihai, 2012; Koopman et al., 
2013; Mitra et al. 2009).  As the cell progresses through the G1 phase, mitochondria 
convert from isolated, fragmented elements into a giant hyperfused and remarkably 
hyperpolarized, tubular network at the G1-S transition.   
 
The decreased ΔΨm observed after 24 hours of treatment with green rooibos could 
possibly be related to the corresponding cell cycle analysis results (5.3.2), given that 
the green rooibos treated cells could have proceeded through the G1-S transition 
faster than the untreated cells.  This would not only account for the significantly 
decreased G1/G0 phase cell population along with the increased S phase cell 
population, but also the decreased ΔΨm, due to the fact that the highest ΔΨm is 
observed at the G1-S transition (large hyperfused tubular network), after which the 
mitochondrial network fragments and separates in preparation for the G2/M phase.   
Similarly, the hyperpolarized ΔΨm observed for green rooibos after 72 hours, and 
fermented rooibos after 48 and 72 hours, could also be related to the corresponding 
cell cycle analysis results (5.3.2).   
 
However, seeing as the formation of the hyperpolarised, hyperfused tubular network 
at the G1-S transition is transient, and that the cell cycle analysis results indicated no 
significant changes in the distribution of cells throughout the cell cycle compared to 
untreated cells, it should be considered that the increased ΔΨm could be associated 
with processes such as the activation of mitocheckpoint, autophagy, or other 
metabolic processes. Additionally, hyperpolarisation of ΔΨm has previously been 
shown to inhibit mitogenesis of lymphocytes and spleen cells (Chang et al., 2001).   
102 
 
Interestingly, the green extract showed a more prominent effect on the cell cycle and 
cell growth characteristics compared to the fermented extract, however it exhibited a 
lessor effect on the mitochondrial membrane potential compared to the fermented 
extract, suggesting that these effects are independent, at least within the context of 
this experimental model, and that additional molecular mechanisms may also be 
involved.  This discrepancy could be attributed to the varied antioxidant activities and 
the threshold required to initiate a particular cellular response.   
  
5.3.5 Metabolic parameters: glucose utilization and lactate production  
 
Given that glucose metabolism is strongly correlated to mitochondrial function, 
glucose utilization and lactate production was investigated as markers for changes in 
mitochondrial function upon treatment with rooibos using both wildtype and ρ0 mutant 
cells.  Considering the variation in cell growth characteristics (5.3.2), results were 
normalised to the respective cell densities.  Results are expressed as a percentage 
of glucose utilization (Figure 5.11 and 5.13) and lactate production (Figure 5.12 and 
5.14) relative to untreated cells.     
 
 
Figure 5.11: Normalised glucose utilization by rooibos treated (100 μg/mL) wildtype 
cells after 24, 48 and 72 hours, represented as a percentage of the untreated wildtype 
control (100%).  Error bars represent SD of nine replicate values (n=3).  Statistical 
significance was determined using the two-tailed Student t-test and is indicated for p < 0.005 
(**) relative to untreated control. 
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Figure 5.12: Normalised lactate production by rooibos treated (100 μg/mL) wildtype 
cells after 24, 48 and 72 hours, represented as a percentage of the untreated wildtype 
control (100%).  Error bars represent SD of nine replicate values (n=3).  Statistical 
significance was determined using the two-tailed Student t-test and is indicated for p < 0.005 
(**) relative to untreated control. 
 
Numerous studies have demonstrated that rooibos treatment increases glucose 
uptake (Joubert & de Beer, 2011; Muller et al., 2012; Sanderson et al., 2014).  It is 
therefore not surprising that an increase in glucose utilization was observed after 24 
and 48 hours of treatment with green and fermented rooibos.  However after 72 hours 
of treatment, glucose utilization is significantly reduced relative to untreated cells.  A 
progressive increase in lactate production can be observed as the green and 
fermented rooibos treatment time increases.         
 
Mitochondrial respiration and oxidative phosphorylation is impaired in ρ0 mutants, 
resulting in an overreliance on glycolysis to produce the required cellular ATP.  
Considering that only 2 ATP molecules are produced per glucose molecule during 
glycolysis, compared to a total of 36 produced through the complete mitochondrial 
respiration process, it is clear that a significant increase in glucose utilization is 
expected.  The overreliance on glycolysis leads to an accumulation of NADH, which 
has to be regenerated to NAD+ through the conversion of pyruvate to lactate via 
lactate dehydrogenase resulting in an increase in lactate production.  Therefore, 
compared to wildtype cells, glucose utilization and lactate production are significantly 
increased in ρ0 mutants (4.3.1.4). 
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Figure 5.13: Normalised glucose utilization by rooibos treated (100 μg/mL) ρ0 mutant 
cells after 24, 48 and 72 hours, represented as a percentage of the untreated ρ0 mutant 
control (100%).  Error bars represent SD of nine replicate values (n=3).  Statistical 
significance was determined using the two-tailed Student t-test and is indicated for p < 0.005 
(**) relative to untreated control. 
 
 
Figure 5.14: Normalised lactate production by rooibos treated (100 μg/mL) ρ0 mutant 
cells after 24, 48 and 72 hours, represented as a percentage of the untreated ρ0 mutant 
control (100%).  Error bars represent SD of nine replicate values (n=3).  Statistical 
significance was determined using the two-tailed Student t-test and is indicated for p < 0.05 
(*) and p < 0.005 (**) relative to untreated control. 
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As shown in Figure 5.13 glucose utilization is increased after 24 hours of treatment 
with green and fermented rooibos, and progressively decreased as the treatment time 
increased.  Lactate production (Figure 5.14) is decreased after 24 hours of rooibos 
treatment, and progressively increased as the treatment time increased.  Overall, the 
increase in glucose utilization indicates an improvement in the mitochondrial function.  
However, the progressive decrease in glucose utilization, along with a concomitant 
increase in lactate production is quite unexpected considering that increased lactate 
production is usually associated with significantly increased glucose utilization.   
 
These results could indicate that rooibos does not directly target mitochondrial 
function.  Alternately, this could indicate that rooibos induces a metabolic shift in which 
carbon flow is directed away from mitochondrial metabolism, and more towards lactate 
production.  Therefore, the cell would become resistant to mitochondrial dysfunction 
and subsequently an improvement in growth kinetics is observed.  This is in 
accordance with results published on the anti-diabetic properties of rooibos, indicating 
an increase in glucose uptake concurrent to an activation of AMPK.  Interestingly, 
studies have indicated that AMPK signalling controls energy metabolism, autophagic 
degradation, stress resistance, as well as the process of ageing, as indicated by a 
decreased sensitivity toward AMPK activation (Salminen & Kaarniranta, 2012).  
Additionally, results by Chen et al. (2013) indicated that treatments with aspalathin can 
extend the life span of C. elegans during stressed conditions through regulation of the 
DAF-16/FOXO insulin-like signalling pathway, in addition to enhancing resistance to 
oxidative stress through the up-regulation and expression of stress-response related 
genes.  Considering the direct relation between AMPK signalling and DAF-16/FOXO 
activation, investigation of this with regards to possible conserved mammalian 
pathways could be a vital component to gain more understanding of the complex 
process of ageing (Salminen & Kaarniranta, 2012; Tullet et al., 2014).   
 
Adipocytes are particularly sensitive to oxidative stress, during which responses such 
as increased lactate production have been observed, which is subsequently involved 
in the development of insulin resistance (Soares et al., 2005).  This might provide an 
explanation for the above results, however the effects of rooibos in the treatment of 
insulin resistance has been extensively characterised, therefore making this 
observation highly unlikely.   
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Considering that resistance to oxidative stress is linked to lactate production, due to 
the fact that an increased glucose flux also stimulates glutathione production through 
the glucose-6-phosphate dehydrogenase reaction, the same argument can be 
offered as above, in that inducing a metabolic shift and redirecting the metabolism 
could provide resistance to oxidative stress.        
 
The difference in treatment times could also be of significant importance, seeing as 
other studies report treatment times of only 3 – 6 hours (Muller et al., 2012; Mazibuko 
et al., 2013; Dludla et al., 2014), compared to the 24 to 72 hour treatment time used 
in this study.  This could be attributed to an increase in the pro-oxidant properties of 
phenolic compounds due to their instability in culture medium however it should also 
be considered that, after extensive treatment time intervals such as the 72 hour 
treatment time used in this study, glucose consumption would no longer simply be 
restricted to energy homeostasis, and will also support cell growth etc., consequently 
the correlation between glucose utilization and lactate production becomes far more 
complex.   
 
In support of the results obtained in this study, studies using the exact same rooibos 
extracts reported an increase in glucose uptake in C2C12 skeletal myotubes and 
Chang liver cells, which was attributed to the increased aspalathin content in the 
green relative to the fermented rooibos (Table 5.1).   
 
Likewise, Mazibuko et al. (2013) reported that these rooibos extracts produced an 
increase in glucose uptake, mitochondrial activity and ATP production in insulin 
resistant C2C12 cells, with the green rooibos exhibiting an increased effectivity 
relative to the fermented rooibos.  PPAG has also been shown to increase glucose 
uptake in 3T3-L1 adipocytes, and was present in green (0.491 g/100g) and 
fermented (0.713 g/100g) rooibos, and finally a synergistic effect has been reported 
for aspalathin and rutin, showing an improved hypoglycaemic activity (Muller et al., 
2012; Muller et al., 2013).   
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However, it is also important to consider the different cell types, specifically with 
regards to the different glucose transporters, seeing as C2C12 myotubes express 
GLUT4 transporters, whereas undifferentiated 3T3-L1 cells would primarily express 
GLUT1, and Chang liver cells are capable of expressing both GLUT1 and GLUT2.  
Whilst this cannot provide an explanation as to the differences in the results obtained 
for green and fermented rooibos, it would provide insight into the mechanism of 
glucose uptake between different cell lines, and should perhaps be considered for 
future studies.       
 
5.3.6 Confocal microscopy 
 
To confirm and visualise the mitochondrial membrane potential (ΔΨm) changes 
observed using flow cytometry (5.3.3), rooibos treated wildtype and ρ0 mutant cells 
were stained with JC-1 and viewed using confocal microscopy.   
 
Using the confocal microscopy images obtained for JC-1 stained mitochondria, 
individual rooibos treated and untreated wildtype and ρ0 mutant cells were isolated 
and analysed using Zen software post-acquisition processing.  A ratio of red / green 
fluorescence intensity, indicating the ΔΨm, was determined for 10 randomly selected 
cells exposed to either green or fermented rooibos, for both the wildtype and ρ0 
mutant cell populations, as shown in Table 5.4.   
 
Table 5.4: Results obtained from post-acquisition confocal microscopy image 
processing indicating the ΔΨm for wildtype and ρ
0 mutant cells.  Representing ΔΨm as: 
a ratio of the mean fluorescence intensity of FL3 (red) to FL1 (green) ± SD.    
 wildtype ρ0 mutants 
untreated 1.345 ± 0.49 1.093 ± 0.20 
green 1.369 ± 0.29 1.120 ± 0.17 
fermented 1.445 ± 0.51 1.316 ± 0.43 
 
The above results are in agreement with results obtained for JC-1 staining and 
analysis using flow cytometry (5.3.4) indicating an increase in ΔΨm after 48 hours of 
treatment with fermented rooibos for both the ρ0 mutant and wildtype cells, relative to 
the negligible / small increase observed for green rooibos treated ρ0 mutant and 
wildtype cells.   
108 
 
Representative images can be seen in Figure 5.15, where live cell imaging was 
performed using confocal microscopy after 48 hours of treatment with rooibos 
extracts (63x oil immersion magnification).  Mitochondria were stained using the 
polychromatic ΔΨm sensitive fluorescent probe JC-1, which exhibits a membrane 
potential dependent accumulation and aggregate formation within the mitochondria.  
Polarized (red) and depolarized (green) mitochondria are indicated with yellow 
colouration representing overlap.  One representative of 15 images taken for each 
respective treatment, during a single experiment is shown.   
 
During the progression of the cell cycle, mitochondria undergo changes in 
morphology, size, distribution and abundance (Ferree & Shirihai, 2012; Arakaki et al., 
2006).  This morphological spectrum has been characterised according to the cell 
cycle progression into tubular, intermediate and fragmented conformations (Mitra et 
al. 2009; Margineantu et al., 2002).  As can be seen in Figure 5.15, green and 
fermented treated wildtype and ρ0 mutant cells have a more intermediate 
mitochondrial arrangement, typical of proliferating cells (G1-S or S phase), with 
tubular elements clearly visible.   
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   wildtype               ρ0 mutants 
       
      
       
 
Figure 5.15: Representative confocal microscopy images of JC-1 stained mitochondria 
in individually characterised untreated (U) as well as green (G) and fermented (F) 
rooibos treated wildtype (left) and ρ0 mutant cells (right).   
G 
F F 
G 
U U 
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5.4 Conclusion 
 
Wildtype 3T3-L1 preadipocytes   
The effects of rooibos in 3T3-L1 adipocytes have previously been reported with 
regards to its antidiabetic action as well as the potential to prevent obesity through the 
modulation of glucose uptake, leptin secretion etc. (Joubert & de Beer, 2011; Muller et 
al., 2012; Mazibuko et al., 2013; Sanderson et al., 2014).  No literature pertaining to 
the effect of rooibos on preadipocytes could however be found.  The results obtained 
in this study indicated that treatment with green and fermented rooibos extracts had a 
positive effect on cell proliferation after 48 hours of treatment, which was associated 
with an increase in mitochondrial membrane potential.  As expected, glucose 
utilization was increased after 24 and 48 hours of treatment with green rooibos in both 
the wildtype and ρ0 mutant cells, whereas treatment with fermented rooibos only 
produced a significant increase in glucose utilization after 24 hours.        
 
Ρ0 3T3-L1 preadipocytes  
Throughout this study, rooibos treatments had a more significant effect on ρ0 mutant 
cells relative to the wildtype cells.  This was illustrated by the stimulation of cell growth 
after 24 and 48 hours of treatment, most notably with the green rooibos treatment – 
although subsequent experiments, as discussed in Chapter 6, need to be performed 
to confirm this observation.  The same trend was observed for the effects of rooibos 
on the mitochondrial membrane potential, relative to wildtype cells.  Once again, the 
expected increase in glucose utilization was observed after 24 hours, and decreased 
as the treatment time was increased.   
 
Therefore the results obtained highlight the potential restorative effect of rooibos on 
the age associated mitochondrial dysfunction observed in preadipocytes, especially 
with regards to the possible metabolic shift, AMPK activation and DAF-16/FOXO 
activated signalling pathways as discussed previously (5.3.5), keeping in mind 
however, that the AMPK regulation of DAF-16 activation through the insulin/IGF 
signalling pathway has been identified in C. elegans (Chen et al., 2014) and although 
evidence of activation of AMPK subunits in mammals suggests that such FOXO-
AMPK interactions may be evolutionarily conserved, a great deal more research is 
required (Tullet et al., 2014).     
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CHAPTER 6: Concluding remarks 
 
The aim of this study was to investigate the potential anti-ageing properties of green 
and fermented rooibos (Aspalathus linearis) using an in vitro cell culture model 
representative of the age-related mitochondrial dysfunction observed in 
preadipocytes.  Mitochondrial dysfunction was induced through mtDNA depletion as 
a result of long term exposure to sub lethal concentrations of EtBr, as described in 
Chapter 4.  Compared to wildtype cells, ρ0 mutants exhibited a much slower growth 
rate in culture, congruent with a significant delay in G1 phase cell cycle progression, 
as well as a significantly reduced mitochondrial membrane potential, an increased 
glucose utilization and lactate production.  Treatment with green rooibos stimulated 
cell growth and proliferation, and attenuated the G1 phase delay.  This was also 
observed in the fermented treated cells but to a lesser extent.  Both fermented and 
green rooibos significantly improved the mitochondrial membrane potential, as well 
as demonstrating some ability to regulate glucose utilization in relation to lactate 
production.  Although less apparent, a similar effect was observed in wildtype cells.  
In conclusion, the results obtained indicate that rooibos extracts exhibit effects which 
preserve the functional capacity of preadipocytes exposed to ageing related insults.  
Clearly, the health benefits of rooibos may be context dependent and thus require 
careful experimental design and data interpretation to ensure accurate conclusions. 
   
Throughout this study, notable differences in activity were observed between the 
green and fermented rooibos treatments, with the former being more effective at 
improving cell growth and proliferation, as well as modulating glucose utilization and 
lactate production.  Interestingly, compared to the green rooibos, treatment with the 
fermented extract exhibited a more prominent effect on mitochondrial health, as 
shown by the increased mitochondrial membrane potential.  This can be attributed to 
the different phenolic compositions.  Further conclusions can however not be made 
with regards to the activity of specific isolated compounds due to the limited amount 
of literature available on the activities of isolated compounds, as well as the effects of 
rooibos on ageing.  Therefore, the isolation and identification of active compounds in 
relation to the anti-ageing potential of rooibos would be extremely beneficial.   
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Furthermore, the synergistic and antagonistic effects of a combination of active 
compounds should also be investigated.  The importance of this lies not only in the 
fact that it would provide some much needed insight into the process of ageing, but 
also due to the fact that rooibos is well known for its perceived anti-ageing effects, 
with both green and fermented extracts being commonly used in skin care products 
and as dietary supplements, without much published research supporting these 
claims.   
 
The ρ0 3T3-L1 preadipocyte cell line developed and characterised in this study, 
represents a novel concept in the field of ageing research, specifically relating to 
mitochondrial dysfunction within ageing preadipocytes.  Likewise, although other 
studies have previously investigated the anti-ageing properties of rooibos using the 
nematode C. elegans (Chen et al., 2013), and Japanese quail (Coturnix coturnix 
japonica) hens (Juráni et al., 2008), the ρ0 3T3-L1 preadipocyte cell line represents 
the first in vitro cell culture model used in the investigation of the anti-ageing 
properties of rooibos on a cellular level.        
 
Apart from the points discussed above, other considerations for improvement of this 
study are listed below.   
 
Considerations for improvement of this study 
 
 Investigate the effect of rooibos on AMPK signalling pathways and its 
interaction with FOXO, specifically with regards to its role as a possible anti-
ageing mechanism.  
 Repeat proliferation studies to more accurately determine S phase 
populations, using assays such as the 5-bromo-2-deoxyuridine (BrdU) 
labelling assay, for example.  The uridine derivative BrdU, is a structural 
analogue of thymidine, and will be incorporated into DNA as a substitute for 
thymidine during S phase, thereby serving as a marker for proliferation. 
 Measure ATP production to evaluate metabolic activity as well as cell viability. 
 Further investigate effects of long term rooibos treatments / optimize treatment 
concentration and / or time. 
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 Mitochondrial function is regulated by autophagy (mitophagy).  Segregation of 
damaged mitochondria depends on fission and fusion events which are 
altered in mitochondrial dysfunction (García-escudero et al., 2013).  
Considering the potential of rooibos to induce autophagy (unpublished data) 
this could provide important information on the anti-ageing potential of rooibos 
– specifically relating to the development of age related neurodegenerative 
diseases.             
 The time lapse confocal imaging performed in this study could not provide 
sufficient quantitative or qualitative information due to the non-specific nature 
of the experiment.  Optimization could provide information on the effect of 
rooibos on mitochondrial dynamics including fission and fusion events (Detmer 
& Chan, 2007).    
 Investigate the restorative effect of rooibos through the repletion of mtDNA 
(Biswas et al., 1999; Park & Lee 2007).   
 Investigate the capacity to differentiate, which is decreased during the ageing 
process. 
   
 
Other molecular mechanisms involved in the age associated decline in preadipocyte 
function include oxidative stress, hypoxia, and inflammation.  Due to time constraints 
however, only some initial investigations were made into the generation of a second 
in vitro cell culture model representative of oxidative stress in ageing preadipocytes.   
 
Although promising results were obtained, these findings are not included in this 
document due to the fact that much more work was required to complete this model.  
Hopefully further investigations can be done in the future to complete the 
characterisation of this model, as well as evaluating the effects of rooibos on 
oxidative stress as observed in the age-related decline in preadipocyte function.  Due 
to the anti-inflammatory activity of rooibos, as well as the effects of dietary 
polyphenols on signal transduction pathways, it would also be interesting to 
determine the effects of rooibos on the age related progression of inflammation in 
preadipocytes.     
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Prospective for future studies  
 
Mitochondrial dysfunction is considered a critical component in the development of 
diabetes and insulin resistance (Lim et al., 2006).  Considering the well-known anti-
diabetic activity of rooibos, similar models of mitochondrial dysfunction within 
appropriate cell lines such as C2C12 myotubes for example, could provide vital 
information on the anti-diabetic properties of rooibos.      
 
 
 
Within the last decade or so, discovery of mitochondrial signalling mechanisms and 
the involvement of mitochondrial dysfunction in stress responses, has revolutionized 
the way in which we view mitochondria.  Mitochondria are no longer just seen as ATP 
producing / apoptosis regulating organelles, and are now understood to be dynamic, 
mobile structures, constantly undergoing fusion and fission, and engaging in intimate 
interactions with other cellular compartments and structures, such as the 
endoplasmic reticulum, to modulate an extensive range of intracellular signalling 
(McInnes, 2013).  Therefore, it is not surprising that an increasing number of human 
diseases have been associated with functional defects in mitochondria, and the 
processes they regulate.  During this study, a new appreciation for the mitochondria 
was developed and of particular interest to the author were the pathophysiological 
outcomes in mitochondrial diseases.  A brief overview of mitochondrial diseases is 
given in Appendix IV seeing as this is not technically within the scope of this study, 
however it has definitely provided a vital motivation for prospective studies. 
 
 
 
 
 
 
 
 
 
Thank you 
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APPENDIX I: Materials list 
 
The following table lists the materials referred to in Chapter 3, as well as the relevant 
method and material sections 4.2 and 5.2.  Consumables are listed according to the 
manufacturer, and product or catalogue numbers are provided.     
product catalogue / product # 
GE Healthcare Life Sciences (Logan, Utah, USA) 
HyClone™ DMEM (High glucose, with L-glutamine and 
sodium pyruvate) 
SH30243 
HyClone™ DMEM (High glucose, with L-glutamine, without 
sodium pyruvate) 
SH30249 
HyClone™ Foetal Bovine Serum SV30160 
Lonza (Walkersville, MD, USA) 
BioWhittaker® Dulbecco’s phosphate buffered saline (DPBS) 
with Ca2+ and Mg2+ 
17-513F 
BioWhittaker® Dulbecco’s phosphate buffered saline (DPBS) 
without Ca2+ and Mg2+ 
17-512F 
Trypsin-EDTA CC-5012 
Sigma-Aldrich (St. Louis, MO, USA) 
Penicillin / Streptomycin (P/S) P4333 
Uridine U3003 
Trypan blue T6146 
Ethidium Bromide E8751 
Phenol P3653 
Glucose oxidase G0543 
Lactate oxidase L0638 
Peroxidase P8375/8250 
4-Aminoantipyrine 06800 
JC-1 T4069 
Valinomycin V3639 
Thermo Scientific - Thermo Fisher Scientific (Logan, Utah, USA) 
Pierce®  LAL Chromogenic Endotoxin Quantitation Kit 88282 
Promega (Madison, WI, USA) 
CellTiter-Blue™ cell viability assay G8081 
Beckman Coulter (CA, USA) 
Coulter® DNA Prep™ kit 6607055 
Molecular Probes® - Life technologies - Thermo Fisher Scientific (Logan, Utah, USA) 
MitoTracker®  Green FM M7514 
Click-iT®  EdU Alexa Fluor® 488 Kit C-10425 
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APPENDIX II: Reagent preparation 
 
The glucose oxidase and lactate oxidase assay reagents were prepared as follows:  
  
Phosphate buffer   Solution A (7 g NaH2PO4 in 100 mL water) 
Solution B (18.4 g Na2HPO4 in 400 mL water) 
 
Add 10 mL (A) to 40 mL (B) and dilute to final volume of 1.3 L (pH 7.4) 
 
Assay reagent    
Into 100 mL phosphate buffer add: 
 
0.028 g phenol 
0.008 g 4-aminoantipyrine 
0.074 g EDTA  
65 μL glucose oxidase 
0.001 g peroxidase  
 
Prepare fresh before use.  Alternatively, store at 4°C and add enzymes just before 
use.  The lactate oxidase assay reagent was prepared in exactly the same manner, 
the only difference being the substitution of the glucose oxidase enzyme for the 
lactate oxidase enzyme.      
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APPENDIX III: Project outputs and awards 
 
International conferences:  
 
Delivered as a poster presentation at the 62rd International Congress and Annual 
Meeting of the Society for Medicinal Plant and Natural Product Research (GA), in 
Portugal (September, 2014).   
 
Hattingh, A., van De Venter, M., Joubert, E. & Koekemoer, T. (2014) The anti-
ageing potential of Rooibos (Aspalathus linearis): Preserving preadipocyte 
function, Planta Medica, 80 (16). 
 
National conferences:  
 
Delivered as a poster presentation at the 17th annual conference of the Indigenous 
Plant Use Forum (IPUF) and received a Best poster presentation award (June, 
2014).   
 
Hattingh, A., van De Venter, M., Joubert, E. & Koekemoer, T. (2014) The anti-
ageing potential of Rooibos (Aspalathus linearis): Preserving preadipocyte 
function, In IPUF, 17th Annual Conference: Green Gold, Available: 
http://www.uj.ac.za/EN/Faculties/science/departments/botany/research/ipu
f/Documents/IPUF2014_PRogramme_and_abstracts.pdf 
    
Others:  
 
Delivered as an oral presentation, throughout the duration of this study, at the NMMU 
Masters and Doctoral (M&D) Research day to fellow students and academic staff 
members of the Department of Biochemistry, Microbiology and Physiology (2012, 
2013 and 2014). 
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APPENDIX IV: Mitochondrial dysfunction and diseases 
 
Since the first documented case of mitochondrial disease in 1962, numerous 
pathological conditions associated with mitochondrial dysfunction have been 
identified.  Human mitochondrial diseases are an extremely diverse and complex 
group of diseases predominantly defined as any disease caused by alteration in 
oxidative phosphorylation (Chinnery, 2014; Lombès et al., 2014).  Mitochondrial 
diseases can present at any age and can affect multiple organ systems 
simultaneously, or present in a tissue specific manner within which different target 
cells may be involved - thereby creating an extremely diverse disease phenotype 
(Chinnery, 2014; Taylor & Turnbull, 2005, Nunnari & Suomalainen, 2012).   
 
Mitochondrial diseases are extremely difficult to diagnose due to the considerable 
clinical variability caused by the numerous combinations of a myriad of symptoms, 
including: migraine, epilepsy, dementia, spasticity, dysphagia, cardiomyopathy, 
exercise intolerance, diabetes, thyroid disease, ptosis, optic atrophy, sensorineural 
deafness, as well as mid- and late stage pregnancy loss (Schapira, 2012; Alexeyev 
et al., 2013; Chinnery, 2014).  Currently only symptomatic treatment is available.  
 
Etiology of disease is predominantly attributed to any number of mutations in 
mitochondrial and / or nuclear DNA implicated in mitochondrial function, and can 
therefore be inherited maternally, from an autosome, or X chromosome (Chinnery, 
2014; Taylor & Turnbull, 2005, Nunnari & Suomalainen, 2012).  Additionally, 
environmental factors can also contribute to mitochondrial disease as well as interact 
and intensify predisposed genetic risk factors (Meyer et al., 2013).  Changes in 
cellular energy demands, poor diet and lifestyle (excessive alcohol consumption, 
smoking and lack of exercise), as well as adverse side effects of drugs 
(Aminoglycoside antibiotics, doxorubicin, nucleoside analogue reverse transcriptase 
inhibitors (NRTI)) are just some environmental factors that can contribute to 
mitochondrial dysfunction and disease (Taylor & Turnbull, 2005; Wallace, 2013; 
Meyer et al., 2013, Stankov, 2010; Greaves et al., 2012) 
 
 
142 
 
mtDNA mutations:  
Mutations in mtDNA, including: point mutations, rearrangements and deletions, are 
considered the primary cause of mitochondrial diseases, and more than 300 
pathogenic mutations have been identified (Greaves et al., 2011; Chinnery, 2014; 
Schapira, 2012).  Mitochondrial point mutations and rearrangements are inherited 
maternally, whereas mtDNA deletions generally occur de novo and often due to 
mutations in nDNA encoding mitochondrial maintenance genes (Chinnery, 2014; 
Schapira, 2012).  Somatic mutations caused by faulty repair or free radical mediated 
damage, also play an important role in mitochondrial disease and ageing (Schapira, 
2012).   
 
nDNA mutations:  
Nuclear gene mutations can be inherited in an autosomal (recessive / dominant) or 
X-linked manner and have been implicated in mtDNA instability leading to alterations 
in: mtDNA content (deletion / depletion), structural subunits, as well as assembly and 
translation factors involved in mitochondrial function and maintenance (Nunnari & 
Suomalainen, 2012; Copeland & Longley, 2014; Chinnery, 2014).  At least 13 nuclear 
genes affecting mtDNA stability have been identified in mitochondrial disease 
patients, most important of which is POLG which encodes the only replicative DNA 
polymerase known to function in the mitochondria, Pol γ (Copeland & Longley, 2014).   
 
Pol γ is exclusively responsible for mtDNA replication and repair, therefore it is not 
surprising that any alteration in its function will have profound effects on mtDNA 
stability.  Currently more than 200 mutations in POLG are associated with 
mitochondrial diseases, and spontaneous replication errors made by Pol γ account 
for almost all of the base substitutions in mtDNA (pathogenic or neutral variants), and 
subsequently contributes to mtDNA deletions and depletions that occur over time 
(Copeland & Longley, 2014).  Accordingly Pol γ activity is also considered to be 
involved in the natural process of ageing (Copeland & Longley, 2014; Schapira, 
2012).   
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Considering that tissues with a high energy demand such as the brain, heart, 
muscles, kidneys and endocrine systems are more commonly and severely affected 
by mitochondrial diseases, and that the same genetic mutation may not lead to the 
same disease phenotype in affected individuals, it becomes clear that the nature of 
the genetic mutation is not the only contributing factor to the clinically heterogeneous 
nature of mitochondrial diseases (Lombès et al., 2014; Wallace & Chalkia, 2013).  
Factors such as the target tissues’ metabolic requirements, capacity to subsequently 
develop compensatory responses as well as the heteroplasmic nature of mtDNA 
should also be considered (Lombès et al., 2014; Wallace & Chalkia, 2013).    
 
In conclusion, the definition of mitochondrial disease has been extended to include 
any disease associated with alterations in any mitochondrial component since 
mitochondrial dysfunction has also been implicated in many other acquired and age 
related diseases such as: diabetes, cancer, neurodegenerative diseases 
(Huntington’s, Alzheimer’s and Parkinson’s) cardiovascular disease, atherosclerosis, 
as well as the general process of ageing and senescence (Schapira, 2012; Alexeyev 
et al., 2013).  Therefore, when considering the strong antioxidant properties of plant 
phenolic compounds as well as their capacity to influence various signal transduction 
pathways, together with the significance of oxidative stress etc. on mitochondrial 
dysfunction, a clear direction for various prospective studies can be identified.                
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